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Abstract 
Maternal microbiota during pregnancy, as well as maternal disease state, may impact offspring gut 
bacterial colonisation. Here, we explore the impact of maternal antibiotics during gestation and/or 
nursing on offspring gut microbiota. Further, we investigate the effect of preconception helminth 
infections on maternal and infant gut microbiota. For maternal antibiotic experiments, dams were 
fed vancomycin, polymyxin B, or both, in drinking water during gestation, nursing or gestation 
plus nursing, and their offspring microbiota analysed at 14 days of life, alongside immunity in the 
spleens. Offspring born to vancomycin treated mothers had significantly higher relative abundance 
of Proteobacteria and Tenericutes while maternal oral polymyxin B led to significantly lower 
abundance of Proteobacteria and Deferribacteres in infants. Maternal oral vancomycin led to 
significant reduction in proportions of infant central memory CD4+ T cells 
(CD4+CD44hiCD62Lhi) regardless of antibiotic timing. Effector memory CD4+ T cells were 
significantly lower in pups born to dams treated with polymyxin B while nursing while proportions 
of central memory CD4 T cells were significantly increased in gestation only or gestation plus 
nursing pups. In addition, oral vancomycin in dams during nursing resulted in significantly reduced 
proportions of both total and follicular B cells in offspring born to antibiotic treated dams. Pups 
born to Vancomycin treated mothers had a significant delay in growth when infected with 
Respiratory Syncytial Virus (RSV). On the other hand, pups born to mothers treated with 
Polymyxin B during gestation or gestation plus nursing were susceptible to Nippostrongylus 
brasiliensis (Nb) infections. In the second study, we infected female BALB/c mice with 500Nb L3 
three weeks prior to mating and examined the effect of preconception helminth infection on 
offspring microbiota and immunity. Preconception Nb infections led to alterations of maternal gut 
microbiota during pregnancy. In addition, we observed dramatic differences in offspring 
microbiota in pups born to previously helminth infected dams. Coriobacteriaceae were 
predominant in pups born to previously Nb infected dams when compared to uninfected dams. 
Overall, manipulation of maternal microbiota during gestation or lactation profoundly impacts 
offspring growth, intestinal microbiota and immunity to RSV and helminths. 
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CHAPTER 1. 
1.0 Introduction 
1.1 Mammalian gut microbiota 
Virtually all multicellular organism live in close proximity with microbes and the human host is 
no exception. The human body is home to a range of microorganism including viruses, bacteria, 
fungi, archae and unicellular eukaryotes. These collection of microbes that coexist peacefully with 
their host has been referred to as the microbiota, normal flora, or microflora (Neish, 2009). While 
the gut is in continuous contact with these microbes, cells such as the endothelium must remain 
sterile for local function and for the health of an individual. These commensal bacteria have been 
demonstrated to affect our health in profound ways, bringing into the forefront the symbiotic 
relationship that exists between the microbes and the human host. The microbiota colonises 
virtually every part of our skin and body that is exposed to the external environment with the 
highest colonisation being in the gastrointestinal tract; particularly the colon which contains about 
70% of all microbes in the human body (Chiller et al., 2001; Ley et al., 2006b). Additionally, the 
gut is rich in various nutrients which are needed by commensals, making it a preferred site of 
colonisation. In terms of function, the gut microbiome plays key roles in regulating metabolic, 
immunological, physiological and gene expression patterns in the body (O’Hara & Shanahan, 
2006; Qin et al., 2010). In the current study, we were particularly interested in understanding how 
maternal helminth infections or antibiotic treatment impact neonatal gut colonisation and the 
ramifications of the inherited neonatal microbiome on neonatal immunity. Recently, it has been 
demonstrated that gut colonisation in neonates within a critical window period has lasting 
metabolic consequences (Cox et al., 2014; Nobel et al., 2015). This section will review some 
relevant literature on factors that influence gut colonisation in infants, host microbiome 
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interactions and the impact of early microbial gut composition on offspring susceptibility to 
disease. 
1.2 Factors that influence gut colonization 
Until a recent study by Aagaard et al, the placenta had been thought to be sterile, and the prevailing 
belief was that gut colonisation begins after birth when the infant comes into contact with the extra 
uterine environment. However, the placenta has been shown to harbour a low abundance but 
metabolically rich microbiome composed of non-pathogenic commensal bacteria from Firmicutes, 
Tenericutes, Fusobacteria, Bacteriodetes and Proteobacteria phyla. This profile was most akin to 
oral microbiome of nonpregnant humans (Aagaard et al., 2014; Carmen Collado et al., 2016). 
These data has bought into question the idea that the fetus is sterile, and indeed, recently, a number 
of studies have found bacteria present in meconium, the first infant stools (Ardissone et al., 2014; 
Hu et al., 2013; Jiménez et al., 2008). Regardless of when gut colonisation begins, the microbiome 
develops rapidly in the first years following birth, changing in both diversity and complexity before 
becoming stable at adulthood (Nylund et al., 2014). A series of factors influence gut colonisation 
in infants including gestational age, mode of delivery, host genetics, antibacterial drugs, lifestyle 
and diet (Alderete et al., 2015; Dominguez-Bello et al., 2010). 
1.2.1 Age 
The development of the microbiome is a rapidly changing process where individuals’ express 
different microbial profiles at different life stages (Fig. 1) (Power et al., 2014). Enterobacteriaceae, 
Streptococci and Staphylococci are predominant early in life (Marques et al., 2010). However, the 
recent improvement of hygienic conditions during delivery alongside shorter hospital stays have 
led to an alteration of the initial colonisation pattern with skin derived staphylococci being among 
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the first colonisers and not the fecal Enterobacteriaceae (Marques et al., 2010). Increase in the 
Caesarean (C-section) deliveries has fundamentally contributed to these colonisation pattern. 
 
Figure 1.1: (a) Variation in microbial numbers across the length of the gastrointestinal tract. (b). 
Factors affecting the establishment and maintenance of the microbiota. (Power et al., 2013). 
 
1.2.2 Mode of delivery 
The mode of delivery also impacts the microbiome. Vaginally born infants encounter microbes in 
the birth canal while infants born by caesarean section derive their first major microbe source from 
the environment, mainly the skin. Therefore, infants born via C section have lower intestinal 
bacteria counts and reduced diversity in the first weeks of life (Morelli, 2008). Neonates have been 
found to harbor communities that are undifferentiated across multiple body habitats regardless of 
delivery mode (Dominguez-Bello et al., 2010). Vaginally born infants acquire bacteria 
communities resembling their mothers vaginal microbiome dominated by Lactobacillus, 
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Prevotella or Sneathia species while C section infants harbored bacteria similar to those found on 
the skin surface dominated by Staphylococcus, Corynebacterium and Propionibacterium species 
(Dominguez-Bello et al., 2010). A recent systematic analysis by Rutayisire et al. observed that 
cesarean delivery was associated with both lower abundance and diversity of Actinobacteria and 
Bacteroidetes, and higher abundance and diversity of Firmicutes from birth to 3 months of life 
(Rutayisire et al., 2016). 
1.2.3 Mode of feeding and diet 
Breast-fed infants have a microbiota dominated by Bifidobacteria and Ruminococcus (Favier et 
al., 2002). In contrast, their formula-fed counterparts have a complex more diverse microbiota 
comprising Streptococcus, Bacteroides, Clostridium and Atopobium (Bezirtzoglou et al., 2011). 
Human milk oligosaccharides (HMO) are thought to function as growth factors for beneficial 
bacteria, inhibitory receptors for binding of various pathogens and may promote development of 
the early immune system (Kunz et al., 2000). Recently, more physiological formulas has been 
developed which contain prebiotics such as galactooligosaccharide and fructooligosaccharide 
which have been proven to increase the abundance of Bifidobacteria and Lactobacilli in the gut 
(Chen et al., 2014). 
Postpartum, diet is the greatest environmental factor that impacts the microbiome. Diet not only 
provides nutrients for the host but also bacteria in the gastrointestinal tract. Most enzymes required 
for the breakdown of the plant polysaccharides are not encoded by the mammalian genomes. 
Alterations in the bacteria composition in the gut occurs because different bacteria utilize different 
substrates as sources of energy (Bellei et al., 2012). Dietary history is associated with lifestyle, 
geography, cultural beliefs, and socioeconomic status. Significant differences in gut microbiota 
have been reported in people living in different environments and social status. In a study 
13 
 
comparing the intestinal microbiome of rural children in Burkina Faso who consumed plant 
derived diet with Italian children who consumed a low fiber diet, authors reported profound 
differences in the gut composition between the two groups (De Filippo et al., 2010). African 
children exhibited higher levels of Firmicutes than Bacteroidetes while the European children had 
an abundance of Enterobacteriaceae (Shigella and Escherichia). Others have compared the gut 
microbiota composition of Korean residents with those from other countries including USA and 
Japan (Nam et al., 2011).  UniFrac analysis revealed slight differences at the phyla level for each 
cohort with Americans exhibiting higher Firmicutes, Japanese having higher Actinobacteria while 
the Koreans had enrichment of Bacteroides (Nam et al., 2011). Therefore, it is plausible that the 
gut microbial composition is tied to long-term dietary patterns. 
1.2.3.1 Effect of breast milk on microbiota composition 
The human milk provides the infant gut with a rich bacteria consortium promoting the colonization 
of beneficial microbes that impact metabolism and help in programming immunity (Jeurink et al., 
2013). Human milk oligosaccharides (HMO) are vital in promoting development of normal infant 
physiology and immune development. As has been discussed above, the gut microbiota of breast-
fed infants has been characterized to be less diverse and as having a high abundance of 
Bifidobacteria and Lactobacillus when compared to their nonbreast-fed counterparts. Recently, 
Bifidobacteriaceae (61%), Enterobacteriaceae (8%) and Coriobacteriaceae (6%) were identified as 
the most abundant taxa in the stool of breast-fed babies (Tannock et al., 2013). Regardless of mode 
of feeding, the composition of the gut bacteria begins to change with the introduction of solid foods 
at weaning (Palmer et al., 2007). Although the source of bacteria in human milk is not clear, it is 
now established that the human milk plays a central role in shaping the neonatal gut early in life. 
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1.2.4 Antibiotics 
Antibiotics were designed to help in the treatment of infections by targeting pathogenic organisms. 
Depending on their spectrum of activity, they can potentially disrupt the native gut community. 
Previous studies have described this as the etiology of some antibiotic-associated diarrhea and why 
probiotics are often administered during broad-spectrum antibiotic therapy (Hickson, 2011; 
McFarland, 2006). However, antibiotic administration can interfere with the coevolved 
interactions of the commensals with their host. Various studies have demonstrated the role of 
antibiotics in driving dramatic alterations of the microbiome both in adults and neonates (Cox et 
al., 2014; Nobel et al., 2015; Tormo-Badia et al., 2014). Generally, antibiotic treatment leads to 
reduction in diversity and richness in the gut communities (Jernberg et al., 2007). Nonetheless, the 
microbiome has potential to recover after weeks of withdrawal of treatment to the pre-treatment 
state (Claesson et al., 2011; Dethlefsen & Relman, 2011). However, in some cases, microbial 
changes persist long after withdrawal from treatment and some bacteria are permanently lost from 
the native community (Dethlefsen & Relman, 2011; Jakobsson et al., 2014; Jernberg et al., 2007). 
1.2.5 Probiotics 
The World Health Organization’s (WHO) 2001 definition of probiotics is, “live micro-organisms 
which when administered in adequate amounts can confer health benefits to the host (WHO, 2001). 
Studies have shown their impact in favorable influence of the stability of the microflora, inhibition 
of pathogen colonization and stimulation of specific and nonspecific components of the immune 
system (Kalliomaki et al., 2003). Furthermore, probiotics have been suggested as potential 
therapeutic agents in lowering necrotizing enterocolitis among preterm infants and preventing 
infections in immunocompromised patients (Guillemard et al., 2010; Martin & Walker, 2008). In 
addition, probiotics have been shown to have a role in ameliorating various disorders. Lee et al. 
have shown the anti-obesity effects of Lactobacillus rhamnosus PL60 in diet induced obesity study 
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conducted in mouse models ( Lee et al., 2006). Johnson-Henry et al. demonstrated that probiotics 
(Lactobacillus rhamnosus and Lactobacillus acidophilus) attenuate the effects of Citrobacter 
rodentium in mouse models (Johnson‐Henry et al., 2005). Moreover, a proliferative 
Bifidobacterium strain in the gut has been reported to ameliorate progression of metabolic 
disorders via microbiota modulation and acetate elevation (Aoki et al., 2017). 
1.2.6 Prebiotics 
Prebiotics are nondigestible food components that stimulate the selective growth of particular 
microbes in the gut that confer beneficial outcomes to the host (Roberfroid, 2007). Some prebiotic 
rich-foods have been reported to regulate the gut microbiota by elevating the levels of 
Bifidobacteria and Lactobacilli (Kleessen et al., 2007). 
1.3 Microbiome and health 
The human gut microbiota confers health benefits to the host in multiple ways, including by 
protecting against colonization by pathogens. The microbiota serves as a physical barrier mainly 
by formation of microbial biofilms (Macfarlane & Dillon, 2007), and protect  against pathogen 
colonization by competitive exclusion and by secretion of antimicrobial compounds (Belkaid & 
Hand, 2014). For example, members of the genera Lactobacillus release lactic acid which have an 
inhibitory activity towards the growth of bacteria and also potentiates the antimicrobial activity of 
the host lysozyme (Alakomi et al., 2000). The microbiota also stimulates the production of 
antimicrobial compounds by the host mucosa. Various compounds, including cathelicidins, 
defensins and C-type lectins are released in the mammalian gastrointestinal tract (GIT) and act by 
disrupting surfaces of both commensals and pathogenic bacteria (Salzman et al., 2007). In addition 
to production by microbial cells, microbial metabolites also have potential to lead to expression of 
antimicrobial peptides in vivo and in several cell lines. Short chain fatty acids led to the production 
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of LL-37 cathelicidins by human lung epithelial cells (Kida et al., 2006). Therefore, it is likely that 
the presence of gut commensal bacteria and their metabolites contribute towards expression of 
antimicrobial peptides thus protecting the host against colonization by pathogens and also 
preventing an overgrowth of the commensals themselves. 
1.3.1 Microbiome and disease 
Gut colonization within a critical window period early in life has been shown to have lasting 
metabolic consequences and  can have effects on later immunity (Cox et al., 2014; Nobel et al., 
2015). Aberrations in the adult microbiome has also been linked to various diseases and disorders 
including allergic disease and asthma (Trompette et al., 2014), colon cancer (Scanlan et al., 2008), 
autoimmune diseases (Candon et al., 2015), obesity (Ley et al., 2005), type 1 diabetes (Scott, 
1996), and even progression and severity of HIV (Gori et al., 2008). Disruption in the native 
microbiome, referred to as dysbiosis is accompanied by an overgrowth of pathogenic organisms 
and fungi and loss of particular functional groups from the microbial ecosystem (Manichanh et al., 
2006). This in turn results in inflammatory responses by the host which contributes to diseases and 
various disorders (Gori et al., 2008; Stecher et al., 2007). Further, gut dysbiosis has been linked to 
the imbalance between T helper and anti-inflammatory T regulatory cells in the host. Prolonged 
overproduction of Th1 and Th17 cytokines has been linked to Inflammatory Bowel Disease (IBD) 
as well as other autoimmune conditions for example Multiple Sclerosis and Systemic Lupus 
Erythematosus (Cultural & Lloreda, 2011; Fujino et al., 2003). Consequently, host driven 
inflammatory responses disrupt the gut microbiota further and permanently eliminate commensal 
bacteria and allow for colonization by the pathogenic microbes which maintain an inflammatory 
state (Fujino et al., 2003). Recently, helminth infections have been shown to impact the microbiota 
and to attenuate pathology associated with allergic asthma in a microbiota dependent manner 
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(Zaiss et al., 2015). Reynolds and others linked Heligmosomoides polygyrus to the expansion of 
lactobacillus species in murine models (Reynolds et al., 2014), while Broadhurst demonstrated 
how helminths interact with resident bacteria communities to drive control against diarrhea 
(Broadhurst et al., 2012).  Furthermore, a recent study revealed that enteric helminth infection can 
have protective antiviral effects in the lung through the induction of a microbiota-dependent type 
1 interferon response (McFarlane et al., 2017). Helminths remain endemic in sub Saharan Africa 
and susceptibility is enhanced during gestation (de Silva et al., 2003; Yatich et al., 2009). Yet 
whether the interplay between maternal helminth infections and the microbiota impact offspring 
microbiota as well as immunity is unknown. Importantly, a dysbiotic gut microbiota has a reduced 
microbial diversity; a characteristic that has been associated with microbiome associated disorders. 
Reduction in diversity following gut dysbiosis leads to a loss of key bacteria taxa that are butyrate 
producers. Butyrate is an important gene regulator and serves as an energy source for particular 
mucosa associated microbial groups (Canani et al., 2011). 
1.3.2 Prenatal exposure to microbes and microbial compounds 
The fetus has long been believed to be biologically sterile before birth but this dogma has recently 
been challenged with the discovery of a placenta microbiome (Aagaard et al., 2014; Carmen 
Collado et al., 2016). Further, reports of bacteria in amniotic fluid suggest that the fetus is 
continuously exposed to microbes in utero. Recent studies have determined that predisposition to 
disease may at least in part be determined in utero. Maternal exposure to stimuli during pregnancy 
programs postnatal immunity and susceptibility to allergic conditions (Penders et al., 2006). A 
large European study revealed that mothers exposed to farm animals during pregnancy were less 
likely to have children who developed allergies later adulthood (Schaub et al., 2009a). Thus it is 
plausible that microbiota exposure in utero impacted neonatal immune responses and increased 
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numbers of regulatory T cells dampening TH2 responses in cord blood which drive allergic 
responses (Fujimura et al., 2010). 
Similarly, maternal exposure to pets has also been shown to protect against allergic disease 
development (De Meer et al., 2005) and this protection is thought to be microbiome dependent. 
Pet exposure has been associated with reduced cord blood levels of IgE (Niladri et al., 2008), 
elevated levels leads to development of allergic disorders (Bergmann et al., 1997). Wegienka et 
al. also demonstrated that exposure of pregnant women to pets is associated with enhanced T 
regulatory cell numbers (Wegienka et al., 2009) suggesting that the protective role of pet exposure 
against allergic conditions may in part be mediated by T regulatory cells (Schaub et al., 2009a). 
The dogma that microbial exposure in utero is central in defining development of immunity 
postnatally is further supported by a study showing that parental dietary lifestyle during gestation 
and lactation impacts neonatal microbiome and response to infection (Myles et al., 2013). Parental 
high fat diet during gestation or nursing resulted in alteration in offspring gut microbiome and poor 
clinical outcomes when offspring are subjected to bacterial challenge (Myles et al., 2013). 
However, whether these prenatal exposures to stimuli directly or indirectly impact offspring 
immunity is not well understood. Further, as to whether alterations in neonatal immunity are 
mediated by the microbes themselves or their metabolites through other pathways remains to be 
elucidated. 
1.4 Early life microbiota 
The first fecal specimen to be produced by the infant is termed the “meconium”. This consists of 
mainly the amniotic fluid, intestinal epithelial cells and pancreatic secretions (Kumagai et al., 
2007). Recent reports have described a meconium microbiome providing strong evidence that 
neonatal colonization begins long before birth (Hu et al., 2013; Moles et al., 2013). A number of 
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bacteria phyla including Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria have been 
detected in meconium (Hu et al., 2013; Moles et al., 2013). Vaginally born infants acquire bacteria 
communities resembling their mothers vaginal microbiome dominated by Lactobacillus, 
Prevotella or Sneathia species while C section infants harbored bacteria similar to those found on 
the skin surface dominated by Staphylococcus, Corynebacterium and Propionibacterium species 
(Dominguez-Bello et al., 2010). Postpartum, diet is the greatest determinant of microbiome 
colonization. Majority of breast-fed infants have an increased abundance of Bifidobacteria in their 
fecal microbiome which persists to three months after birth (Turroni et al., 2012). In contrast, 
formula-fed infants have a reduced abundance of Bifidobacteria, which form approximately 25% 
of their microbiota composition (Roger & McCartney, 2010). 
At weaning, as infants start to feed on solid food, the abundance of Bifidobacteria begins to 
decrease gradually to around 60% at 4 months, 25% at 6 months and 10% at 2 years (Avershina et 
al., 2014; Nylund et al., 2013). Simultaneously, the abundance of Lactobacilli decreases while 
bacteria abundant in the adult microbiota including Bacteroidetes and Clostridium cluster XIVa 
and XIV increase (Fallani et al., 2011). However, bacterial abundances early in life vary greatly 
due to interindividual variations and will fluctuate further due to different environmental stimuli 
including dietary lifestyle and antibiotic exposure (Avershina et al., 2014; Koenig et al., 2011; 
Palmer et al., 2007). However, considering the physiological processes and changes that the human 
host undergoes including adolescence and the impact this could have on the developing 
microbiome, it is plausible that the gut consortia of bacteria continues to change over time and 
only stabilizes at adulthood.  
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1.5 Metagenomic technology for microbial community analysis 
Sequencing and phylogenetic analysis of 16S rRNA has provided the foundation for modern study 
of microbial communities (Zhou et al., 2015). PCR based 16S RRNA cloning analysis has driven 
the explosion of information about community membership and vastly expanded the known 
diversity of microbial life. Community DNA is extracted from environmental samples using 
various extraction and purification kits (Hurt et al., 2001). Once high quality DNA is obtained, 
targeted genes are amplified with conserved primers. Each set of primers is generally barcoded for 
sample multiplexing (Caporaso et al., 2012). Non target DNA are removed by gel electrophoresis, 
target DNA quantified, sequenced and analyzed by bioinformatic approaches (Zhou et al., 2015). 
After quality filtering, sequences are clustered into operational taxonomic units (OTUs, sometimes 
referred to as phylotypes) which provide a working name for groups or related bacteria. OTUs are 
based on sequence identity (97%) and the degree of sequence variability will depend on the 16S 
region in question (Goodrich et al., 2014). The OTUs are then assigned to their corresponding 
bacteria taxonomy using a reference 16S bacteria data base such as Greengenes (McDonald et al., 
2012). Many OTUs will lack a complete taxonomy label, for example an OTUs may be annotated 
to the family level but lack the genus or species level. Abundances can then either be assessed at 
higher levels such as order or family by summing up the sequences for all OTUs belonging to the 
group of interest (collapsing taxonomies) or picking OTUs at a lower threshold (%) which can in 
turn yield different results (Goodrich et al., 2014). 
1.6 The Immune system 
The immune system is an organization of cells with specialized roles in defending the body against 
pathogens including bacteria, viruses, and fungi among others. There are two types of responses 
following infection: Innate immunity which is historically thought to occur in the same way no 
matter the number of times the same infection is encountered while the adaptive immune response 
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improves with repeated exposure to the same infection (Parkin & Cohen, 2001). Recent 
observations have challenged the notion of innate immunity being nonspecific and lacking in 
immunological memory (Netea et al., 2011; Stevens et al., 2016). An increasing body of evidence 
suggests that exposure to pathogens lead not only to specific immunological memory (T and B 
cells) but also an enhanced innate immune response. Memory properties have been proposed for 
NK and macrophages, which are prototypical cells for innate immunity following first encounter 
with antigen which has led to the term “trained immunity” being proposed (Netea et al., 2011). 
The concept of trained immunity is whereby a heightened response to a secondary infection is 
exerted both towards the same organism and a different one, and therefore in a sense, have 
“memory” (Netea et al., 2011; Stevens et al., 2016). Phagocytic cells (neutrophils, macrophages 
and monocytes), and those that release inflammatory mediators (basophils, mast cells and 
eosinophils) as well as natural killer cells are involved in innate immunity (Delves, 2000). 
Adaptive immune responses involve the proliferation of antigen specific B and T cells which 
occurs when the surface receptors of these cells bind to specific antigens. Specialized cells called 
antigen presenting cells (APCs) process the antigen and present it on their surface in the correct 
MHC complex to T cells. Therefore, the T-cell receptor (TCR) recognizes an individual’s own 
MHC molecule (self) together with peptides derived from foreign antigen. The adaptive immune 
response is the hallmark of the immune system in higher animals and has immunological memory 
which enables the mounting of a stronger immune response although this is not immediate (Delves, 
2000). 
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1.6.1 Innate Immunity 
1.6.1.1 Neutrophils 
Neutrophil recruitment to the site of infection and phagocytosis and killing of pathogens is central 
to innate immunity (Janeway, 2001). The same process occurring inappropriately can lead to 
inflammation and tissue damage and injury. Like most immune cells, neutrophils are not static and 
travel through the body. They move freely from a marginating pool in response to proinflammatory 
mediators, chemokines and adhesion molecules (Andrian & Mackay, 2000). 
1.6.1.2 Complement 
The complement system has several important functions in innate immunity and consists of about 
20 serum glycoproteins with some being regulatory (Parkin & Cohen, 2001). These proteins are 
activated in a cascade sequence with the activation of a single molecule leading to thousands of 
molecules being generated. There are three pathways involved in the complement system: the 
classical pathway, activated by antigen antibody complex, alternative pathway by polysaccharides 
from yeast and gram negative bacteria, and most recently described, the lectin pathway which 
activates complement by stimulations of mannose containing lectins (Andrian & Mackay, 2000). 
1.6.1.3 Innate lymphoid cells (ILCs) 
ILCs are a growing family of immune cells that mirror the phenotypes and functions of T cells. 
They include natural killer (NK) cells which are considered innate counterparts of cytotoxic CD8 
T cells and ILC1, ILC2 and ILC3 which may represent the innate counterparts of TH1, TH2 and 
TH17 respectively (Cherrier et al., 2012). ILCs play fundamental roles in processes such as 
cytotoxicity, lymphoid organogenesis, intestinal homeostasis and immunity against infections 
(Hwang & Mckenzie, 2013). However, in contrast to T cells, ILCs do not express antigen receptors 
or undergo clonal selection and expansion when stimulated (Eberl et al., 2015). 
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1.6.1.3.1 Natural killer cells 
These cells have the morphology of lymphocytes but lack the antigen specific receptor. They 
recognize abnormal cells in either of two ways: first is by the antibody receptor (Fc) on their 
surface that enables them to bind to antibody-antigen complexes and drive killing by antibody 
dependent cellular cytotoxicity (ADCC) or by recognition of antigens presented to them in the 
MHC class I complex (Parkin & Cohen, 2001). NK cells are activated in the absence of MHC 1 
expression (Mandal & Viswanathan, 2015) and tolerized towards normal cells by their expression 
of germline-encoded inhibitory receptors that recognize MHC I (Campbell, 2013). However, when 
mature NK cells encounter abnormal cells that do not express MHC I, inhibitory receptors are not 
engaged which triggers targeted attack of the cell (Campbell, 2013). The principal inhibitor 
receptors are killer cell Ig-like receptors (KIR) in humans and Ly49 in mice. Activating receptors 
expressed on NK cells include FcRIIIA, activating forms of KIR (KIR2DS, KIR3DS) and the 
Natural Cytotoxicity Receptors (NCR) called NKp30, NKp44 AND NKp46 (Campbell, 2013). 
FcRIIIA triggers ADCC upon encounter with cells opsonized with IgG while NCR are key in 
stimulating responses against tumor cells (Huntington, 2014).  
1.6.1.3.2 ILC1s 
ILC1s are largely non cytotoxic lineage negative cells that produce Interferon gamma and tumour 
necrosis factor and have been implicated in immunity to intracellular bacteria and parasites (Klose 
et al., 2014). 
1.6.1.3.3 ILC2s 
ILC2s are derived from the lymphoid lineage and express a combination of hematopoietic (CD45, 
sca-1) and lymphoid markers (IL-7Rα, ICOS, Thy 1.2 and CD44) (Kabata et al., 2015; Neill et al., 
2010). They produce TH2 cell associated cytokines (including IL-4, IL-13, IL-5 and IL-9) and 
promote type 2 inflammation which is central for helminth immunity, allergic inflammation and 
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tissue repair (Kabata et al., 2015; Price et al., 2010). Type 2 ILCs do not differentiate into other 
lineage cell types in the presence of SCF and IL-13 suggesting that they are terminally 
differentiated (Neill et al., 2010). 
1.6.1.3.4 ILC3s 
ILC3s produce IL-17A, IL-17F,IL-22, granulocyte macrophage (GM) colony stimulating factor 
(CSF) and TNF and can promote immunity against bacteria, chronic inflammation and tissue repair 
(Satoh-Takayama et al., 2008; Sonnenberg et al., 2011). In mice, two subsets can be distinguished 
on the basis of their expression of the chemokine receptor CCR6 while in humans almost all ILC3s 
express CCR6 and CD117, and at least two subsets can be distinguished on the basis of the 
expression of natural cytotoxicity receptor NKp44 (Satoh-Takayama et al., 2008; Sonnenberg et 
al., 2011). 
1.6.1.4 γδ-T cells 
γδ- T cells are one of the immune cell types that express antigen receptors that undergo somatic 
recombination, and they contribute to immune responses to infection, cellular transformation and 
tissue damage (Vantourout & Hayday, 2013). They develop in the thymus generating their 
signature receptor via RAG-mediated V (D) J recombination. Key properties that distinguish these 
T cells from the αβ T cells include their ability to recognize qualitatively distinct antigens, fact that 
they are suited for protection of defined anatomical sites, are of primary value in young animals 
and although not invariably important, γδ- T cells mediate critical responses to specific pathogens 
in a manner similar to NK cells (review (Vantourout & Hayday, 2013). 
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1.6.1.5 Eosinophils 
Eosinophils are innate immune granulocytes best recognized for their cytotoxic effector functions, 
causing damage to parasitic pathogens in helminth infections, and to host tissues in allergic disease 
(Shamri et al., 2011). Interleukin-5 is produced by several cell types and is responsible for the 
maturation and release of eosinophils in the bone marrow (Greenfeder et al., 2001; Nakajima & 
Takatsu, 2007). 
1.6.1.6 Mast cells and basophils 
Mast cells and basophils are relatively few in the body, yet are involved in some of the most severe 
immunological reactions, for example anaphylaxis. These cells have high affinity receptors for Ig 
E and once bound and crosslinked, there is degranulation and release of preformed mediators such 
as serotonin, amines and histamines (Delves, 2000). 
1.6.2 Adaptive Immunity 
The adaptive immune response is characterized using antigen specific receptors on T and B cells 
to drive targeted effector response in two stages; first the antigen is presented to and recognized 
by the corresponding T cell leading to cell priming, activation and proliferation which occurs in 
specific areas of the lymphoid tissue. Second, the effector response occurs either due to the 
activated T cell leaving the lymphoid organs and homing to the disease site, or the release of 
antibodies by activated B cells (plasma cells) into blood and tissue fluids (Parkin & Cohen, 2001). 
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1.6.2.1 T lymphocytes 
The major class of T cells is defined by surface expression of αβ T cell receptor (TCR). Individual 
T cells bear antigen specific TCRs (Chaplin, 2010). This receptor has evolved to enable antigen 
recognition by both MHC class I and II proteins. Further, these T cells differentiate primarily into 
T cell subsets that enable killing of cells infected by intracellular pathogens (CD8+ T cells) or 
those that regulate both cellular and humoral responses (CD4+ T cells) (Chaplin, 2010). T cell 
development occurs in the thymus which contains three compartments. The first termed the sub 
capsular zone is where bone marrow derived pro-thymocytes differentiate and rearrange their TCR 
β chains. In the second, the thymic cortex, there is rearrangement of the α chain eventually forming 
a functional TCR chain (Janeway, 2001). In addition, the cells test whether these receptors have 
sufficient affinity to recognize self MHC antigen complex which involves the interaction between 
the developing lymphocytes and the cortical epithelium (Nitta et al., 2008). Lymphocytes that fail 
this positive selection process are cleared by thymic cortical macrophages. Finally, cells are 
screened for potential autoreactivity in the thymic medulla. Cells recognizing self-peptides that are 
expressed by the thymic epithelial cells are removed by apoptosis. T cells that survive this negative 
selection are then exported to the circulation which normally constitute less than 5% of the total 
developing T cells (Chaplin, 2010). 
1.6.2.1.1 T cell sub populations 
During their migration within the thymus, αβ T cell differentiate into several T cell subsets each 
with different effector functions. In the thymus, most T cells follow a developmental program 
where they first express neither CD8 nor CD4 (double negatives) and then express both CD8 and 
CD4 (double positives) (Chaplin, 2010). These double positives then undergo positive selection 
and those selected on MHC class I molecules become CD4-CD8+ while those selected on MHC 
class II molecules become CD4+CD8-. Both CD4+ and CD8+ differentiate into functionally 
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distinct subsets when they experienced their cognate antigens. CD4 T cells are involved in multiple 
functions ranging from activation of cells of the innate immune system, B-lymphocytes, cytotoxic 
T cells and immune regulation. They differentiate into various subsets including TH1, TH2, TH17, 
TH9 and T regulatory cells. This differentiation is controlled by a complex network of specific 
cytokine signaling and transcription factors allowed by epigenetic modifications (Luckheeram et 
al., 2012). IL-12, IFN-gamma and the transcription factor T bet drive the differentiation into TH1 
cells (Trinchieri et al., 2003) while IL-4, IL-2 and STAT6 are critical for TH2 differentiation 
(Kaplan et al., 1996). 
1.6.2.2 B lymphocytes 
B-lymphocytes constitute about 15% of peripheral leukocytes in blood. B cells produce antibodies 
which serves a range of functions including: neutralizing toxins, preventing organisms adhering to 
mucosal surfaces, activating complement, opsonising bacteria, and also antibody dependent 
cellular cytotoxicity (Parkin & Cohen, 2001). They differentiate from hematopoietic stem cells in 
the bone marrow where their antigenic receptors are assembled in a RAG-1/RAG-2 mediated 
process similar to the development of the TCR in T cells (Thomas et al., 2009). Akin to the TCR, 
the fully mature B lymphocyte also express the transmembrane proteins Igα and Igβ involved in 
intracellular signaling following antigenic exposure (Khan, 2009). Moreover B cells have a co-
receptor complex comprising CD19, CD81 and CD21 which is activated by binding to the 
activated complement protein C3d (Carroll, 2008). 
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Figure 1.2: Innate and adaptive immunity. Innate immunity provides initial defense against 
infection. Adaptive immune responses develop later and consist of lymphocyte activation (From 
the immunology textbook by Abul Abbas, 7th edition). 
  
1.7 Neonatal immunity 
The neonatal immune system is considered “immature” and is functionally different from the adult 
immune system (Basha et al., 2014). Maternal IgG that crosses the placenta barrier contribute to 
neonatal protection early in life (Virella et al., 1972). However, this protection is short lived, as 
the amount of antibody wanes after birth. Moreover, IgA antibodies are continuously supplied 
through breastmilk from the mother and protect the gastrointestinal tract against colonization by 
pathogens without having an effect on the immune responses (Edwards, 2015; Niewiesk, 2014). 
Infant cellular immunity develops within the first three months and this process is influenced by 
multiple factors (Hodgins & Shewen, 2012; Siegrist, 2007). 
1.7.1 Neonatal cellular immunity 
T cell progenitors that express CD34 receptors migrate to the thymus and differentiate into mature 
CD4+ and CD8+ cells after 7 weeks of gestation (Borgella et al., 2013). Human studies 
demonstrate that multi-potent lymphoid progenitors (CD34+CD7+ and CD34+CD10+CD19+) 
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differentiate to become B cells (Hodgins & Shewen, 2012; Siegrist, 2007). Development of the 
neonatal lymphoid progenitors is influenced by multiple factors including cytokines, stromal cells, 
transcription factors and extracellular matrix components (Basha et al., 2014). Moreover, in utero 
exposure to allergens, microbial infections or maternal immune-mediated disease can also impact 
fetal immunity, postnatal immune development and susceptibility to disease later in life. Earlier 
studies revealed that maternal infections with malaria in the third trimester of pregnancy are 
strongly associated with increased neonatal susceptibility to malaria (Borgella et al., 2013). 
Similarly, maternal filarial infections influence neonatal immunity and drive imbalanced cytokine 
levels in plasma (Achary et al., 2013). In humans, maternal HIV infection may impact neonatal 
immunity and susceptibility to infection (Kidzeru et al., 2014). Other factors such as maternal 
nutritional imbalance, both deficiency or excess also impact neonatal immunity (Fisher et al., 
2012). 
1.7.2 Neonatal innate immunity 
Neonatal innate immune components include granulocytes (mostly neutrophils), antigen 
presenting cells, natural killer and γδ-T cells (Wynn & Levy., 2014). 
1.7.2.1 Pattern recognition receptors (PRRs) 
The immune system is equipped with receptors called PRRs to detect pathogens such as bacteria 
and viruses. PRRs are divided into 4 families: (1) Toll-like receptors (TLRs), Nucleotide 
oligomerization receptors (NLRs), C-type lectin receptors (CLRs) and Retinoic acid inducible 
gene-like receptors (RLRs) as reviewed by (Philbin & Levy, 2009). These receptors recognize 
conserved molecular structures of pathogens called pathogen associated molecular patters 
(PAMPs). These motifs are specific to the micro-organism and essential for its viability. Activation 
of PRRs on antigen presenting cells enhances co-stimulatory function, and thus PRRs agonists are 
30 
 
potential vaccine adjuvants (Philbin & Levy, 2009). Toll-like receptors are the most extensively 
studied and are so far composed of 11 members in mammals named TLR1 to 11 and are specialized 
in recognition of conserved molecular structures in bacteria, viruses, fungi and parasites 
(Thompson et al., 2011). 
1.7.2.2 Neonatal neutrophils 
Neutrophils form a major component of innate immunity and are responsible for engulfing 
pathogens and killing them by phagocytosis. They form the highest number (70-75%) of immune 
cells in human blood (Willems et al., 2009). However, neonatal neutrophils have qualitative and 
quantitative deficiencies. For example, they have a lower surface expression of Toll-like receptor 
4 (TLR4) but similar level of expression of TLR2 when compared to adults (Melvan et al., 2011). 
In addition to a deficits in TLR expression on neonatal neutrophils, they also have deficiencies in 
downstream signaling via the MyD88 adaptor molecule following stimulation (Melvan et al., 
2011). 
In addition, neonatal neutrophils respond poorly to Fas-mediated apoptosis and this has been 
associated with low surface expression of the Fas receptor (Howard & Meyer, 1984). Similarly, 
these neutrophils are defective in making Neutrophils Extracellular Traps (NETs), which comprise 
granules that are vital for the killing of extracellular bacteria (Willems et al., 2009). In summary, 
functional deficits in neonatal neutrophils enhance susceptibility to neonatal sepsis. 
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1.7.2.3 Neonatal APCs 
Neonatal APCs are mainly monocytes and dendritic cells. Neonatal monocytes have a low level 
of expression of MHC class II which contributes to impaired antigen presentation ( Holloway & 
Warner, 2002). 
Toll like receptors (TLRs) expressed on neonatal dendritic cells, monocytes and other immune 
cells are important in early response to pathogens (Medzhitov & Janeway 2000). However, 
maturation and functional differences of these TLR mediated signaling and associated effector 
cytokines are different from adults. In general, neonatal monocytes, conventional dendritic (cDC) 
cells and plasmacytoid (pDC) dendritic cells exhibit and altered immunological profile with low 
level expression of MHC II, CD80, CD86, CD40 and ICAM-1, and are biased towards TH2 
environment which leaves them susceptible to microbial infections and also results in poor 
responses to certain vaccines (Basha et al., 2014). Neonatal T cells have a reduced capacity to 
produce TH1 cytokine (IFN-γ) but this capacity is enhanced when these T cells are cultured with 
adult, rather than cord, APCs suggesting that APCs lack the capacity to deliver important TH1 
polarizing signals (Delespesse et al., 1998). While reports suggest that neonatal and adult 
peripheral blood mononuclear cells (PBMCs) synthesize equivalent amounts of IL-12p40, 
secretion of bioactive IL-12p70 by cord blood  is generally thought to be defective (reviewed 
(Upham et al., 2002). Reduction of IL-12 production drives impairment of TH1 responses but this 
can be corrected by provision of exogenous IL-12 (reviewed (Upham et al., 2002). Recent studies 
in the neonatal mouse have revealed that lung CD103+ DC are functionally limited in infants and 
CD11b+ DC are diminished in both numbers and function which affects the cross presentation and 
the CD8 T cell effector response (Ruckwardt et al., 2014). Further, CD103+ DC in the gut are also 
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thought to be involved in establishment of oral tolerance as they interact with naïve T cell and 
drive differentiation into FOXP3+ T regulatory which prevent food allergies (Stern et al., 2013).  
1.7.2.4 Neonatal NK cells 
Neonatal blood counts of NK cells are higher than adults with a higher expression of the inhibitory 
receptor CD94/NKG2A (Guilmot et al., 2011). NK cells are activated upon contact with DCs, 
monocyte/macrophages and cytokines (Guilmot et al., 2011). Activated NK cells drive effector 
functions by releasing large amounts of IFN-γ (Guilmot et al., 2011). However, the natural killer 
cytotoxic capability of neonatal NK cells is 3-fold lower than that of adults (Dalle et al., 2005). 
The capacity of neonatal NK cells to produce effector cytokines is highly reduced when compared 
to adults. The impaired ability of cord blood to produce IL-12 and IFN-γ may impair NK cell 
functionality (Suen et al., 1998). Neonatal NK cells are central in the resolution of severe acute 
respiratory infections such as respiratory syncytial virus and influenza (Culley, 2009). 
1.7.2.5 Neonatal γδ-T cells 
γδ- T cells represent less than 5% of the total lymphocytes in the peripheral blood and a lower 
percentage in cord blood. This subset of T cells provides the first response to microbial infections 
including Mycobacterium tuberculosis, Listeria monocytogenes and Brucella arbutus. Further, 
they release substantial amounts of IFN-γ as part of their effector mechanism among other 
cytotoxic responses. Moreover, human cord blood γδ- T cells have lower levels of perforin and 
granzymeB effector molecules (Moens et al., 2011). γ/δ T cells do not migrate to the thymus and 
play a central role in protection from microbial infections in early life. Murine studies reveal that 
these T cells stimulate dendritic cells to release cytokines thus activating specific immunity (Shi 
et al., 2011). 
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1.7.3 Neonatal adaptive immunity 
1.7.3.1 Neonatal T cells 
The α/β T-cells migrate to the thymus where they undergo various developmental stages and 
finally become either CD4+ or CD8+ T cells. They then leave the thymus in a phenotypically and 
functionally immature state called recent thymic emigrants (RTEs) (Fink, 2013). 
1.7.3.2 Neonatal CD4 T cells 
Murine studies have revealed that CD4+ Recent Thymic Emigrants (RTEs) are biased towards the 
production of IL-4, IL-13 and IL-5 as compared to their mature naïve counterparts (Hendricks et 
al., 2011). In neonatal humans CD4+ RTEs proliferate in response to IL-7 in the absence of TCR 
stimulation (Opiela et al., 2009). The TH2 bias of neonatal CD4+ is revealed at the chromatin level 
where the TH2 cytokine locus is hypo-methylated and subject to enhanced transcription (Webster 
et al., 2007). A number of studies have shown that the environment in utero could provide some 
co-stimulatory signals that influence the TH cell differentiation profile and could help establish 
particular subsets early during immune development (Basha et al., 2014) 
Differentiation into either TH17 or Treg populations depends on the local cytokine environment. 
An abundance of TGF-β, IL-6 and IL-21 drive naïve T cell differentiation into TH17 cells while 
IL-2 induces TGF-β treated cells to differentiate into T regulatory cells (FOXP3+) (Zheng, 2013). 
Tregs are important in maintaining immunologic tolerance and negatively regulate various 
immune response. Regulatory T cells (CD4+CD25+FOXP3+) encompass two categories of 
lymphocytes that are distinct in origin, antigen specificity as well as stimuli driving differentiation 
(Chatenoud, 2011). Natural Tregs are an independent lineage generated in the thymus by high 
avidity interactions with their T cell receptor and are specific for self-antigens (Chatenoud, 2011; 
Curotto de Lafaille & Lafaille, 2009). Adaptive or induced Tregs stem from mature CD4+CD25-
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FOXP3- precursors under subimmunogenic antigen presentation, during chronic inflammation and 
during normal gut homeostasis (Curotto de Lafaille & Lafaille, 2009). They are essential in 
mucosal immune tolerance and in control of chronic allergic inflammation (Chatenoud, 2011). 
These regulatory cells are present in high numbers at infancy, both in human cord blood and 
neonatal lymph nodes (Burt, 2013). Fetal naïve T cells demonstrate a greater propensity to 
differentiate into T regs in response to maternal antigens that cross the placenta (Mold et al., 2008). 
Further, maternal CD4+CD25+FOXP3+ Tregs control maternal alloreactivity to the developing 
fetus and help in establishing central tolerance during pregnancy (Schumacher & Zenclussen, 
2014). 
1.7.3.4 Neonatal CD8 T cells 
Human cord blood and neonatal murine studies demonstrate deficiencies in numbers and 
functionality of the CD8+ response early in life (McCarron & Reen, 2010). Recently, human 
neonatal CD8+ T cells have been shown to be less toxic than adult cells and do not produce the 
degranulation molecule, granzyme B (Galindo-Albarran et al., 2016). Murine studies have shown 
that infantile CD8+ responses are distinct and are influenced by inherent T cell properties in RSV 
infected mice (Ruckwardt et al., 2014). Impairment of neonatal CD8+ response is also in part due 
to the decreased APC expression of CD80 and CD86 (Ruckwardt et al., 2014). CD8 T lymphocytes 
are important in immunity against intracellular pathogens, antiviral and antitumor immunity. 
Human infants mount adult-like CD8 T cell responses to viral infections and DNA vaccines 
(Zhang et al., 2002). 
1.7.3.5 Neonatal B cells 
Neonatal B cells are immature and naïve largely due to lack of antigenic exposure with consequent 
poorly developed immunoglobulin repertoire on the surface (Walker et al., 2011). Human infants 
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have high numbers of B cells increasing gradually from the first weeks and remaining high for the 
first year (Walker et al., 2011). Based on the expression of surface CD5, B cells can be categorized 
into B-1 and B-2 B cells.  B-1 class of B cells differ functionally from the B-2 and has a natural Ig 
repertoire, and are vital for early immunity against bacterial and viral infections. They express 
CD11b+, high levels of IgM (sIgM) and low levels of secreted IgD (sIgD), CD21, CD23 and 
CD45R (B220) (Ghosn et al., 2008). Furthermore, this class has been demonstrated to be involved 
in T independent antibody production and protect against Borrelia hermsii (Alugupalli et al., 
2004). Studies on neonatal B cells have shown the deficiencies in antibody production following 
T independent stimulation with pneumococcal polysaccharides (Klein Klouwenberg & Bont, 
2008). Stimulation of human neonatal B cells following the CD40 co-stimulatory signal alongside 
IL-4 signaling results in increased expression of the B cell receptor (BCR) negative regulator 
(CD22) and lowers the magnitude of the BCR signaling (Tian et al., 2006). Overall, neonates have 
underdeveloped germinal centers in the lymph nodes and spleens and low-level expression of B 
cell receptors including CD40, CD80, and CD86, which result in deficiencies in IgG responses to 
primary infections and vaccination. 
1.8 Microbiome and immunity 
The innate and the adaptive arms of the immune system work together to direct appropriate 
response to invading pathogens and they make up the host immune system (Iwasaki et al., 2015). 
The immune system and the intestinal microbiota develop and evolve together beginning at birth 
or possibly start in utero (Aagaard et al., 2014). This mutual maturation starting early in life is 
central to development of tolerance and avoidance of unwanted immune responses to microbial 
components which could be deleterious to the host (Tomkovich & Jobin, 2015). The concept of 
the microbiome influencing immunity is better understood in germ free mouse models. Germ free 
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mice lack intestinal microbiota. These animals have abnormal numbers of immune cells and have 
deficits in both local and systemic immune structures. For example, their spleens and lymph nodes 
are poorly formed and they exhibit reduced levels of IgA and cytokine production (Bouskra et al., 
2008). The incomplete nature of the immune system in the germ-free mice highlight the 
importance of gut microbes in immune development. Studies in mouse models show that the 
presence and the composition of the microbiota are critical in promoting effective immune 
response to pathogens and maintaining homeostasis (Maynard et al., 2012). However, whether the 
species of commensal present influence the type of memory T cells that reside there is not known. 
Although memory T cells specific for commensal bacteria have recently been detected in mice 
(Hand et al., 2012), they are associated with a pathogenic infection and could be due to a 
dysregulated immune system. In humans, memory T cells survive longer and are exposed to more 
antigens during their lifetime, thus commensal specific responses may be part of healthy immune 
balance between microflora and indigenous T cells (Farber et al., 2014). 
1.8.1 Intestinal effects 
The rapid early changes in the microbiota coincide with the development of the immune system. 
Throughout this developmental period, the innate immune system plays a key role in protecting 
the infants from invasion by pathogens (Tomkovich & Jobin, 2015). IgA present in breast milk 
prevents immune activation in infants and helps protect against pathogenic microbes. Similarly, 
this antibody is produced in the intestinal tract and helps in maintaining homeostasis throughout 
life (Belkaid, 2013). Recently, a study has shown that Proteobacteria; dominant in newborns; 
trigger the induction of IgA which in mouse models which was central in control of Proteobacteria 
colonization in adulthood (Mirpuri et al., 2014). In addition, 16S sequencing of the rRNA gene 
revealed Sutterella species to be partly responsible for variable IgA levels probably by degrading 
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the IgA secretory component (Tomkovich & Jobin, 2015). Evidence shows that the microbiota 
continues to impact immunity long after attaining stability. For example, antibiotic induced 
alterations of the gut microbiome which reduces Clostridiales members among others, reduces 
intestinal T regulatory cells and alter colonic thymic T reg repertoire indicating that microbes are 
key influencers in the dynamics of T regulatory cells in the gut (Cebula et al., 2013). These findings 
support previous work where indigenous Clostridia species have been shown to induce colonic T 
regulatory cells via SCFA production (Atarashi et al., 2011, 2013). 
Among the most studied class of microbes are the segmented filamentous bacteria (SFB), which 
colonise the terminal ileum in mice. SFB, previously known as Candidatus arthromitus, are 
closely related to the genus Clostridium and have been shown to induce  IgA and expand the T 
helper 17 immune subset (Ericsson et al., 2014). Goto et al. demonstrated that TH17 cells reside 
in the ileum rather than peyers patches or the mesenteric lymph node ( Goto et al., 2014). These 
authors also provide evidence that MHCII presentation by innate lymphoid cells may inhibit Th17 
differentiation. Important to note is that SFB have not been detected in the human GIT, but there 
is evidence that human cell lines support its growth (Schnupf et al., 2015). Although majority of 
the microbiota reside in the gut, the microbiome in extra-intestinal regions also influence local 
host immunity (Surana & Kasper, 2014). 
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Figure 1.3: The microbiota affects local and systemic immunity. The intestine contains the greatest 
number of microbiota and diversity. From Tomkovich & Christian (2015). 
 
1.8.2 Bacterial components that effect innate and adaptive immunity 
1.8.2.1 Structures detected by pattern recognition receptors 
The innate immune system detects microbial components through several pattern recognition 
receptors that are found on the surface of macrophages, dendritic cells and epithelial cells (Iris K. 
Pang and Akiko Iwasaki, 2012).  Bacteroides fragilis polysaccharide A (PSA) is one of the most 
characterized bacterial immunomodulators. PSA is recognized by toll like receptor-2 (TLR2) and 
influences T cell development and homeostasis (Troy & Kasper, 2010). TLR5 which is expressed 
on several intestinal epithelial cells and dendritic cells recognizes bacterial flagellins (Tomkovich 
& Jobin, 2015). TLR5 signaling influences microbiota composition and host immune response 
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(Chassaing et al., 2014). Recent work has shown that the microbiota also impacts vaccine 
responses to inactivated influenza vaccine via TLR5 mediated signaling (Oh et al., 2014). 
Nod like receptors (NLRs) also recognize bacterial components particularly the peptidoglycan 
through muramyl dipeptide. Studies using the NOD2-/- mice reveal reduced intraepithelial 
lymphocytes (IEL), and administration of muramyl dipeptide to antibiotic treated mice restores the 
numbers of IEL via the elevation of IL-15, suggesting that Nod2 mediated sensing of the 
microbiota impacts IEL homeostasis (Jiang et al., 2013). 
1.8.2.2 Metabolites 
Metabolites are intermediates or by-products of diet dependent commensal bacterial metabolism 
and are normally present in the millimolar range. These metabolites serve as signaling molecules 
for interbacteria communication and quorum sensing (Shapiro et al., 2014). 
1.8.2.2.1 Short-chain fatty acids 
Diet profoundly impacts on the composition and function of the microbiota (David et al., 2014). 
Components of the human diet include plant-derived polysaccharides such as cellulose, which are 
only broken down by the resident gut bacteria. Bacterial metabolism of these polysaccharides 
produces short chain fatty acids (SCFA) which are about 1-6 carbons in length, including acetate, 
propionate and butyrate (Shapiro et al., 2014). SCFA receptors include GPR41, GPR43 and 
GPR109A (Shapiro et al., 2014). Recently, SCFA have been described as key regulators of host 
metabolism and immunity. These metabolites dampen inflammatory responses through GPR43 
and studies show that mice deficient in this receptor are susceptible to colitis, arthritis and asthma 
(Maslowski et al., 2009). Further, SCFA have been shown to expand the number and suppressive 
function of colonic T regulatory cells through Treg intrinsic expression of GPR43 (Smith et al., 
2013). Similarly, propionate has been shown to have the potential to enhance peripheral T 
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regulatory cell subset (Arpaia et al., 2013). Other SCFA also impact on host immunity. For 
example butyrate, which acts as a histone deacetylase inhibitor, dampens the production of pro-
inflammatory cytokines by intestinal mononuclear phagocytes (Chang et al., 2014). Moreover, 
butyrate also exerts anti-inflammatory function acting via the GPR109A receptor (Singh et al., 
2014).  
SCFA have likewise been shown to impact brain development and the central nervous system. 
Germ free mice have deficits in the microglial maturation as well as poor responses to 
lipopolysaccharides. However the microglial maturation is restored when a mixture of propionate, 
butyrate and acetate is administered in drinking water (Erny et al., 2015). Therefore, SCFAs impact 
both innate and adaptive immunity in the intestines (Fig. 1.4) (Tomkovich & Jobin, 2015). The 
relevance of other metabolites including serotonin and tryptophan has also been described (Shapiro 
et al., 2014). Serotonin, a neurotransmitter, is synthesized through the interaction of the host and 
its microbiome and acts locally to regulate gastrointestinal, cardiac, respiratory and endocrine 
functions as well as crossing the blood brain barrier (Berger et al., 2009). Serotonin is derived from 
tryptophan by tryptophan hydroxylases -1 or -2 (Walther, 2003), while tryptophan is obtained from 
dietary or microbial sources (Young, 2013). Germ free mice have lower levels of serotonin, 
tryptophan and indole compared to conventionally raised of humanized mice (Marcobal et al., 
2013). Bacteria phyla including Proteobacteria, Firmicutes and Actinobacteria have been 
implicated in tryptophan biosynthesis (Yanofsky, 2004) 
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Figure 1.4: Bacteria components that affect innate and adaptive immunity in the intestines. 
(Tomkovich et al., 2015). 
 
1.8.3 Maternal factors influencing prenatal immune development the neonatal gut. 
There is constant cross talk between the mother and fetus which impacts fetal development. 
Therefore, maternal exposure to environmental stimuli, including microbes, during pregnancy can 
influence fetal immune development.  
1.8.3.1 Maternal diet 
Maternal malnutrition can severely compromise fetal growth and maturation of the fetal immune 
system (Hovdenak & Haram, 2012). Maternal undernutrition leads to deficiencies in important 
nutrients required by the fetus including minerals and vitamins. In addition, dietary lifestyle during 
pregnancy impacts on the developing neonatal gut community and immunity. For example, a 
recent murine study reveal that parental high fat diet during gestation alters infant microbiome and 
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leads to poor clinical outcomes to bacterial challenge among her offspring (Myles et al., 2013). 
Similarly, pups born to obese mothers have decreased lymphocyte count and reduced antigen 
specific antibody production implying that maternal obesity is detrimental to the developing infant 
immunity (Odaka et al., 2010). Maternal obesity is also associated with abnormal feto-placental 
function and increased disease risk in general (Kristensen et al, 2005). 
1.8.3.2 Animal exposures 
As already highlighted, maternal exposure to farm animals impacts neonatal immunity and can 
protect against the development of allergies and asthma (Ege et al., 2006; Schaub et al., 2009a). 
These prenatal exposures led to an increase in the numbers of T regulatory cells in cord blood 
which ameliorated the effects of allergy mediated by Th2 cytokines. Pet exposure is also associated 
with lower cord blood levels of IgE; which is associated with the development of allergies 
(Bergmann et al., 1997). Similar findings were reported by Aichbhaumik et al. who found that 
mothers with either cats or dogs in their home during pregnancy delivered children with lower 
cord blood IgE compared to mothers who did not live with these pets (Aichbhaumik et al., 2008). 
Others have shown that protection from allergy when exposed to farm dust is mediated via the 
induction of an ubiquitin modifying enzyme, A20 (Schuijs et al., 2015). While it is not clear what 
the mechanism of allergic protection is when infants are exposed to pets or farm animals, it is 
tempting to speculate that part of the environmental effect can be explained by the modulation of 
the microbiota composition. 
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1.8.3.3 Maternal disease and infection status 
Maternal disease and infection status prior to conception and during pregnancy can influence 
neonatal gut microbiome and immune development. Diversified microbiota in the meconium has 
been reported in infants born to diabetic mothers (Hu et al., 2013). Commensal bacteria from the 
maternal gut have been isolated from umbilical cord blood of healthy neonates born by caesarean 
section (Jimenez et al., 2005) and oral bacteria have been found in the placenta and amniotic fluid 
in healthy term pregnancies(Jimenez et al., 2005). Thus, it is likely that maternal dysbiosis could 
impact offspring intestinal microbiome. A recent study has also shown that maternal HIV status 
impact infant gut microbiome (Bender et al., 2016). 
1.8.3.4 Effect of antibiotics on gut microbiome and disease outcomes 
Antibiotic perturbations of the rapidly developing neonatal gut has consequences on health, as this 
may contribute towards programming of metabolism and immunity and may dictate future actions 
of the immune system. The impact of antibiotics on the intestinal microbiome has recently been 
investigated through a variety of “omic” techniques as has been reviewed (Franzosa et al., 2015). 
Further, reports show that short-term parental antibiotic intake may influence the composition and 
type of bacteria colonizing the infant gut. Indeed, it has recently been demonstrated in a mouse 
models that antibiotic administration during gestation or while nursing has lasting metabolic 
consequences in the offspring (Cox et al., 2014; Nobel et al., 2015). Here, the authors showed that 
altering the gut microbiome using low dose penicillin within a critical window period at infancy 
was sufficient to drive far reaching metabolic consequences that persisted to adulthood. Similarly, 
Choe et al. have shown that early life exposure of mice to sub-therapeutic doses of antibiotics, 
alongside the alteration of the intestinal microbiome resulted in increased total and relative body 
fat mass, bone density and microbiota driven production of short chain fatty acids and an altered 
hepatic metabolism (Cho et al., 2012). Apart from these obesity related traits, antibiotics have also 
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been implicated in other conditions. For example, antibiotics have been shown to increase the risk 
of type 1 diabetes (Candon et al., 2015). Furthermore, early antibiotic exposure reduced infant gut 
diversity and altered bacteria composition with a reduction of Bifidobacteria and increases in the 
abundance of Proteobacteria. Untreated infants born to mothers treated with antibiotics prior to 
delivery revealed the same gut alterations as treated infants (Tanaka et al., 2009). 
Antibiotic driven gut alterations can also impact basic immune development and could have other 
far-reaching long term repercussions. Atopic, inflammatory and autoimmune diseases have been 
associated with gut dysbiosis and in some cases significant associations have been drawn between 
development of these conditions and early antibiotic intake (Arrieta et al., 2015; Foliaki et al., 
2009; Murk et al., 2011).  A recent meta-analysis found that antibiotics exposure during pregnancy 
may increase the risk of asthma/wheeze in childhood (Zhao et al., 2015). However, the authors 
noted that availability of various confounding factors, for example, impact of maternal asthma on 
childhood asthma may influence associations. Therefore, prospective studies with large cohorts 
should be conducted to assess whether the associations were causal. Consequently, there is still no 
consensus whether antibiotic use at infancy increase susceptibility to asthma and allergies. There 
are still gaps in current knowledge and fundamental questions that remain unanswered. The impact 
of antibiotics on neonatal infections such as respiratory syncytial virus is unclear. How maternal 
use of broad spectrum antibiotics during gestation or while nursing impact infant disease outcomes 
remain to be conclusively investigated. 
Importantly, most of these studies have used orally bioavailable antibiotics as penicillin in their 
studies. These antibiotics could therefore potentially have effects beyond just alteration of the gut 
microbiome.  Data are limited on the impact of alteration of maternal gut microbiome in isolation, 
using broad-spectrum antibiotics that are poorly absorbed from the gut, during gestation and 
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nursing on infant microbiome, immunity and development. Whether alteration of only the maternal 
gut bacteria (and not microbiota elsewhere such as vagina or breast milk) during gestation or 
lactation is sufficient to influence neonatal gut community and immunity is not clear. 
 
Figure 1.5: Antibiotic effects on the gut microbiome and associated effects (Francino et al., 2016). 
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1.9 Experimental models of infection 
1.9.1 Helminthiasis 
Approximately a quarter of the world’s population is infected with helminths with majority 
residing in developing countries (Hotez & Kamath, 2009). 750-1300 million people are infected 
with hookworms and this is restricted to sub Saharan Africa, Latin America and South East Asia 
(Hotez & Kamath, 2009). Helminths are largely successive parasites that establish long lasting 
infections in the definitive host. They compete for nutrients with the host and result in 
immunological pathology as they migrate through various tissues (Finlay et al., 2014). Children 
are more vulnerable to infection and harbor greater worm burdens as compared to adults, reviewed 
in (Hotez et al., 2008). Furthermore, helminth infections have serious effects in children including 
growth retardation, anemia, impairment in cognitive development and reduced physical fitness 
(Crompton, 2002). Studies have revealed a strong association between maternal helminth 
infections and altered offspring health and development. Maternal helminth infections could lead 
to maternal malnutrition and anemia, which ultimately result in low birth weight among neonates, 
a risk factor for disease later in life (Gluckman, 2008). In terms of childhood immunizations, 
children born to mothers in sub-Saharan Africa have been shown to respond poorly to BCG, 
Typhoid and Measles vaccinations (Labeaud et al., 2009). Protective immunity to helminths is 
mediated by TH2 cells and the cytokines they produce including IL-4, IL-5, IL-10 and IL-13 
(Maizels et al., 2012). These responses rarely kill the parasite but they limit their viability and 
reproducibility in the human host and contribute to their expulsion from mucosal barriers. Most of 
the understanding of helminth immunity has been from murine infection models. 
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1.9.1.1 Nippostrongylus brasiliensis 
Nippostrongylus brasiliensis (N. brasiliensis) is a rat gastrointestinal nematode that establishes 
acute infections in wildtype mice. Worms are generally cleared after 9 days leaving behind 
sustained memory against secondary infections (Finkelman et al., 2004). N. brasiliensis is similar 
biochemically and physiologically to the human hookworms, Necator americanus and 
Ancylostoma duodenale. For this reason, this murine infection model has been used to understand 
the pathogenesis of human hookworm (Else & Finkelman, 1998). It is easy to handle in the 
laboratory as it does not require an intermediate host and is not fatal to rodents. Also this parasite 
is not infectious to the human host (Camberis et al., 2003). 
1.9.1.1.1 Life cycle of N. brasiliensis 
Infection occurs by the L3 larvae stage which is injected subcutaneously in animal models. Once 
under the skin, the larvae migrates in circulation to the lungs where they are trapped in the 
capillaries, undergo maturation and moulting to the L4 stage, and subsequently enter the 
pulmonary alveoli within 24-48 hours (Finkelman et al., 2004; Reece et al., 2008). They then move 
up the trachea and are swallowed back to the gastrointestinal tract by day 4-5 post infection. The 
L4 stage find their way into the small intestines where they undergo the final moult (L5) into 
mature adults. Here the adult worms establish themselves and lodge into the intestinal epithelium, 
mate and produce eggs by day 6 post infection, which then leave the host in feces (Zhao et al., 
2007). In BALB/c mice, egg production stops at day 9 post infection when the worms are expelled 
due to robust immune response from the host (Reece et al., 2008). N. brasiliensis induced IL-13 
stimulation of the intestinal cells has been demonstrated to be the likely cause of worm expulsion 
from an immunocompetent host during a primary infection (Finkelman et al., 2004). 
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Figure 1.6: Life cycle of primary N. brasiliensis infection. There is no intermediate host. Eggs 
leave the host in feces. L3 larvae is the infective stage. 
 
1.9.1.1.2 Primary immunity to N. brasiliensis 
TH2 cells orchestrate helminth immunity through the production of signature cytokines that direct 
and activate other cell types which synergistically act to expel the worm from the host. An effective 
anti-helminth response includes eosinophilia, basophilia, goblet cell hyperplasia and mucus 
secretion, CD4 T cell dependent secretion of cytokines (IL-4, IL-13, IL-9 and IL-5) as well as 
isotype class switching in B cells to produce antigen specific IgG1 (Finkelman et al., 2004; Urban 
et al., 1998). IL-4 acts by binding both IL-4R and the IL-13R resulting in STAT6 activation. 
Moreover, both receptors share the IL-4Rα subunit which is a critical receptor for optimal helminth 
immunity (Finkelman et al., 2004). IL-4 is also key in driving isotype class switching in B cells 
leading to the production of antigen specific IgG1 (mouse), IgG4 (human) and IgE. N. brasiliensis 
leads to alternative activation of macrophages (M2) which induce fibrosis through the expression 
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of fibronectin and matrix metalloproteinases (Maizels et al., 2004). Although IL-4 is central in 
orchestrating TH2 immunity, it is not required for expulsion of N. brasiliensis from the host. 
However, IL-13, IL-4Rα and STAT6 activation are critical for worm clearance indicating that 
particular facets of TH2 work together to drive optimal helminth immunity ( Urban et al., 1998). 
Overall. IL-4 orchestrates a TH2 immune responses and signals B cells to initiate antibody 
production, while IL-13 stimulates intestinal cells and smooth muscle expulsion of worms from 
the intestines. Both cytokines signal through a common receptor, IL-4Rα, which is critical for anti-
helminth immunity. 
1.9.2 Respiratory syncytial virus 
Respiratory syncytial virus (RSV) is the commonest cause of bronchiolitis in children under 5 
years and is estimated to cause 3.4 million hospitalization and at least 66,000 deaths annually 
around the world (Hall et al., 2012). Childhood asthma and wheezing has also been linked to RSV 
infections in infancy (Welliver, 2003). Immunity to re-infection is partial, as infection with 
antigenically similar strains occurs throughout life (reviewed in Lambert et al., 2014). Moreover, 
RSV infection results in production of Th2 cytokine leading to eosinophilic infiltration into the 
lung which drives lung pathology and airway hypersensitivity (Matsuse et al., 2000). Much of the 
available information on RSV pathogenesis is derived from animal models. However, it is unclear 
how the available murine data on RSV accurately represents human disease. In particular, the adult 
mouse has historically been used to study immunity to RSV. It is likely that some of the 
discrepancies between human and animal data could be due to the use of adult mice to mimic the 
immunological environment in human infants. Therefore, a corrective measure could be the use of 
neonatal or infant mice as a model for human RSV infection in infants. There exists no vaccine 
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against RSV, which necessitates the need to better understand immunity to RSV as a way of 
reducing the global mortality and morbidity associated with RSV infections.  
1.9.2.1 Virology of RSV 
Respiratory syncytial virus is an enveloped, non-segmented, negative strand RNA virus of the 
order paramyxoviridae. It is comprised of a 15.2kb genome with 10 genes encoding a total of 11 
proteins as depicted in a recent review (Lambert et al., 2014). Antibody responses to RSV infection 
target two major proteins: F and the highly glycosylated G protein. Antigenic variability in protein 
G accounts for the majority of the differences between the two major RSV strains (A and B). The 
F protein promotes fusion of viral and cell membrane resulting in the transfer of viral genetic 
material and the fusion of infected and adjacent cell membranes causing the formation of syncytia 
(Domachowske & Rosenberg, 1999) Moreover, RSV infections are confined to the respiratory 
mucosa and do not disseminate to other organs or blood. 
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Figure 1.7: Structure of RSV virus. The 15.2kb negative sense  
RNA RSV genome consisting of 10 genes encoding 11 proteins.  
(Figure from Lambert et al., 2014). 
1.9.2.2 Pathogenesis and Pathophysiology 
Transmission of RSV occurs through inoculation of the nasopharyngeal mucosa with respiratory 
secretions from infected individuals. The incubation period ranges from 2-8 days and 
immunocompetent individuals can shed the virus for up to 3 weeks (Piedimonte & Perez, 2014). 
Infection starts in the nasopharyngeal epithelium then spreads through the lower airways reaching 
the terminal bronchioles where replication of the virus is most efficient (Piedimonte & Perez, 
2014). Several observations suggest that immunological mechanisms may be the key to the 
severity of RSV bronchiolitis in infancy. For example, RSV-induced cytokines and chemokines 
recruit and activate neutrophils, monocytes, eosinophils , dendritic and T cells which in addition 
to fixed lung macrophages, produce proinflammatory mediators such as TNF-α and 
cyclooxygenase which contribute to lung damage and pathology (Pribul et al., 2008). This acute 
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inflammatory changes following RSV replication leads to airway obstruction and air trapping, 
producing the classic clinical triad of polyphonic wheezing, patchy atelectasis and bilateral 
hyperinflation (Piedimonte & Perez, 2014). Airway obstruction in infants has a greater clinical 
significance compared to obstruction in adults. Sloughed necrotic epithelium and excessive mucus 
production also add to airway obstruction and the formation of mucus plugs (Mcnamara & Smyth, 
2002). Therefore, disease severity and duration are primarily a function of the immune response 
mounted by the host. 
1.9.2.3 Mouse RSV model 
The most widely used model for human RSV are the inbred laboratory mouse strains because of 
ease of housing and handling them, availability of wide variety of transgenic and gene-deletion 
mice as well as immunopathological pathways (Bem et al., 2011). However, they are at best a 
semi-permissive host, their lung anatomy is much simpler compared to humans and do not mirror 
clinical manifestations observed in humans as signs of illness include weight loss, ruffled fur and 
lethargy. In addition, the virus is a human pathogen and replicates poorly in mice thus requiring 
high inoculums for productive infection and induction of pathology (reviewed (Cormier et al., 
2010)). Despite these differences, many of the immunological responses of mice to RSV infection 
are similar to humans and the use of the mouse model has enhanced understanding of RSV 
pathogenesis (Openshaw, 1995). Cormier et al. estimated that 77% of RSV published studies have 
been carried out in mice (Cormier et al., 2010).  Majority of studies using animal models have 
been performed in adult animal models. It can be argued that the use of adult animal models could 
be a contributing factor to the discrepancies between human and mouse data. Current data suggest 
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that a more relevant model for the human infant is the neonatal mouse (Culley, 2009; Harker et al, 
2014). 
1.9.2.4 Immune response to RSV infection 
Data are limited on neonatal immune responses to RSV, especially at the site of disease (lung) 
rather than in peripheral blood; human studies of lung pathology are not feasible. Consequently, 
much of the available information is derived from animal studies, clinical trial in human adults or 
very few severe cases in babies in which postmortem analyses were performed. Tissue analysis 
has revealed that the virus infects the superficial ciliated cells of the upper airway, the epithelium 
of the bronchioles, and the type 1 pneumocytes (Johnson et al., 2007). Reports suggest that severe 
disease is characterized by higher viral loads and a paucity of lymphocytes in the lung (Welliver 
et al., 2007). Maternal RSV specific antibodies generated before or during pregnancy are 
transferred via the placenta or breastmilk and can influence offspring RSV and other vaccine 
responses (Guzman Sanchez-Schmitz, 2011). Viral detection occurs through pattern recognition 
receptors (PRRs) expressed on the surface of fibroblast, epithelial cells and antigen presenting 
cells of the respiratory tract. Some PRRs that are central to RSV recognition include TLR3, TLR4, 
TLR 2/6 and TLR7/8 [reviewed in (Kolli, Velayutham, & Casola, 2013)]. Once the host immune 
system detects the virus, pro-inflammatory responses are initiated leading to production of 
cytokines which then trigger cell recruitment into the airways. Ruckwardt and colleagues revealed 
imbalances in particular DC subsets in neonates infected with RSV with an increase of 
CD103+CD11c+ cells found in the lymph nodes (Ruckwardt et al., 2014). Natural killer cells are 
also important in RSV control in murine models providing an early source of IFN-γ, which activate 
DCs and primes T cell response, as well as destroying virus infected cells (Culley, 2009). However, 
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there is no consensus as to whether NK cells contribute to protection or immunopathology in 
human infants. 
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CHAPTER 2 
2.0 CURRENT STUDY 
2.1 Background 
As discussed above, the gut microbiota plays significant roles in maintaining our homeostasis and 
ability to combat disease (Atarashi et al., 2011; Nistal et al., 2012; Nylund et al., 2014). The 
composition of bacterial species colonizing our gut influence our immune system (Round, 
O’Connell, & Mazmanian, 2010). Indeed, recent evidence demonstrates that the immune system 
and the microbiota evolve concomitantly starting at birth or possibly in utero (Aagaard et al., 
2014). Infant acquisition of microbiota and how this pioneer microbiota could impact on immune 
development and disease susceptibility is an area actively under investigation. Until recent work 
by Aagaard and others showing the placenta to harbor a unique microbiome, the fetus was believed 
to be sterile and to be only colonized after birth (Aagaard et al., 2014). Various factors impact 
infant gut colonisation majority of which are derived from the mother. Maternal disease and 
infections alter infant microbiome. Helminth infections are endemic in sub Saharan Africa and 
susceptibility has been shown to be enhanced during gestation (de Silva et al., 2003; Yatich et al., 
2009). Yet whether, maternal helminth infections impact infant gut microbiome and immunity is 
unknown. 
It is also apparent that antibiotics profoundly impact the microbiota (Cox et al., 2014; Nobel et al., 
2015). Generally, antibiotic treatment leads to reduction in diversity and richness in the gut 
communities (Jernberg et al., 2007). These drugs are widely used during pregnancy in the 
treatment of respiratory, sexual and urinary tract infections. However, how the unintended gut 
dysbiosis driven by maternal antibiotic use during either pregnancy or lactation could influence 
offspring gut microbiota as well as immune development remains to be elucidated. In addition, 
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whether manipulation of maternal microbiome during pregnancy and/or lactation has 
consequences on offspring ability to control infections is not clear to us. 
2.2 Objectives 
Although the fetus has for a long time been considered sterile, recent findings show that 
colonization may infact begin in utero. Therefore, the maternal microbiome during the last 
trimester of pregnancy could be important in influencing infant gut composition. Maternal 
helminth infections have been shown to be enhanced during pregnancy with recent data showing 
the impact of helminths on the microbiota. Further, administration of antibiotics to mothers during 
pregnancy and lactation are likely to impart on the bacteria that are transferred to her offspring 
possibly in utero or in breast milk respectively. Our primary objective was to evaluate the effect 
of maternal gut microbiome manipulation on infant microbiome and consequent immunity. To do 
this, we utilized two models. First, we utilize oral broad-spectrum antibiotics (vancomycin and 
polymyxin B) to study the effects of manipulating maternal microbiome during gestation and/or 
nursing on offspring intestinal microbiota and immunity to various challenge models. Second, we 
investigate the role of preconception maternal helminth infections on infant microbiome as well 
as immunity. We had two hypotheses: (1) Antibiotic driven manipulation of maternal gut 
microbiota during gestation and/or nursing impacts offspring intestinal microbiota and results in 
increased susceptibility to infections. (2) Preconception helminth infections alter infant 
microbiome and immunity. The aims of this study were: 
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1. To investigate the effect of maternal oral broad spectrum antibiotics on offspring intestinal 
microbiota and immunity 
2. To determine the ability of offspring born to antibiotic breeders to control Respiratory 
Syncytial Virus and Nippostrongylus brasiliensis infections. 
3. To investigate the impact of preconception helminth infections on infant gut microbiome 
and immunity 
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CHAPTER 3. 
3.0 MATERIALS AND METHODS 
3.1 Maternal oral antibiotics and the impact on infant gut microbiota and immunity 
3.1.1 Mice, mating and litters 
Female BALB/c mice, 6-8weeks of age, were used for these experiments. For mating, two females 
and an adult male per group were housed in the same cage for 7 days after which the male was 
removed. Dams were treated with antibiotics (vancomycin, polymyxin B or both) in drinking water 
for 5 days prior to giving birth (gestation group), for 14 days after delivery (nursing group), or for 
5 days prior to birth until 14 days postpartum (gestation plus nursing group). There were no 
antibiotics administered to the control dams. We investigated the effect of single antibiotics when 
administered at various phases as well as a mixture of these antibiotics on offspring growth, gut 
microbiome and immunity. This timing was informed by our preliminary study where we observed 
that antibiotic exposure from conception to delivery had no effect on infant body weight and 
immunity at 14 days. Cox et al found that antibiotic treatment 3 days prior to delivery had lasting 
metabolic consequences in offspring (Cox et al., 2014), indicating that maternal antibiotics are 
most consequential when administered in the last trimester of pregnancy. 
3.1.2 Experimental design 
Two, 6 week old female BALB/c mice were used per group. Controls dams were not subjected to 
any antibiotic treatment. Offspring from the four groups were then killed day 14 postpartum 
alongside their mothers for microbiome and immune analysis. We analysed pups at 14 days for 
two reasons: (1) Pups are still breastfeeding and have not yet begun coprophagic behaviour which 
allows us to examine impact of an altered maternal microbiome transferred via nursing (2) A 
neonatal period of 1-2 weeks has been established by previous studies where mice are able to elicit 
an antibody response suggesting establishment of the adaptive immune response (Brandt et al., 
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1997; Siegrist, 2001). This critical period allowed us to examine how the establishment of 
microbiota and immunity impacted each other. Fecal samples were collected from individual pups 
from their colons. Spleens were collected for immunological analysis. 
3.1.2.1 Antibiotics 
Vancomycin and Pomymyxin B (PMB) were used each at a concentration of 1mg/ml and were 
administered orally in drinking water. Vancomycin is produced by Actinobacteria species and acts 
by inhibiting proper cell wall synthesis in gram positive bacteria while Polymyxin B is derived 
from Bacillus and is active against gram negative bacteria. It acts by altering outer membrane 
permeability in gram negative bacteria leading to cell death 
 
Figure 3.1: Schema of maternal antibiotic experiments. Dams are treated with antibiotics during 
gestation, nursing, gestation plus nursing or not treated at all. Pups are killed two weeks postpartum 
for microbiome and immune analysis. 
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3.1.3 Immunological challenges 
3.1.3.1 Respiratory syncytial virus (RSV) infections 
RSV A2 viral strain is maintained in the Horsnell’s lab in the Division of Immunology, University 
of Cape Town. Briefly, the virus is maintained by propagating in HEp-2 cells and the viral titer 
determined by plaque assay or PCR. Viral stocks are frozen down at -80°C until infection. 3-week-
old pups were anesthetized and infected intranasally with 8 X105 PFU in a volume of 40µl. RSV 
inoculum per g body weight and killed 4 or 8 days post infection.  
3.1.3.2 Quantification of viral RNA 
Viral RNA in the lungs of RSV infected infants was quantified by PCR according to (Culley et al., 
2002). RNA was extracted from the lungs using the RNeasy mini kit (Qiagen, CA) and cDNA 
generated with random hexamers using the transcription cDNA synthesis kit (Roche). PCR 
specific for RSV L gene was performed at 95°C for 5 minutes followed by 45 cycles (15s at 95°C, 
15s at 60°C, 10s at 72°C and 1s at 68°C) using SYBR green master mix (Roche) and 900nM 
forward primer (5-GAACTCAGTGTAGGTAGAATGTTTGCA-3), 300nM reverse primer (5-
TTCAGCTATCATTTTCTCTGCCAAT-3). We used cDNA obtained from day 4 post-infection 
to generate standard curves with a 10fold dilution starting at 106 copies/μl. Melting curve analysis 
was performed at the end of the PCR to determine if the SYBG/DNA intercalation assay produced 
single specific PCR products. 
 
 
 
61 
 
3.2 Preconception helminth infections and influence on infant microbiome 
3.2.1 Mice, mating and litters 
Female BALB/c mice from University of Cape Town specific pathogen free (SPF) facility were 
used. Mice were kept under SPF conditions (light/dark cycles of 12h) in ventilated cages equipped 
with standard bedding, filter tops, environmental enrichment and fed standard diet and autoclaved 
water ad libitum.  
3.2.2 Parasite and Infections 
Female mice were injected with 500 Nippostrongylus brasiliensis (Nb) L3 larvae subcutaneously 
in 200µl of 0.9% NaCl using a 21G needle ensuring the larvae were in suspension. The infection 
was then cleared 7 days post infection by treating mice with Ivermectin (10mg/ml, VetServ) in 
drinking water for 7 days. An immunocompetent host expels the Nb adult worms in feces at day 
9-12 post infection (Panhuys et al., 2013). Deworming of mice was to ensure we investigate impact 
of Nb associated memory and not Nb antigen, prior to conception and how this imprint on the 
offspring. One week after Ivermectin treatment (three weeks post N.b infection), mice were mated. 
Control mice were not infected but were treated with Ivermectin in the same fashion as infected 
mice. 
3.2.3 Experimental Design 
6-week-old BALB/c female mice housed in separate cages were infected subcutaneously with 500 
Nb L3. Mice were dewormed by Ivermectin (VetServ) treatment 7 days postinfection and mated 
three weeks post infection. Control mice were not infected but were treated with ivermectin and 
mated simultaneously alongside the experimental mice. Male BALB/c were used for mating. For 
mating, two, 6-week-old female mice were housed in a single cage with a single male for 8 days 
after which the male was removed. Females gave birth 21 days post fertilization and the pups were 
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culled to 6 pups per mother and monitored daily for 14 days. Maternal fecal samples for 
microbiome analysis were collected between day 16 and 19 of gestation. Pups were sacrificed by 
cervical dislocation after inhalation of halothane at day 14 postpartum and fecal samples collected 
from their colons for microbiome analysis. Breast milk samples from pups’ stomach were also 
collected for microbiome analysis. Spleens and mesenteric lymph nodes were collected for 
immune analysis. 
 
Figure 3.2: Schema of the maternal helminth experiments. 6-week-old female mice are infected 
with 500Nb L3 three weeks prior to mating. Pups are killed 14 days postpartum 
 
3.2.4 Nippostrongylus brasiliensis (Nb) 
3.2.4.1 Maintenance of Nb 
Nb is maintained by Horsnell’s lab at the Division of Immunology, University of Cape Town. 
Briefly, naïve rats are infected subcutaneously with 5000Nb L3 per rat every two weeks. Rat fecal 
pellets are collected on day 6, 7 and 8-post infection and liquefied in 5µg/ml Fungizone then 
incubated in moist filter paper in petri dishes at room temperature. The larvae hatch after 7 days 
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and migrate to the edge of the filter paper where they are harvested at the L3 stage and used for 
future infections. 
3.2.4.2 Infections with Nb 
For infections, the L3 larvae from the filter papers are washed in 0.9% NaCl and the larvae counted 
under a dissecting microscope to establish a concentration of 2500L3/ml. Infections are performed 
at the Research Animal Facilities (BSL 2) and each mouse is injected subcutaneously with 500Nb 
L3 in 200 µl of 0.9% NaCl using 21G needles. Pups receive half the adult dosage (250Nb L3) and 
are killed 5 days post infection. 
3.2.4.3 Intestinal worm counts 
Small intestines were harvested from mice at the termination of the experiment. Mice were incised 
longitudinally to expose the abdominal lumen and intestines collected in 0.9% NaCl. The tissue 
was then incubated at 37° C for 4 hours which induces the migration of the worms from tissue to 
the supernatants. Afterwards, the supernatant was poured off into a large graded petri-dish and the 
total worms per mouse counted under a dissecting microscope. 
3.2.5 Sample preparations and DNA extractions 
Fecal samples from colons and breast milk from pups’ stomach were collected and stored at -20º 
C. After defrosting,1 ml of sterile PBS was added to the breast milk pellet and the suspension 
homogenized. Samples were then spun at 3500rpm for 10 minutes and the aqueous phase isolated 
which was used for further downstream analysis. We included an additional enzymatic lysis 
procedure (Yuan et al., 2012) before using the Powersoil Isolation Kit (Mo Bio Laboratories) for 
DNA extractions from both stool and breast milk. Briefly, 50µl lysozyme (10mg/ml, Sigma-
Aldrich), 6µl mutanolysin (25KU/ml, Sigma-Aldrich), and 3µl lysostaphin (4000U/ml, Sigma-
Aldrich) were added to 100µl aliquot of cell suspension followed by incubation for 1 hour at 37º 
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C. The lysate was then subjected to further DNA isolation and purification using the Powersoil 
DNA Isolation Kit (Mo Bio Laboratories) as per the manufacturers instructions. The final DNA 
concentration was determined by the Quanti-It Picogreen dsDNA HS assay kit (Invitrogen, UK). 
3.2.5.1 16S rRNA Next Generation sequencing 
16S rRNA sequencing was performed on fecal and breast milk samples. Extracted DNA was used 
for library construction according to (Arthur et al., 2012). Two sets of primers were used (Table 
1). The first set were the MF/MR; V6 universal primers modified by adding barcodes 4 to 6 
nucleotides long to allow for multiplexing and the Illumina paired-end sequencing adapters 
(Caporaso et al., 2011). A total of 12 different barcodes were generated for each end, allowing for 
144 combinations. The second set was designed to have the Illumina paired-end sequencing 
adapters and the flow-cell adapters. The hypervariable V6 region of the 16S rRNA gene was 
amplified via PCR in two steps: step one used the first set of primers allowing for a unique 
combination of barcodes for individual samples. 50ng of template DNA was used per PCR 
reaction. Cycling was done at 98º C for 30 s, followed by a touch down protocol  consisting of 15 
cycles with a denaturation step of 98º C for 5 s, annealing at 61º C for 15 s with a 1º C drop in 
each cyle until the temperatures reached 51º C, and an extension at 72º C for 15 s. PCR was then 
terminated with a final elongation step of 72º C for 5 min. In the 2nd  PCR, 10µl of 1st PCR products 
were used per reaction with the second set of primers. The concentration of all other reagents 
remained the same. Cycling was done at 98º C for 30 s and amplification proceeded for 15 cycles 
with a denaturation step of 98º C for 30 s, annealing at 65º C for 15 s, extension at 72º C for 15 s 
and a final elongation step of 72º C for 5 mins. The PCR amplicons were purified using the Qiagen 
96 well purification kit (Qiagen, CA). DNA concentations per reaction were then determined using 
the Quanti-It ds DNA BR assay (Invitrogen, UK) and 50ng from each reaction pooled into a single 
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tube. Pooled DNA was run on a 1.5% agarose gel and visualised using blue light. The 330bp band 
was carefully excised from the gel and purified using a gel purification kit (Qiagen, CA). The final 
DNA concentration was determined and the library sequenced at the Centre for Applied Genomics 
at the Hospital for Sick Children in Toronto, Canada on the Illumina HiSeq 2000 platform. 
Sequencing reads were 2x100bp in length. 
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Table 1 Primer sequences used for preparing the V6 Illumina library. Underlined nucleotides 
represent barcodes used for sample multiplexing 
Primer Primer sequence 
MF1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTATAGCGAAACTCAAAKGAATTGACGG 
MF2 ACACTCTTTCCCTACACGACGCTCTTCCGATCTAGGGTAAACTCAAAKGAATTGACGG 
MF3 ACACTCTTTCCCTACACGACGCTCTTCCGATCTTTCATAAACTCAAAKGAATTGACGG 
MF4 ACACTCTTTCCCTACACGACGCTCTTCCGATCTGATCGTAAACTCAAAKGAATTGACGG 
MF5 ACACTCTTTCCCTACACGACGCTCTTCCGATCTGCCCGTAAACTCAAAKGAATTGACGG 
MF6 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTGTCAAACTCAAAKGAATTGACGG 
MF7 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCACGTAAACTCAAAKGAATTGACGG 
MF8 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGTACGAAACTCAAAKGAATTGACGG 
MF9 ACACTCTTTCCCTACACGACGCTCTTCCGATCTGGACAAACTCAAAKGAATTGACGG 
MF10 ACACTCTTTCCCTACACGACGCTCTTCCGATCTTAGAAAACTCAAAKGAATTGACGG 
MF11 ACACTCTTTCCCTACACGACGCTCTTCCGATCTTCATAAACTCAAAKGAATTGACGG 
MF12 ACACTCTTTCCCTACACGACGCTCTTCCGATCTACTTAAACTCAAAKGAATTGACGG 
MR1 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTATAGCGACGAGCTGACGACARCCATG 
MR2 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTAGGGTACGAGCTGACGACARCCATG 
MR3 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTTTCATACGAGCTGACGACARCCATG 
MR4 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGATCGTACGAGCTGACGACARCCATG 
MR5 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGCCCGTACGAGCTGACGACARCCATG 
MR6 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTGTCACGAGCTGACGACARCCATG 
MR7 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTCACGTACGAGCTGACGACARCCATG 
MR8 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTCGTACGACGAGCTGACGACARCCATG 
MR9 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGGACACGAGCTGACGACARCCATG 
MR10 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTTAGAACGAGCTGACGACARCCATG 
MR11 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTTCATACGAGCTGACGACARCCATG 
MR12 CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTTACGAGCTGACGACARCCATG 
PCRFWD1 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
PCRRVS1 CAAGCAGAAGACGCCATACGAGATCGGTCTCGGCATTCCGTCTGAACCGCTCTTCCGATCT 
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3.2.6 Microbiome analysis 
Sequence data was pre-processed in QIIME and UPARSE with support of our bioinformaticians. 
Briefly sequences lacking  barcodes were removed and samples with less than 100,000 reads 
discarded. PCR errors were removed by SeqNoise (Quince et al., 2011). Primers and barcodes 
were removed from de-noised sequences. Consequently, de-noised sequences were clustered into 
operational taxonomic units (OTUs) at 97% sequence similarity using de novo picking. OTUs 
appearing in less than 10% of the samples were eliminated from downstream analysis. Taxonomic 
assignment was done by RDP classifier using the Green genes data base. Statistical analysis was 
done using the Calypso software version 6.4 using default parameters. Analyses were performed 
by ANOVA or t test and p-values were corrected for multiple testing by false discovery rate (FDR). 
Differences in abundances of various OTUs was assessed using the anova plots with p-value 
correction by FDR. Principal Coordinate analysis (PCA, Bray curtis distance) and alpha diversity 
(Shannon or Chao1) were run in Calypso with default parameters (Zakrzewski et al., 2016). 
Corrected p values less than 0.05 were considered statistically significant. 
3.2.7 Cell and Tissue processing 
Spleens and mesenteric lymph nodes were isolated aseptically and single cell suspensions made in 
complete media comprising Iscove’s Modified Eagle Medium (IMDM) (Invitrogen) supplemented 
with 10% heat inactivated fetal bovine serum (FBS) and 100U/ml penicillin G and 100µg/ml 
streptomycin. Lymph nodes were pooled due to few cells in pups from these organs. Single cell 
suspension was achieved by passing the organs through a 40µm nylon cell strainer (Becton 
Dickson, NJ) using a 2ml syringe plunger. Cells were then spun at 1200rpm for five minutes, 
media discarded, and red blood cells lysed by resuspending in 1 ml RBC lysis buffer for 1 minute. 
Cells were pelleted again and resuspended in complete media. Viability was determined by using 
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trypan blue and cells counted using the Neubaeur chamber under the microscope. Cells were then 
constituted to a working concentration of 107 cells/ml and were used for culture and flow 
cytometry. Cells from both organs were plated in a 96 well plate and stimulated with PMA 
(50ng/ml) and Ionomycin (500ng/ml) for 4 hr at 37º C in the presence of brefeldin A for detection 
of intracellular proteins.  
3.2.7.1 Flow cytometry 
Splenic and lymph node lymphocytes were analyzed for different surface and intracellular markers 
by flow cytometry. For extracellular markers, single cells were stained at 2 x106 cells per well in 
a 96 well V bottomed plate. In particular, cells were stained for B and T cells with anti-CD3 Alexa 
700, anti-CD4 PerCP, anti-CD8 V500, anti- CD19 PEcy7, anti-CD21 APC, anti-CD23 PE, anti-
CD80 V450, anti-CD44 FITC, anti-CD62L V450 and anti-FOXP3 APC.  All antibodies were from 
BD, Becton Dickinson. We also stained for innate cells in the RSV models. These were anti-
SIGLECF PE, anti-CD11c APC, anti-Ly6G APCcy7 and anti MHC II FITC. For intracellular 
cytokine staining, 2 x106 cells were plated on a flat bottomed 96 well plate, stimulated with PMA 
(50ng/ml) and Ionomycin (500ng/ml) for 4 hr at 37º C before being transferred into a V bottomed 
plate for staining. Cells were fixed using the BD cytofix/cytoperm (Becton Dickinson, NJ), washed 
with MACS buffer and stained with anti-CD3, anti-CD4, anti-IL 13 PEcy 7 and anti-IFN-gamma 
V500. 50µl of the antibody master mix prepared in MACS buffer was added per well in all staining 
procedures. Cells were acquired on an LSRII (Becton Dickinson) and analyzed by FlowJo version 
9.8 (Tree Star, Ashland) software.  
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Flow Cytometry gating strategies for different cell populations in spleen and lung 
 
Figure 3.3: T cell gating strategy (top panel) and B cell gating strategies (bottom panel). First, 
doublets were excluded, then lymphocytes were gated. Thereafter, T cells are gated by CD3 
expression while B cells are identified via CD19 and B220 on their surface. CD3+ cells are then 
stratified into CD4+ or CD8+cells. Within the CD4+ cells, we used CD62L and CD44 expression 
to define the memory and activated phenotype which we expressed as proportions of CD4+ cells. 
Within the CD19+B220+ cells, we used CD23 and CD21 to define Follicular and Marginal Zone 
B cells respectively. CD80+ was used to identify activated B cells. 
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Figure 3.4: Flow cytometry gating of innate immune cells in the lung. First, doublets were 
excluded then we gated on total cells. Thereafter, Alveolar macrophages were characterized as 
Siglec F+ CD11c+. Neutrophils were defined by Gr-1 expression. Within the SiglecF- Gr-1- cells, 
we gated on MHCII+CD11c+ to identify immature dendritic cells (DCs).  
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Antibodies used in this study alongside their clones, isotype controls and working concentrations 
are shown in Table 2. 
Antibody Fluorophore Clone Rationale Isotype Control Working Concentration 
CD3 Alexa 700 500A2 Lineage, T cell IgG2 1/400 
CD4 PerCP RM4-5 Lineage IgG2a 1/500 
CD8 V500 53-6.7 Lineage IgG2a 1/400 
CD44 FITC IM7 Activation  IgG2b 1/320 
CD62L V450 MEL-14 Homing marker IgG2a 1/640 
CD19 PEcy7 6D5 Lineage, B cell IgG2a 1/800 
B220 FITC RA3-6B2 Lineage IgG2a 1/400 
CD21  APC 7G6 Marginal B IgG2b 1/500 
CD23 PE B3B4 Follicular B IgG2a 1/500 
CD80 V450 16-10A1 Activation IgG2 1/320 
SIGLEC F PE E50-2440 Eosinophils IgG2a 1/320 
CD11c APC HL3 Macrophages IgG1 1/320 
Gr-1 APCcy7 RB6-8C5 Neutrophils IgG2b 1/640 
MHC II FITC NIMR-4 Dendritic cells IgG2b 1/320 
CD49b PEcy7 DX5 NK cell IgM 1/320 
IL-13 PE eBio13A Cytokine IgG1 1/100 
IFN-γ V500 XMG1.2 Cytokine IgG1 1/100 
FOXP3 Alexa Fluor 647 MF23 T regulatory IgG2b 1/200 
Table 2:  Monoclonal antibodies used for analysis of immune populations by flow cytometry 
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3.2.7.2 Preparation of compensation controls 
In multicolor flowcytometry it is necessary to acquire individually stained controls to compensate 
for spectral overlap in every channel. Spectral overlap occurs when fluorochrome signals are 
detected in more than one detector (Roederer, 2001). Failure to compensate may lead to false 
positives or false negatives events. Therefore, we prepared a compensation control for each 
fluorochrome used alongside appropriate negative controls. Briefly, a single drop of antimouse or 
antirat BD CompBeads (BD Bioscience, USA) was added to a labeled falcon tube and correct 
calculated volume of each fluorochrome conjugated antibody added in single tubes. Individual 
tubes were then incubated at 4°C for 15 minutes in the dark to allow for the binding of the antibody 
to the beads. After incubation, 300 µl of PBS was added to all the compensation tubes to stop the 
binding reaction. 
3.2.7.3 Fluorescence Minus One (FMO) controls 
FMO controls are important to identify positive events in a sample and to assist with identifying 
gating boundaries. A FMO control is a sample stained with all fluorochromes used in the panel 
except for the one of interest. We used FMO controls in our intracellular cytokine staining to 
identify the true positive events. At least 100,000 events were acquired on the LSR II flow 
cytometer. 
3.2.7.4 BD LSRII configurations 
The LSR II flow cytometer (BD Bioscience) was used in this study. The cytometer has four lasers 
(violet laser, 405 nm; green laser, 543 nm; blue laser, 488 nm; red laser, 633 nm) enabling the 
detection of more than 18 colors.  Acquisition was done on the BD Diva software and data further 
analyzed in FlowJo version 9.8 (Tree Star, Ashland) software. Figure 2.4 shows the fluorochromes, 
which can be detected, and the longpass and bandpass filters used for each detector.  
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Figure 3.5: BD LSR II configuration for different lasers. Courtesy of the Agano, Erica and Gwen 
who maintain the LSR II facility. 
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3.2.8 Enzyme-linked Immunosorbent Assay (ELISA) 
3.2.8.1 Antibody ELISA 
Relative antigen-specific serum antibody levels were determined by the antibody ELISA. Briefly, 
flat bottomed 96 well plates (Nunc, Maxisorp) were coated with the N. brasiliensis or RSV antigen 
(Horsnell lab) at optimal concentrations (5-10µg/ml) diluted in carbonate buffer at a volume of 
50µl/well overnight at 4° C. The next day, plates were blocked with 200µl/well  of 4% BSA in 
PBS (Appendix) for 3 hours at 37° C. After washing three times, samples were added. Serum 
samples were diluted to a starting concentartion of 1:3 in dilution buffer and serially diluted across 
six wells. Samples were left overnight. Plates were washed and AP conjugated secondary antibody 
(IgG, IgG1, IgG2a) added at a dilution of 1:1000 (Southern Biotech) at 50µl/well  and incubated 
at 37° C for 3 hours. Plates were then washed and the signal detected using the substrate p-
Nitrophenylphosphate (PNP) (Sigma-Aldrich) powder at 1mg/ml in substrate buffer (Appendix). 
Plates were incubated at 37° C until the desired coloration was obtained after which they were read 
at a wavelength of 405nm using the Softmax Pro Program. Relative antibody titres were plotted 
as dilution graphs versus optical densities. 
3.2.8.2 Cytokine ELISA 
Cytokines were quantified from supernatants obtained from tissue homogenates. Briefly, IL-10, 
IFN-γ, and IL-13 levels were quantified by coating 96 well plates (Nunc, Maxisorp) with 
appropriate coating antibody in 1 X PBS overnight at 4° C. Plates were then washed three times 
and blocked with 200µl/well  of blocking buffer (Appendix) for 3hours at 37° C. Samples were 
then added starting at a neat concentration, 1:2 then a 1:4 dilution. Recombinant protein standards 
were used to generate standard curves and were diluted serially at 1:2  from 100ng across 15 wells. 
Plates were incubated overnight after samples and standards were added. Plates were washed and 
biotinylated secondary antibody added in dilution buffer and incubated at 37°C for 3 hours. 
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Streptavidin-linked horseradish peroxidase or alkaline phosphatase was then added at a 1:5000 
dilution for an hour at 37°C. Plates were again washed and developed with 50µl/well. TMB 
microwell peroxidase substrate system or by p-Nitophenylphosphate until desired coloration was 
obtained after which the reaction was stopped (mainly for the TMB detection system, stopped by 
adding 25µl/well of 1M phosphoric acid). Plates were then read at a wavelength of 450nm against 
a reference filter of wavelength 540nm (TMB detection system) or at a wavelength of 405nm 
against a refernce filter of wavelength 492nm (AP detection system). All antibodies were from BD 
Pharmingen. 
3.2.9 Statistical analysis 
Data was summarized using routine methods. Kruskal Wallis test was used to compare more than 
two means. Two-way associations were explored using the Mann-Whitney test for non-parametric 
data. All statistical analysis were two tailed and p values less than 0.05 were considered statistically 
significant. Microbiome analysis was performed by QIIME, UPARSE and Calypso version 6.4 as 
described in section 3.2.6.  
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CHAPTER 4. 
4.0 RESULTS SECTION I 
4.1 Influence of maternal antibiotics during pregnancy and/or nursing on infant immunity 
and intestinal gut microbiome 
4.1.1 Introduction 
Prenatal microbial exposure has been shown to influence postnatal immune development (Schaub 
et al., 2009b). Also, the gut microbiota has been shown to program immunity, a process that is 
thought to begin at birth as the microbiota and the immune system are simultaneously establishing 
in the host. Historically, the mantra has been that the fetus is sterile and that gut colonization only 
begins at birth (Ley, Peterson, & Gordon, 2006a). However emerging evidence has revealed a 
unique microbiome within the placenta suggesting that neonatal colonization may begin in utero 
(Aagaard et al., 2014). A relationship between mode of delivery and infant gut microbiome has 
been described, and thought to be due to exposure to vaginal microbiota during vaginal delivery, 
versus skin and environmental microbiota during C section (Dominguez-Bello et al., 2010). 
Moreover, exposure to maternal fecal microbiota during vaginal delivery may also occur (Backhed 
et al., 2015; Khoruts, 2016). The impact of maternal microbiome during pregnancy on infant 
microbiome has not been investigated. Data from large cohorts suggest that the developmental 
origins of health and disease begin in utero, or even prior to conception (Wadhwa et al., 2009), but 
the relationship between these findings and maternal microbiome have not been explored. 
Furthermore, due to the relative vulnerability to infections during pregnancy, and the increase in 
sexually transmitted infections worldwide, antibiotics have become widely used during gestation. 
In this chapter, we investigate how the unintended dysbiosis of maternal microbiota during 
pregnancy and/or lactation impacts infant immunity and gut microbiota. We utilized vancomycin 
(active against gram positive) or polymyxin B (active against gram negative) as a means of 
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manipulating maternal microbiome. These broad-spectrum antibiotics were used as monotherapy 
or in combination during gestation, during nursing, or both and we investigated the overall impact 
on offspring fecal microbiome, growth and immunity 14 days postpartum. 
4.1.2 RESULTS 
4.1.2.1 Maternal oral antibiotics during gestation and/or lactation profoundly impacts infant 
intestinal microbiota 
At day 14 of life, pups were killed from the vancomycin alone and polymyxin B alone experiments. 
Pups born to control dams are designated (C), those born to dams treated with antibiotics during 
gestation only (G), those born to dams treated with antibiotics while nursing (N) and pups born to 
dams treated with antibiotics during gestation plus nursing (GN). We collected fecal samples from 
their colons and extracted fecal DNA. We sequenced the V6 region across all groups to analyze 
infant microbiome. Treatment of dams with either vancomycin or polymyxin B during gestation, 
nursing or both profoundly impacted the gut community in her offspring.  
4.1.2.2 Vancomycin mediated alterations of maternal microbiome significantly impacts 
infant gut microbiome. 
We measured vancomycin levels in maternal and infant serum samples. Dams treated with 
vancomycin 5 days prior to delivery were sacrificed 2 days after delivery and serum samples 
collected. Additional maternal serum samples were collected from dams treated with vancomycin 
5 days prior to delivery through 14 days postpartum. Infant serum samples were collected 14 days 
postpartum. There were undetectable vancomycin levels in all serum samples as determined by 
Abbott Architect ELISA (detection limit 3mg/L) (Appendix A, Table A1). Therefore, the effect 
of vancomycin was intraabdominal only, and any alterations in microbiome elsewhere in mothers 
or pups would therefore have been mediated by changes in maternal gut microbiome only. 
Although we did not measure polymyxin B levels in serum, we do not expect to detect any levels 
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in circulation. We analysed infant fecal microbiome fourteen days postpartum by sequencing the 
V6 region of the 16S gene. We had a total of 32,470,176 reads; a minimum of 4542 reads and a 
maximum of 1683427 when we looked at all samples. 104 OTUs were identified in the sequencing 
run. We found a significant reduction in microbial diversity by the shannon index when comparing 
control pups versus pups born to vancomycin breeders regardless of antibiotic timing (p<0.0001, 
ANOVA) (Fig. 4.1A). Furthermore, principal coordinate analysis revealed distinct infant 
microbiome when we compared antibiotic versus control pups. There was strong clustering based 
on grouping with the largest variation of 41% being explained on PC1 and associated with maternal 
vancomycin treatment (Fig. 4.1B). Pups born to mothers treated during gestation only had a 
microbiome distinct from the control group (Fig. 4.1B) which supports recent findings that fetus 
may not be sterile (Aagaard et al., 2014). Together, our data shows that maternal vancomycin 
treatment in dams resulted in profound alterations of offspring gut microbial communities. 
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Figure 4.1: Maternal vancomycin treatment impacts offspring gut bacterial diversity and 
taxonomic abundance at phylum level. Female BALB/c mice were treated with vancomycin 
orally 5 days prior to delivery (gestation), 14 days after birth (nursing), 5 days prior to delivery 
through 14 days of nursing (gestation plus nursing) or untreated throughout the experiment 
(controls). Pups were killed 14d postpartum and fecal microbiota analyzed and are represented as 
G, N, GN and C pups respectively. (A) Alpha diversity of offspring microbiota. (B) Principal 
coordinate analysis of offspring microbiota by bray Curtis distance representing 60% of total 
variation. PC1 represents 41% while PC2 represents 19%. (C) Significantly different bacteria taxa 
at the phylum level across all infant groups (ANOVA with FDR correction). Error bars show SEM. 
Data are representative of two independent experiments. n=6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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When we analyzed abundance at the phylum level, pups born to vancomycin breeders displayed 
significantly higher abundance of Tenericutes, Proteobacteria and Deferribacteres (p<0.001, 
FDR=0.000029, 0.00042, 0.00029 respectively) regardless of antibiotic timing in their mothers 
(Fig. 4.1C). Firmicutes were significantly increased in gestation plus nursing pups compared to 
controls (Fig. 4.1C). Moreover, we observed a significantly greater abundance of Actinobacteria 
in gestation pups while the difference did not reach statistical significance for other groups 
compared to controls (Fig. 4.1C). In stark contrast, Bacteroidetes were significantly reduced in all 
vancomycin infant groups compared to pups born to untreated mothers (p<0.001, FDR=0.000012) 
(Fig. 4.1C). Although the spectral activity of vancomycin is limited to gram positive bacteria and 
only in the maternal gut, it is interesting to note that Bacteriodetes (gram negatives) were 
significantly lower among all offspring born to antibiotic dams. 
At the class level, Mollicutes, Gammaproteobacteria, Deferribacteres were prevalent in 
vancomycin treated pups (Fig. 4.2A). However, Coriobacteria and Bacteroidia were significantly 
reduced in the vancomycin groups (Fig. 4.2A). Nursing only pups had significantly lower 
abundance of Erysipelotrichi compared to controls while there was no difference in the abundance 
of Bacilli and Actinobacteria in the gestation plus nursing and gestation only pups respectively 
compared to control pups (Fig. 4.2A). We observed similar trends at order level with a 
preponderance of Pasteurellales, Mycoplasmatales and Enterobacteriales in offspring born to 
vancomycin breeders (Fig. 4.2B). Clostridiales, Coriobacteriales and Bacteroidales were 
significantly reduced in these offspring (Fig. 4.2B). Finally, we identified genera that were distinct 
to various infant groups. Adlercreutzia, Streptococcus, Bacteroides, Prevotella and 
Parabacteroides were significantly elevated in control pups (Fig. 4.2C). However, Allobaculum 
and Ruminococcus were abundant in gestation pups, Actinobacillus and Lactobacillus in gestation 
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plus nursing pups while Staphylococcus were predominant in nursing pups (Fig. 4.2C). All three 
of the vancomycin infant groups had distinct microbiota, suggesting that the influence of maternal 
gut microbiota during gestation is distinct from that during breastfeeding.  Taken together, our data 
demonstrates that maternal vancomycin treatment during gestation, nursing or gestation plus 
nursing has a profound impact on the establishment of the gut flora in her offspring. 
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Figure 4.2: Maternal vancomycin treatment alters offspring intestinal microbiota at class, 
order and genus level. (A) Significantly altered infant bacteria taxa at class level (B) Significantly 
altered infant bacteria taxa at order level. (C) Heatmap constructed by unsupervised clustering 
using bray curtis distance showing bacteria taxa at genus level significantly differentially abundant 
in various infant groups. Analysis by ANOVA with FDR correction for multiple comparisons. 
Error bars show SEM. Data are representative of two independent experiments. n=6-10 per group. 
*p<0.05, **p<0.01, ***p<0.001. 
 
4.2 Impact of maternal oral Polymyxin B on infant microbiome 
We sequenced 29 offspring samples and found 134 operational taxonomic units (OTUs), a 
minimum of 377,208 reads and a maximum of 1,385,245 reads. Pups born to polymyxin B (PMB) 
treated mothers, regardless of antibiotic timing exhibited a trend towards reduced alpha diversity 
compared to controls (p=0.598, ANOVA) (Fig. 4.3A). 
Similar to the maternal oral vancomycin data, principal coordinate analysis of OTUs among 
offspring by bray curtis distances revealed distinct clusters based on grouping (Fig. 4.3B). 26% of 
total variability was explained by PC1, which seemed to be largely determined by the additive 
effect of PMB administration during gestation and nursing (Fig. 4.3B). Control pups clustered 
distinctly from PMB infant groups. Consistent with our vancomycin data, pups exposed to 
polymyxin B only during gestation revealed a distinct cluster from the controls indicating profound 
differences in their microbiome. This provides evidence to further support and extend emerging 
paradigm that neonatal gut colonization could begin in utero. 
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Figure 4.3: Maternal polymyxin B treatment impacts offspring gut bacterial diversity and 
taxonomic abundance at phylum level. Female BALB/c mice were treated with polymyxinB 
orally 5 days prior to delivery (gestation), 14 days after birth (nursing), 5 days prior to delivery 
through 14 days of nursing (gestation plus nursing) or untreated throughout the experiment 
(controls). Pups were killed 14d postpartum and fecal microbiota analyzed and are represented as 
G, N, GN and C pups respectively. (A) Alpha diversity of offspring microbiota. (B) Principal 
coordinate analysis of offspring microbiota by bray Curtis distance representing 48% of total 
variation. PC1 represents 26% while PC2 represents 22%. (C) Significantly different bacteria taxa 
at the phylum level across all infant groups (ANOVA with FDR correction). Error bars show SEM. 
Data are representative of two independent experiments. n=6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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Figure 4.4: Maternal polymyxin B treatment alters offspring intestinal microbiota at class, 
order and genus level. (A) Significantly altered infant bacteria taxa at class level (B) Significantly 
altered infant bacteria taxa at order level. (C) Heatmap constructed by unsupervised clustering 
using bray Curtis distance showing bacteria taxa at genus level significantly differentially 
abundant in various infant groups. Analysis by ANOVA with FDR correction for multiple 
comparisons. Error bars show SEM. Data are representative of two independent experiments. n=6-
10 per group. *p<0.05, **p<0.01, ***p<0.001. 
 
We also observed differences in microbiome comparing control pups versus pups born to PMB 
breeders at all taxonomic levels (Fig. 4.3C and 4.4). At the phylum level, we found significantly 
lower abundance of Proteobacteria in offspring born to dams treated with PMB during gestation 
or gestation plus nursing (p<0.001, FDR=0.00078, Fig. 4.3C). Firmicutes were significantly 
reduced in gestation or nursing pups compared to controls while Deferribacteres were less 
abundant in gestation plus nursing or nursing only pups when compared to littermate controls (Fig. 
4.3C). Bacteroidetes were significantly reduced in gestation plus nursing pups while 
Actinobacteria were significantly abundant only in the gestation plus nursing pups (Fig. 4.3C).  
In addition, Gammaproteobacteria were significantly less abundant in infants born to PMB 
breeders compared to controls (Fig. 4.4A). Erysipelotrichi were prevalent in gestation plus nursing 
pups while there were no significant differences in abundance of Bacteroidia and Bacilli in infants 
from PMB treated dams compared controls (Fig. 4.4A). At the order level, Turicibacterales and 
Pasteurellales were predominant in pups from antibiotic treated dams while Enterobacteriales and 
Campylobacterales were significantly reduced in infants born to PMB breeders compared to those 
born to untreated mothers (Fig. 4.4B). Furthermore, certain genera were enriched among the infant 
groups. Klebsiella were preponderant in control pups, Turicibacter in gestation pups, Blautia and 
Sutterella in gestation plus nursing pups while Ruminococcus were predominant in the nursing 
group (Fig. 4.4C).  
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Whether these changes in microbiota could be associated with observed phenotypes in the 
offspring or other biological functions is the topic of discussion in the next chapter. Altogether, 
these data demonstrate that control pups had a distinct microbiota from PMB infant pups. Similar 
to observations we made with the vancomycin data above, we show existence of differences in 
microbiota within the PMB infant groups emphasizing independent effects of maternal 
microbiome during pregnancy as well as nursing. We conclude that maternal oral polymyxin B 
administration during pregnancy, lactation or both drives drastic alterations in infant intestinal 
microbiome 14 days postpartum. 
4.3 Maternal antibiotics treatment during gestation or lactation significantly impacts infant 
growth and development. 
Dams were treated with vancomycin, polymyxin B or a mixture of the two 5 for days prior to 
giving birth (gestation), 14 days postpartum (nursing) or 5 days prior to giving birth through 
nursing (gestation plus nursing), alongside control animals. Pups were born on the same day from 
mothers that were same age. Pups body weight; spleen weight and spleen cell counts were 
measured 14 days postpartum across all experiments.  
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Figure 4.5: Maternal oral vancomycin impacts infant growth and development. Female 
BALB/c mice were treated with vancomycin orally 5 days prior to delivery (gestation), 14 days 
after birth (nursing) or 5 days prior to delivery through 14 days of nursing (gestation plus nursing). 
The body and spleen weights alongside the spleen cell counts of pups born to vancomycin breeders 
were measured 14 days postpartum. (A) Body weight of pups. (B) Spleen weights and (C) spleen 
cell counts. Graphs are shown as mean ± SEM and data analyzed by Kruskal-Wallis test followed 
by Mann Whitney U test. Data are representative of two independent experiments n= 6-10 per 
group. *p<0.05, **p<0.01, ***p<0.001. 
 
Maternal oral vancomycin treatment while nursing led to significant increase in body weight 
among pups (Fig. 4.5A). We observed a trend towards increased body weight in pups born to 
mothers treated with vancomycin during gestation when compared to controls (Fig. 4.5A). Oral 
polymyxin B or mixed antibiotics in dams led to significantly higher body weights in pups born to 
mothers treated during gestation or while nursing (Fig. 4.6A and 4.7A). However, across all 
antibiotic regimens, we found no association between prolonged antibiotic treatment in mothers 
(gestation plus nursing group) with weight gain among her offspring (Fig. 4.5A, 4.6A and 4.7A). 
Maternal antibiotics had no effect on spleen weights in pups (Fig. 4.5B, 4.6B and 4.7B). Although 
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there were no differences in spleen weights, we observed substantial antibiotic dependent effects 
on the total spleen cell counts.  
 
Figure 4.6: Maternal oral polymyxin B impacts infant growth and development. Female 
BALB/c mice were treated with polymyxin B orally 5 days prior to delivery (gestation), 14 days 
after birth (nursing) or 5 days prior to delivery through 14 days of nursing (gestation plus nursing). 
Pup body weight, spleen weights and spleen cell counts were measured in pups born to polymyxin 
B breeders. (A) Pups body weight. (B) Spleen weights. (C) Spleen counts. Graphs are shown as 
mean ± SEM and data analyzed by Kruskal-Wallis test followed by Mann Whitney U test. Data 
are representative of two independent experiments n= 6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
Maternal oral vancomycin treatment led to significantly higher total spleen counts in the infant 
spleen in all antibiotic groups of pups compared to control pup group (Fig. 4.5C). In contrast, 
maternal polymyxin B led to significant decrease in total cell counts in the spleen (Fig. 4.6C). 
Surprisingly, administering a mixture of both vancomycin and polymyxin B to dams also led to 
significant increase in total spleen cells among pups born to antibiotic treated mothers, 
mimicking that of vancomycin alone (Fig. 4.7C). Overall, maternal oral antibiotics regardless of 
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regimen impacted infant growth and spleen cellularity. Polymyxin B and vancomycin had 
contrasting impacts on total spleen cell counts. 
 
Figure 4.7: Maternal broad spectrum antibiotics (vancomycin and polymyxin B) impacts 
infant growth and development. Female BALB/c mice were treated with mixed antibiotics orally 
5 days prior to delivery (gestation), 14 days after birth (nursing) or 5 days prior to delivery through 
14 days of nursing (gestation plus nursing). We measured pup body weight, spleen weights and 
spleen cell counts. (A) Pups body weight. (B) Pups spleen weights. (C) Pups spleen cell counts. 
Graphs are shown as mean ± SEM and data analyzed by Kruskal-Wallis test followed by Mann 
Whitney U test. Data are representative of two independent experiments n= 6-10 per group. 
*p<0.05, **p<0.01, ***p<0.001. 
 
4.4 Antibiotic driven alteration of maternal microbiome alters infant T cell compartment 
We next characterized infant T cell subsets in the spleen. Maternal vancomycin regardless of 
timing did not impact proportions of infant CD4 nor CD8 T cells (Fig. 4.8A and B). Similarly, 
there was no difference in proportions of Effector CD4 T cells comparing antibiotic exposed pups 
versus control pups (Fig. 4.8C). However, offspring born to vancomycin breeders had significantly 
lower proportions of central memory CD4 T cells compared to controls regardless of antibiotic 
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timing in mothers (Fig. 4.8D). In addition, there was no difference in proportions of T regulatory 
cells across all groups (Fig. 4.8E) as well as IL-10, measured as a proxy for T regulatory cells, 
concentrations in both small intestines and colons (Fig. 4.8F).  
 
Figure 4.8: Maternal oral vancomycin drives subtle changes in T cell compartment in 
offspring. Female BALB/c mice were treated with vancomycin orally 5 days prior to delivery 
(gestation), 14 days after birth (nursing) or 5 days prior to delivery through 14 days of nursing 
(gestation plus nursing). Pups were killed 14d postpartum and spleen immunity analyzed. Flow 
cytometry was used to characterize different subsets of T cells. Proportions of (A) Infant CD4 T 
cells (CD3+CD4+), (B) Infant CD8 T cells (C) Effector memory CD4 T cells (CD4+CD44hi 
CD62Llo), (D) Central memory CD4 T cells (CD4+CD44hiCD62Lhi), (E) T regulatory cells 
(CD4+FOXP3+) and (E) IL-10 concentrations in colons and small intestines. Graphs are shown 
as mean ± SEM and data analyzed by Kruskal-Wallis test followed by Mann Whitney U test. Data 
are representative of two independent experiments n= 6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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Polmyxin B (PMB) treatment of dams similarly impacted infant T cells. Here, we observed 
significantly lower proportions of CD3+CD4+ T cells in pups born to dams treated with PMB 
during gestation compared to control pups (Fig. 4.9A). CD8 T cells exhibited a trend towards an 
increase in gestation pups (Fig. 4.9B). Furthermore, proportions of effector CD4+ T cells were 
significantly reduced in nursing versus control pups while other PMB infant groups exhibited a 
trend towards decreased proportions (Fig. 4.9C). In contrast, proportions of central memory CD4 
T cells were significantly increased in pups born to dams treated with PMB during gestation or 
gestation plus nursing (Fig. 4.9D). Akin to trends observed on central memory T cells, we noted 
significant increase in proportions of regulatory T cells in G and GN pups versus control pups 
(Fig. 4.9E).  
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Figure 4.9: Impact of maternal oral polymyxin B on infant T cells in spleen. Female BALB/c 
mice were treated with polymyxin B orally 5 days prior to delivery (gestation), 14 days after birth 
(nursing) or 5 days prior to delivery through 14 days of nursing (gestation plus nursing). Pups were 
killed 14d postpartum and spleen immunity analyzed. Flow cytometry was used to characterize 
different subsets of T cells. T cells subsets were phenotyped based on their surface marker or 
transcription factor expression. (A) CD4 T cells (CD3+ CD4+), (B) CD8 T cells (CD3+CD8+), 
(C) Effector memory CD4 T cells (CD4+CD44hiCD62Llo), (D) Central memory CD4 T cells 
(CD4+CD44hi CD62Lhi) and (E) T regulatory cells (CD4+FOXP3+). Graphs are shown as mean 
± SEM and data analyzed by Kruskal-Wallis test followed by Mann Whitney U test. Data are 
representative of two independent experiments n= 6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
 
When mothers are treated with a mixture of both vancomycin and PMB, we also observed 
significant alterations in T cells among the offspring. We found no difference in proportions of 
CD4 T cells (Fig. 4.10A). However, CD3+CD8+ T cells were significantly reduced in offspring 
born to antibiotic treated mothers regardless of timing compared to those born to control mothers 
(Fig. 4.10B). Furthermore, effector CD4 T cells were significantly increased across all pups born 
to antibiotics treated dams versus control pups (Fig. 4.10C).  We found no difference in both 
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frequencies of central memory CD4 T cells and T regulatory cells across all infant groups (Fig. 
4.10D and E).  
 
 
Figure 4.10: Maternal mixed antibiotics (vancomycin and polymyxin B) alter infant CD8 and 
effector memory T cells. Female BALB/c mice were treated with a mixture of vancomycin and 
PMB orally 5 days prior to delivery (gestation), 14 days after birth (nursing) or 5 days prior to 
delivery through 14 days of nursing (gestation plus nursing). Pups were killed 14d postpartum and 
spleen immunity analyzed. Flow cytometry was used to characterize different subsets of T cells. 
(A) Spleen CD4 T cells (CD3+CD4+), (B) CD8 T cells (CD3+CD8+), (C) Effector memory CD4 
T cells (CD4+CD44+CD62L-), (D) Central memory CD4 T cells (CD4+CD44+CD62L+) T cells 
(E) T regulatory cells (CD4+FOXP3+). Graphs are shown as mean ± SEM and data analyzed by 
Kruskal-Wallis test followed by Mann Whitney U test. n= 6-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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Maternal antibiotics during gestation, nursing or both impacts infant B cells 
Prenatal and postnatal antibiotics also had an impact on the infant B cell compartment. Pups born 
to mothers treated with vancomycin during nursing or gestation plus nursing had significantly 
lower proportions total B cells (CD19+B220+), follicular B cells (CD19+CD23+) and marginal 
zone B (CD19+CD21+) compared to control pups (Fig. 4.11A,B,C). There was no association 
between maternal PMB treatment and proportions of B cells (CD19+B220+) in her offspring (Fig. 
4.12A). However, we observed significant increase in proportions of follicular B cells in nursing 
and gestation plus nursing pups versus controls (Fig. 4.12B). Our analysis revealed no difference 
in proportions of marginal zone B cell subset across all groups (Fig. 4.12C). Apart from the 
independent effects of these antibiotics, administration of a mixture of both vancomycin and PMB 
also impacted B cells in infant mice (Fig. 4.13). We found significantly lower proportions of total 
B cells in pup groups when mothers were treated with a mixture of both vancomycin and PMB 
regardless of timing (Fig. 4.13A). Akin to total B cells, and similar to maternal vancomycin 
treatment alone, proportions of follicular B cells were also significantly lower in antibiotic pups 
when compared to controls (Fig. 4.13B). However, we observed no difference in proportions of 
marginal zone B cells in the spleen among infant groups born to dams treated with mix antibiotics 
(Fig. 4.13C). 
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Figure 4.11: Maternal vancomycin impacts offspring B cell development in spleen. Infant B 
cells were analyzed in the spleen 14 days postpartum. (A) Total Infant B cells (CD19+B220+), (B) 
Follicular B cells (CD19+B220+CD23+) and (C) Marginal zone B cells (CD19+B220+CD21+). 
Graphs are shown as mean ± SEM and data analyzed by Kruskal-Wallis test followed by Mann 
Whitney U test. Data are representative of two independent experiments n= 6-10 per group. 
*p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.12: Maternal polymyxin B impacts infant B cells in spleen. Spleen B cells in pups 
were characterized 14 days postpartum by FACS. (A) Infant B cells in spleen (CD19+B220+), (B) 
Spleen B cells stratified into Follicular B cells (CD19+B220+CD23+) and (C) Marginal zone B 
cells (CD19+B220+CD21+). Graphs are shown as mean ± SEM and data analyzed Kruskal-Wallis 
test followed by Mann Whitney U test. Data are representative of two independent experiments 
n= 6-10 per group. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.13: Maternal oral mixed antibiotics (vancomycin and polymyxin B) influences 
offspring B cells in spleen. Infant B cells in the spleen were characterized by FACS 14 days 
postpartum. (A) Total spleen B cells (CD19+B220+), (B) Follicular B cells (CD19+B220+CD23+) 
and (C) Marginal zone B cells (CD19+B220+CD21+). Graphs are shown as mean ± SEM and data 
analyzed by Kruskal-Wallis test followed by Mann Whitney U test. n= 6-10 per group. Data are 
representative of two independent experiments n= 6-10 per group *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
 
 
 
 
 
 
99 
 
4.5 Discussion 
In this chapter, we explore the impact of maternal oral antibiotics during pregnancy and lactation 
on infant growth, intestinal microbiota and immunity. We find that regardless of timing of 
antibiotic administration, alteration of maternal gut microbiome has profound influence on the 
offspring. These data are highly relevant for two reasons: 1. Antibiotic use during these periods in 
humans is a regular occurrence as a means of treating urinary, genital, and respiratory tract 
infections (Hauth et al., 1995; Jaeger et al., 2013). Penicillins, the most common antibiotic class 
administered during pregnancy are delivered intravenously in the form of Ampicillin for 
Streptococcus agalactiae carriage, and therefore would have effects not only on maternal gut 
microbiome, but on the other maternal body sites and potentially even direct effects on fetal or 
infant microbiome. 2. Most Importantly, our study shows, through the use of oral antibiotics that 
are not absorbed from the gut, that an altered maternal gut microbiome alone, during pregnancy 
and lactation, has these profound downstream effects. Although the antibiotic candidates we used 
here are not administered orally in humans, our findings are critical in informing the effects of 
alteration of maternal gut microbiome (through any means) during this period on infant 
development. We developed a murine model of maternal antibiotic treatment during gestation 
and/or nursing to investigate the impact on the establishment of the infant intestinal microbiome, 
body composition and the developing immune system. We selected vancomycin and polymyxin B 
that are active against gram positive and gram-negative bacteria respectively because these 
antibiotics are poorly orally bioavailable. 
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4.5.1 Impact on infant intestinal microbiota 
It is apparent that observed changes in infant growth and immunity were largely driven by 
alterations in gut bacterial composition in the mother, underpinning the importance of maternal 
gut microbes on infant health. We observed profound differences in offspring microbiota following 
maternal oral polymyxin B or vancomycin treatment. Treatment of dams with antibiotics five days 
prior to delivery resulted in distinct offspring microbiome compared to controls, suggesting that 
maternal gut composition during gestation influences the type of bacteria colonizing the infant gut. 
Although we did not investigate the mechanisms behind these biological phenomena, it is likely 
that bacterial translocation occurs from the maternal gut to the placenta and/or maternal breast 
milk or antibiotics alter maternal metabolism, which could begin to impact the fetal microbiome 
in utero. A bi-directional relationship has previously been described between pregnancy and 
periodontal disease, and that periodontal infections at least in some populations can increase the 
risk of adverse pregnancy outcomes (Armitage, 2013). Recently, Aagaard et al. described a 
placental microbiome that was most akin to human oral microbiome (Aagaard et al., 2014). 
Therefore, it is tempting to speculate that there is a bi-directional flow of blood between the mouth 
and uterus producing a similar microbiome in these sites. This blood flow also interacts with the 
GIT where dendritic cells which interact with commensal bacteria squeeze through the lamina 
propria and travel via lymph and circulatory system to mammary glands (Fernandez et al., 2013). 
Using 16S rRNA profiling, we observed significant decrease in abundance of Proteobacteria and 
Deferribacteres in offspring following Polymyxin B treatment regardless of timing. This was 
expected since this antibiotic has spectrum activity against the gram-negative bacteria. Therefore, 
it is reasonable that targeting these bacteria in the maternal gut impacted transfer to offspring. 
However, we also noted a significant decrease in abundance of Firmicutes in gestation or nursing 
pups despite being gram positive bacteria suggesting that PMB treatment could be having indirect 
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impact on gram positive bacteria thus influencing their acquisition in infants. In addition, 
Firmicutes alongside Bacteroidetes are the main bacteria that have been linked to metabolism of 
undigested food remnants (Tsuji et al., 2008). It is possible that increased body weight in gestation 
as well as nursing pups could be attributed to differences in abundance of Firmicutes which may 
have driven metabolic alterations in offspring. Bacteroidetes (gram negatives) were not different 
comparing control against gestation plus nursing as well as gestation pups suggesting significant 
alterations in this phylum in offspring are probably determined by maternal microbiota while 
nursing.  It is interesting that offspring born to PMB treated mothers had high abundance of 
Bacteroidetes although this phylum was absent in maternal gut. This indicates the presence of 
others sources of Bacteroidetes aside from the mother’s gut. We found significantly higher 
abundance of Actinobacteria in offspring born to dams treated with PMB during gestation plus 
nursing compared to controls. Members of this phylum have previously been associated with 
immunity. For example, Bifidobacteria has been shown to influence immune development in 
young rats (Dong et al., 2010) as well as aging mice (Fu et al., 2010). It is likely that the 
preponderance of Actinobacteria in the gestation plus nursing group was associated with profound 
changes observed both in offspring B and T cell compartment. Furthermore, Turicibacterales were 
significantly increased in all PMB pups compared to controls. Member of this order have been 
shown to have an indirect relationship with CD8 T cells. When CD8 T cells are deficient, 
Turicibacter blooms (Presley et al., 2010). Therefore, it is possible that increased abundance of 
Turicibacter among PMB infants was associated with reduced populations of CD8 T cells. 
Although we did not investigate a direct causal effect and the underlying mechanism, it is likely 
that signaling via microbial compounds by members of this order is critical for immune 
development. In the present dysbiotic state, the possibility that immune cells can have impaired 
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functional capability cannot be ruled out. Although we observed increased proportions of certain 
immune cell types, we are not clear yet if functionality of these cells was affected. Whether these 
alterations in intestinal microbiota translated to improved or impaired capability of offspring to 
control pathogenic infections is explored further in the next chapter. Oral vancomycin in dams also 
impacted infant microbiome. We observed distinct beta diversity clusters indicating inherent 
differences in bacteria composition. Akin to the polymyxin B effects, we observed reduced 
bacterial diversity in pups born to vancomycin treated dams, which emphasizes the role of 
antibiotics in reducing microbial diversity. In contrast to PMB data, Proteobacteria and 
Deferribacteres were predominant in vancomycin infant groups regardless of vancomycin timing 
indicating that the antibiotics indeed had different spectra of activity and impacted microbiota 
distinctly. We also observed a high abundance of Enterobacteriales and Pasteurellales in 
vancomycin pups. Others have reported an increase in abundance of Enterobacteriaceae in murine 
models treated with vancomycin (Ubeda et al., 2010). This can be explained by the fact that 
vancomycin has spectral activity against the gram-positive bacteria which prompted an outgrowth 
of compensatory bacteria in the gram-negative family which were possibly transferred to her 
offspring. We also drew associations between the bacterial communities observed in the 
vancomycin study with observed immunological outcomes in offspring. Although all vancomycin 
infants had significantly lower abundance of Clostridia which has been associated with induction 
of T regulatory cells (Atarashi et al., 2011, 2013), we did not find any differences in proportions 
of T regulatory subset in our model. We think the effect on regulatory T cells could be localized 
and not systemic which could explain our inability to detect differences in the spleen. We found 
significantly lower proportions of total B cells, marginal zone and follicular B cells in offspring 
born to dams treated with vancomycin during nursing or gestation plus nursing compared to the 
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control group. These two groups had significantly higher abundance of bacillales compared to 
gestation or control pups. Although we did not investigate the direct role of microbes on systemic 
immunity, it is possible that these Firmicutes are associated with observed immunological 
outcomes especially on the B cell compartment and merits further investigation potentially using 
gnotobiotic mouse models. Moreover, Erysipelotrichiales which are often mentioned in passing 
but are highly immunogenic and thrive post antibiotic treatment ( reviewed in (Kaakoush, 2015)) 
were significantly reduced in the nursing group but not in other vancomycin infants. Members of 
this taxa have been found to be enriched in colorectal cancer although evidence has not been 
consistent (Chen et al., 2012; Palm et al., 2014). Others have shown an association between 
Erysipelotrichaceae and TNF levels (Dey et al, 2013). In our model, the near complete ablation of 
this order in nursing pups could be indicative of an altered innate and adaptive immune profile 
which we did not investigate in our study but would be intriguing to see how these infant pups 
respond to pathogenic challenge in our next chapter. We observed significantly lower proportions 
of central memory CD4 T cells (CD4+CD44hiCD62Lhi) while B cells revealed a trend toward 
decreasing proportions in pups born to dams treated with vancomycin only during gestation. These 
data conflicts recent work by Gomez and colleagues who showed no impact of maternal 
microbiome during pregnancy on infant T cell activation status ( Gomez de Agüero et al., 2016). 
The authors utilized germ free maternal neonatal model where mothers were colonized transiently 
during gestation; an effect that was short-lived as by the time of delivery, the birth canal was sterile 
and neonates remained germ free. This could explain differences in our results as we applied a 
different approach where the possibility of infants being colonized in utero cannot be ruled out.  
104 
 
4.5.2 Impact on infant growth and development 
Pups born to dams with gut dysbiosis induced by either antibiotic alone or in combination during 
gestation or nursing, had significantly higher body weight compared to littermate controls.  
Changes in offspring body weight are likely due to changes in maternal metabolism, which could 
begin to impact the fetus in utero. Our data shows pulsed antibiotic treatment (gestation or nursing 
only) has a significant impact on weight rather than continuous treatment (gestation plus nursing) 
suggesting that certain organisms may compensate metabolically overtime. Indeed, previous 
studies have implicated the gut microbiota in control of metabolism. Wikoff and colleagues 
demonstrated large effects of the gut microflora on mammalian blood metabolites (Wikoff et al., 
2009). Similarly, Vrieze and others showed oral vancomycin to significantly impact host 
physiology, bile acid metabolism and insulin sensitivity in patients with metabolic syndrome 
(Vrieze et al., 2014). These changes in maternal metabolism are largely due to perturbation in the 
resident bacterial community. Maternal microbiome could therefore be acting either directly or 
indirectly to impact adiposity among the offspring.  Further, it is also plausible that offspring 
inherit a unique “obesogenic” microbiome within a critical window period, which begins to 
influence metabolic activity early in life. Our data corroborates the findings of others who reported 
an impact of early life antibiotic exposure on accelerating growth and altering body composition 
(Cox et al., 2014; Nobel et al., 2015). Moreover, our findings expand current knowledge in 
demonstrating that metabolic programming begins in utero. 
4.5.3 Impact on Infant immunity 
We observed a significant impact of maternal oral antibiotics on infant immunity. Firstly, we 
observed differences in total immune cells in spleens that were antibiotic specific. Maternal oral 
vancomycin treatment led to significantly increased spleen cellularity among offspring while 
polymyxin B treatment had contrasting effects. Interestingly, we found a significantly higher total 
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spleen cells numbers in pups born to mothers treated with mixed antibiotics (vancomycin and 
polymyxin B) regardless of phase of treatment. Spleen weights did not correlate with total cell 
numbers. This indicates that effects of antibiotic exposure although sufficient to alter cell counts 
were not matched to those otherwise induced by infections that would induce splenomegaly. 
However, it is possible there was increased blood flow to the spleen albeit not significant to alter 
organ weight. Recent studies have revealed an important programming role of gut microbiota on 
immunity. For example, particular clostridia clusters have been shown to induce T regulatory cells 
in the gut (Atarashi et al., 2011, 2013) while segmented filamentous bacteria induce TH17 subsets 
(Ivanov et al., 2009). Interestingly, maternal oral vancomycin led to significant reduction in central 
memory CD4+ T cells, and a trend towards an increase in effector CD4+ T cells among her 
offspring regardless of phase of treatment. Polymyxin B treatment in mothers while nursing led to 
a reduction in proportions of central memory CD4+ T cells in her offspring. Finally, mixed 
antibiotics, which although had no effect on CD4 T cells, resulted in significantly reduced 
proportions of CD8+ T cells. This implies that the effects of vancomycin and polymyxin B 
treatment on CD4+ T cells may cancel each other out. Although we did not explore the effect of 
vancomycin on CD8+ T cells, the finding that these were reduced in both the polymyxin B and 
mixed antibiotic treated pups implies that polymyxin B sensitive bacteria (gram negatives) are the 
major taxa driving immunological changes for this subset.  
Tormo-Badia et al. demonstrated using non-obese diabetic mice that maternal antibiotic treatment 
during pregnancy led to alterations of neonatal gut T cell compartment. In particular, they reported 
an increase in CD8 T cells and T regulatory cells (Tormo-Badia et al., 2014). Our polymyxin B 
and mixed antibiotics data is consistent with these findings, and show that this phenomenon occurs 
at other immunological sites. Related studies have revealed that maternal diet during pregnancy 
106 
 
can impact development and immune function of the fetus (Hoyo et al., 2011; Myles et al., 2013). 
We also noted discrepancies between frequencies and absolute counts in various immune subsets 
we analyzed. It is possible that although we have increased total counts, the effector functions of 
these cells in response to antigenic challenge may be impaired. However, we will address the 
overall impact of an altered infant immune system on ability to control pathogenic infections when 
we challenge these pups born to antibiotic breeders with various infections models in the next 
chapter. To our knowledge, this is among the very few reports characterizing infant immunity 14 
days post-partum in pups born to dams with an aberrant microbiome. Together, these data reveal 
an indispensable role for maternal microbiome during gestation or breastfeeding on offspring 
immune development. 
Our study had a number of limitations. First, we utilized only two mothers per group in part 
because we get 6-10 litters per mother and we cull to 6 per dam to ensure the mother has enough 
resources for the offspring during breastfeeding. However, in terms of studying the impact the 
antibiotics had on maternal gut microbiome, the numbers were not sufficient. Our main focus was 
largely on infants, an objective we conclusively addressed but we were not able to do the same in 
terms of studying the maternal-infant microbiome transfer and the dynamics involved. Secondly 
and tied to the first limitation is the cage effect which cannot be overlooked. We housed two dams 
per group together and treated them with antibiotics in drinking water. While we expect these dams 
to have a similar microbiome having gone through the same treatment, the microbiota may not 
necessary be exact and given the approach we used in our model, that allowed the two mothers in 
the same group to be cohoused, it is likely we may not have been able to pick up these differences 
albeit subtle. In addition, we did not study the impact of maternal antibiotics on microbiota in extra 
intestinal sites. Although we verified that vancomycin mediated changes were only restricted to 
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the gut, we did not investigate if these antibiotics could be acting indirectly to impact microbiota 
in other sites such as vagina and breastmilk which obviously contribute in shaping offspring 
microbiota early in life. Our immediate future experiments will address this question.  
Nonetheless our data demonstrates that inherited gut dysbiosis very early in life which coincides 
with the developing immune system at infancy impacts inherent adaptive immunity. This to our 
knowledge is one of the very few reports to specifically characterize baseline immunity in infants 
born to mothers with an altered gut microbiome. In the next chapter, we will subject these offspring 
to various challenge models and test their immunity further. Taken together, antibiotic treatment 
in dams during gestation, nursing or both significantly altered infant microbiome and profoundly 
impacted the developing immature immune system. 
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CHAPTER 5 
5.0 RESULTS SECTION II 
5.1 Impact of maternal antibiotics during gestation or lactation on offspring immunological 
ability to control infections and respond to vaccine challenge 
5.1.1 Introduction 
Newborn humans and animals have an impaired ability to mount an immune response to certain 
stimuli. Consequently, they are frequently subject to overwhelming infections (Morein, Blomqvist, 
& Hu, 2007). Stimulation of the neonatal immune system by vaccination is therefore necessary to 
protect infants against some infections. However, some of the neonatal vaccines are not as effective 
owing to various phenomena, including TH2 biased cellular immunity along with transferred 
maternal antibodies that can potentially attenuate neonatal responses (Siegrist, 2007). For example, 
RSV is a significant infection early in life and is the major cause for hospitalizations in infants 
under 3 months (Hall et al., 2012). Although passive immunization exists for this infection, there 
remains no active vaccine for RSV but even in the presence of one, it is likely that booster doses 
will be required for adequate protection, which will then fail to protect infants in the early period 
when they are most vulnerable. Apart from RSV infections, other infections such as helminths 
may also pose an immunological burden to infants. Studies show that in utero helminth exposure 
may influence susceptibility to the same helminths later in life (reviewed (Mpairwe et al, 2014)) 
as well as to unrelated antigens (Gebreegziabiher et al., 2014). Furthermore, lack of gut microbiota 
has been shown to influence host immunity and accelerate susceptibility to helminth induced 
pathology (Holzscheiter et al., 2014). Yet whether maternal gut microbiota during pregnancy or 
breastfeeding impacts infant immunity to helminths is unknown. 
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Considering the challenges of neonatal vaccination and the high risk of overwhelming infections 
in early life, the role of other immune-modulatory factors for example, microbiota in enhancing 
neonatal immunity is not well understood. The gut microbiota coevolves with the immune system, 
and they each in turn influence the establishment of the other. Recent evidence demonstrates that 
microbiota mediated programming of neonatal immunity may begin in utero, underscoring the 
importance of maternal microbiome during pregnancy (Aagaard et al., 2014). In the previous 
chapter (CHAPTER 4), we have shown that antibiotic driven manipulation of maternal gut 
microbiota during gestation, lactation or both phases has profound consequences on infant immune 
cell subsets and inherent activation levels and intestinal microbiota at 14 days postpartum. 
However, what an altered infant immunity translates to in the context of live infections is not well 
understood. In this chapter, we utilized infant RSV and N. brasiliensis challenge models to further 
our understanding on the role of maternal microbiota on infant immunity.  
5.2 Maternal oral vancomycin and the infant RSV model 
Here, we mated dams (2 dams per group) and exposed them to vancomycin in drinking water 
(1mg/ml) 5 days prior to delivery (gestation), for 14 days after delivery (nursing) or both 5 days 
prior to delivery through 14 days of nursing (gestation plus nursing) as shown in the methods 
chapter (Fig. 3.1). Control dams were not treated with antibiotics. Pups were culled to 6 per 
mother. Maternal antibiotic treatment was stopped 14 days after delivery in the nursing or gestation 
plus nursing group. Pups were then each infected intranasally with 8x105 PFUs in 40µl DMEM at 
21 days of life. Severity of RSV was assessed by daily weight monitoring and mice were killed at 
day 4 or 8 post RSV infection and lung immunity analysed. 
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5.2.1 RESULTS 
5.2.1.1 Maternal oral vancomycin treatment increased offspring susceptibility to RSV in the 
early onset of disease 
We challenged offspring with 8x105 PFUs of RSV A2 strain intranasally at 21 days of age. Weight 
was monitored daily, and pups were killed at day 4 or 8 post infection (Fig. 5.1a). Weaned RSV 
infected pups born to vancomycin bredeers had a significant growth delay versus control pups but 
they did not lose weight (Fig. 5.1b). RSV infected pups born to dams treated only during gestation 
begun to catch up with control pups weight by day 5. However, the pups whose mothers had 
received vancomycin during nursing were susceptible to RSV throughout the 8 days post-infection 
(Fig. 5.1b). To tease out the effect that maternal antibiotics could be having on pup weight and 
clearly examine if RSV infection was impacting weight gain in the pups, we examined the effect 
of RSV challenge on all pups against their uninfected controls (Fig. 5.1 c, d, e, f). In control pups, 
we observed that RSV infection caused a significant delay in growth compared to uninfected pups 
for the first few days post-infection, but then had a rapid growth spurt that surpassed that of the 
uninfected pups (Fig 5.1c). RSV infected gestation pups exhibited a similar trend to control pups, 
they surpassed their uninfected littermate controls at day 6 post RSV challenge (Fig. 5.1d). 
However, the nursing or gestation plus nursing pups did not catch up with the weights of their 
control peers after infection (Fig. 5.1e, f). We observed a trend towards increased viral burden in 
the lung among infant antibiotic groups at day 4 post RSV challenge compared to control group 
(Fig. 5.1g). 
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Figure 5.1: Maternal oral vancomycin impacts infant immunity to RSV. (a) Pups born to 
vancomycin breeders treated during gestation, nursing or gestation plus nursing were challenged 
intranasally at 3 weeks with RSV and killed 4 or 8 days post infection. (b) Daily percentage weight 
gain among RSV infected pups born to vancomycin treated or untreated mothers. (c) Percentage 
weight gain in RSV infected or naïve control pups. (d) Percentage weight gain in RSV infected or 
naïve pups born to dams treated with vancomycin during gestation (e) Percentage weight gain in 
RSV infected or naïve pups born to mothers treated with vancomycin during nursing. (f) 
Percentage weight gain in RSV infected or naïve pups born to mothers treated with vancomycin 
during gestation plus nursing. (g) Viral RNA copies at day 4 post RSV infection. Graphs are 
represented as mean ± SEM and data are representative of at least three independent experiments. 
Weight data was analyzed by multiple t test with Holm Sidak multiple comparisons adjustment (b-
f). n=8-12 per group. *p<0.05. 
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5.2.1.2 Maternal vancomycin during pregnancy and/or lactation impacted infant lung 
immunity. 
We next analysed local lung immunity in the infant following RSV challenge at day 4 and 8 post 
infection. RSV infected pups born to vancomycin breeders had reduced total cell counts at both 
time points compared to control group (Fig. 5.2A, Fig. 5.4A). At day 4 post infection, total 
numbers of natural killer cells (CD3-CD49b+), considered among the first immune cells to be 
recruited to the lung following an RSV infection providing an initial source of interferon gamma 
(Openshaw et al., 1995), were significantly lower in offspring born to dams treated with 
vancomycin regardless of timing compared to littermate controls (Fig. 5.2B). Similarly, 
proportions of activated NK cells (CD3-CD49b+CD69+) were significantly lower in the gestation 
plus nursing pups (mean 60.7 versus 41.2, p=0.0022) with a trend towards decreasing proportions 
in other antibiotic groups (Fig. 5.2D). Our analyses of the total numbers revealed significant 
reduction in activated NK cells in gestation and gestation plus nursing pups compared to controls. 
Although total numbers of activated NK cells were reduced for the nursing group, the difference 
did not reach statistical significance (Fig. 5.2D). IFN-gamma concentrations were reduced in 
gestation or gestation plus nursing groups but these were not significant (Fig. 5.2C). Although we 
had NK cell recruitment to the lungs in these groups, we noted discrepancies in levels of interferon 
gamma. Alveolar macrophages have previously been shown to be key mediators of neonatal RSV 
immunity (Eichinger et al., 2015; Empey et al., 2012). There were no differences in proportions of 
alveolar macrophages in our model but total numbers were significantly reduced in gestation plus 
nursing pups compared to control pups (Fig. 5.2E). The proportions and total numbers of CD8 T 
lymphocytes, thought to mediate pathology in RSV infection, were similar across all pup groups 
(Fig. 5.2F). In contrast, we observed significantly increased proportions of CD4 T cells in nursing 
and the gestation plus nursing pups (Fig. 5.3A). Moreover, proportions of effector memory CD4+ 
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T cells were significantly lower in nursing and gestation plus nursing pups (Fig. 5.3B) while those 
of central memory CD4+ T cells were significantly increased in aforementioned infant groups 
(Fig. 5.3C). We found no difference in levels of serum RSV specific IgG (Fig. 5.3D). 
 
 
Figure 5.2: Maternal oral vancomycin impacts offspring NK cells day 4 post RSV infection. 
Pups born to vancomycin breeders were infected intranasally with RSV at 21 days and killed at 
day 4-post infection. Lung samples were harvested and analyzed. Innate immune cells and CD8 T 
cells were characterized by FACS. (A) Total lung counts, (B) NK cells (CD3-CD49b+), (C) BAL 
IFN- gamma levels, (D) Activated NK cells (CD3-CD49b+CD69+), (E) Alveolar macrophages 
(SIGLECF+CD11c+), (F) CD8 T lymphocytes (CD3+CD8+). Data are shown as mean ± SEM. 
Statistical analysis was performed by Kruskal-Wallis test followed by Mann-Whitney U test. Data 
are representative of two independent experiments. n=4-6 per group. *p<0.05 and **p<0.01.  
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Figure 5.3: Maternal oral vancomycin impacts effector memory CD4 T cells in offspring day 
4 post RSV infection. Pups born to vancomycin breeders were infected intranasally with RSV at 
21 days and killed at day 4-post infection. Lung samples were harvested and analyzed. CD4 T 
lymphocytes were characterized by FACS. (A) CD4 T cells (CD3+CD4+), (B) Effector memory 
CD4 T cells (CD3+CD4+CD44+CD62L-) and (C) Central memory CD4 T (CD4+CD44+ 
CD62L+) cells respectively. (D) Serum RSV specific IgG. Data are shown as mean ± SEM. 
Statistical analysis was performed by Kruskal-Wallis test followed by Mann-Whitney U test. Data 
are representative of two independent experiments. n=4-6 per group. *p<0.05 and **p<0.01.  
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At day 8 post infection, when the adaptive immune response peaks and cellular infiltration is 
thought to exacerbate symptoms, we observed a trend towards an increase in proportions of NK 
cells in gestation and nursing pups but not gestation plus nursing. The total number of NK cells 
were significantly reduced in gestation plus nursing pups compared to control pups (Fig 5.4B). 
Proportions of NK cells were significantly reduced in gestation plus nursing pups compared to 
nursing only pups. There were no differences in proportions of activated NK cells (Fig 5.4D). 
Furthermore, IFN-gamma levels in bronchoalveolar lavage exhibited a trend towards decreasing 
concentrations in all offspring born to vancomycin breeders but this was not statistically significant 
(Fig. 5.4C). Similarly, we found no significant differences in proportions of alveolar macrophages 
while the numbers displayed a trend towards a decrease comparing vancomycin infants with 
control infants (Fig. 5.4E). There was no difference in frequencies and numbers of infant CD8 T 
cells (Fig. 5.4F). When we compared proportions of CD8 T cells between day 4 and day 8, we 
noted an increase in frequencies of this subset at day 8 across all groups (Appendix B, Fig B1). 
There was a significant increase in CD8 frequencies for gestation and gestation plus nursing pups, 
where mean proportions increased from 9.626% in day 4 to 23.02% in day 8 (Appendix B, Fig 
B1). Similarly, proportions increased from 17.2% in day 4 to 22.52% in gestation plus nursing 
(Appendix B, Fig B1). Although control and nursing groups also displayed an increase in the CD8 
frequencies, these were not significant.  Proportions of CD4 T cells were significantly reduced in 
gestation plus nursing pups compared to controls (Fig. 5.5A). We also found significantly reduced 
total number of effector memory (Fig. 5.5B) and central memory CD4 T cells (Fig. 5.5C) in this 
group. Taken together, our data demonstrates that vancomycin driven modulation of maternal gut 
microbiome at various phases during gestation and lactation profoundly impacts lung immunity in 
infants and influences immune response and clinical outcomes to RSV infections. 
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Figure 5.4: Maternal oral vancomycin has no effect on most innate cells in infant lung day 8 
post RSV infection. Pups born to vancomycin breeders were infected intranasally with RSV at 21 
days and killed at day 8-post infection. Lung samples were harvested and analyzed. Innate immune 
cells and CD8 T cells were characterized by FACS. (A) Total lung counts, (B) NK cells (CD3-
CD49b+), (C) BAL IFN- gamma levels, (D) Activated NK cells (CD3-CD49b+CD69+), (E) 
Alveolar macrophages (SIGLECF+CD11c+), (F) CD8 T lymphocytes (CD3+CD8+). Data are 
shown as mean ± SEM. Statistical analysis was performed by Kruskal-Wallis test followed by 
Mann-Whitney U test. Data are representative of two independent experiments. n=4-6 per group. 
*p<0.05 and **p<0.01. 
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Figure 5.2: Maternal oral vancomycin induces subtle changes in infant CD4 T cells day 8 
post RSV infection. Pups born to vancomycin breeders were infected intranasally with RSV at 21 
days and killed at day 8-post infection. Lung samples were harvested and analyzed. CD4 T 
lymphocytes were characterized by FACS. (A) CD4 T cells (CD3+CD4+), (B) Effector memory 
CD4 T cells (CD3+CD4+CD44+CD62L-) and (C) Central memory CD4 T (CD4+CD44+ 
CD62L+) cells respectively. Data are shown as mean ± SEM. Statistical analysis was performed 
by Kruskal-Wallis test followed by Mann-Whitney U test. Data are representative of two 
independent experiments. n=4-6 per group. *p<0.05 and **p<0.01.  
 
5.3 Maternal oral polymyxin B and the infant N. brasiliensis model 
In this study, we investigated the impact of targeting gram-negative commensals in the maternal 
gut during gestation and/or lactation on infant ability to control helminth infections. We utilized 
the Nippostrongylus brasiliensis model, which is well developed, in the lab of our collaborator and 
cosupervisor, Dr Horsnell. In chapter 4, we showed that maternal PMB treatment significantly 
impacted infant growth, intestinal microbiota and immunity. Here, we interrogated the Th2 arm of 
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infant adaptive immunity by challenging pups born to polymyxin B breeders at 21 days of age 
with 250Nb L3 of N. brasiliensis and killing the pups 5 days post-infection (Fig. 5.6A). 
 
Figure 5.6: Polymyxin B modulation of maternal microbiome impacts offspring immunity to 
Nippostrongylus brasiliensis. (A) Pups born to polymyxin B breeders were infected 
subcutaneously with 250Nb L3 at 3 weeks of age and killed 5 days post infection, (B) Small 
intestinal worm burden and CD3+CD4+ T cells respectively, (C) CD4 T cells expressing IL-13 
following PMA/Ionomycin stimulation and representative flow plot showing intracellular staining 
for IL-13, (D) Effector memory CD4 T cells (CD3+CD4+CD44+CD62L-) and (E) Central 
memory CD4 T cells (CD3+CD4+CD44+CD62L-). Intracellular IL-13 production by CD4 T cells 
following stimulation by PMA (50ng) and Ionomycin (500ng) for 4 hours in the presence of 
brefeldin A. Graphs are shown as mean ± SEM and data analyzed by Kruskal-Wallis test followed 
by Mann-Whitney U test. Data are representative of two independent experiments. n=4-8 per 
group. *p<0.05. 
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Figure 5.7 Polymyxin B modulation of maternal microbiome impacts IL-13 production in 
offspring following infection with Nippostrongylus brasiliensis. Pups born to polymyxin B 
breeders were infected subcutaneously with 250Nb L3 at 3 weeks of age and killed 5 days post 
infection. (A) T regulatory cells (CD3+CD4+FOXP3+), (B) Intestinal IL-13 concentrations in 
homogenates, (C) CD3- cells expressing IL-13 after PMA/Ionomycin stimulation and 
representative flow plot for all infant groups and (D) Total B cells (CD19+B220+). Graphs are 
shown as mean ± SEM and data analyzed by Kruskal-Wallis test followed by Mann-Whitney U 
test. (E) Serum Nb specific IgG. Data are representative of two independent experiments. n=4-8 
per group. *p<0.05. 
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Pups born to dams treated with PMB during gestation or gestation plus nursing had significantly 
higher worm burden in the small intestines compared to infected controls (Fig. 5.6B). We found 
no difference in splenic cellularity across all infected pups. We found no significant difference in 
both proportions and total cell numbers of CD4+ T cells (Fig. 5.6B), IL-13 producing CD4+ T 
cells (Fig. 5.6C) and effector CD4+ T cells (Fig. 5.6D) across all infected pups. Proportions of 
central memory CD4+ T cells were significantly higher in gestation pups and lower in nursing 
pups. Although not significant, gestation plus nursing pups had a trend towards increased 
frequencies of this subset (Fig. 5.6E). In addition, proportions of T regulatory cells were 
significantly increased in nursing and gestation plus nursing pups but there was no difference in 
total numbers across all groups (Fig. 5.7A). Interestingly, we observed substantially reduced 
intestinal concentrations of IL-13 in gestation and gestation plus nursing pups (susceptible groups) 
compared to control pups (Fig. 5.7B). IL-13 concentrations were significantly lower in gestation 
pups compared to their nursing peers (Fig. 5.7B). Analysis of IL-13 production by CD3- cells 
following PMA/Ionomycin stimulation revealed significantly reduced proportions and numbers in 
gestation plus nursing compared to infected controls. We observed a trend towards a reduction in 
proportions as well as numbers of CD3-IL-13+ cells in other PMB infant groups (Fig. 5.7C). 
Finally, we found no difference in proportions and numbers of B cells across all infected pups 
(Fig. 5.7D). However, we found significantly higher levels of antigen specific IgG in gestation 
plus nursing pups versus control pups (Fig. 5.7E). Taken together, we show that PMB mediated 
alterations in maternal microbiota during gestation or the additive antibiotic effect of gestation 
plus nursing profoundly impacts offspring ability to control Nb infections largely by impairing IL-
13 production which is central in parasite clearance. 
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5.4 Discussion 
5.4.1 Maternal vancomycin and infant RSV model 
Toll like receptor 2 has been shown to control murine immune response to RSV (Murawski et al., 
2009) and is activated by soluble peptidoglycans and lipoteichocic acids, main stimulatory 
components in gram positive bacteria (Schwandner et al., 1999). We tested if depletion of gram 
positive bacteria (TLR2 activators) in mothers impacted RSV recognition and immunity in her 
offspring. Pups born to vancomycin treated mothers are susceptible to RSV infections in the early 
stage of the disease and this phenomenon is maintained throughout the viral pathogenesis in 
offspring born to dams treated with vancomycin during nursing. Unlike in adult mice, where RSV 
infection leads to dramatic weight loss, we and others describe a decline in rate of growth in RSV 
infected pups (Culley et al., 2002). This is expected since healthy pups should gain weight daily. 
Gestation plus nursing pups revealed a trend towards increased susceptibility similar to the nursing 
group but recovered day 7-post RSV challenge. When comparing the antibiotic groups, maternal 
antibiotic exposure during nursing (N, GN pups) led to enhanced susceptibility in offspring as 
these pups did not catch up with growth patterns of their uninfected controls. Exposure during 
gestation only (G pups) resulted in a similar phenotype as pups born to mothers who were not 
treated with vancomycin (C pups). RSV infected pups from these groups began to catch up with 
growth patterns of their uninfected controls from day 4 onwards. Together, our data reveals that 
maternal vancomycin exposure during nursing could accelerate RSV-associated failure to thrive 
in infants. These findings are in agreement with recently published work which demonstrated that 
maternal antibiotics during gestation and nursing accelerated mortality associated with vaccinia 
virus infection (Gonzalez-Perez et al., 2016).  However, our study is fundamentally different from 
Gonzalez-Perez’s, since our antibiotic intervention was only limited to maternal gut and 
vancomycin is poorly absorbed and was not detected either in maternal or offspring sera. In their 
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study, they used a mix of clindamycin and penicillin, both of which are absorbed, raising the 
possibility of these antibiotics being transferred to offspring. Furthermore, in their experiments, 
antibiotics were administered antepartum and throughout nursing to all dams, therefore, the effect 
could have been purely via breastmilk antibiotic transfer.  
Progressive intestinal colonization in infants has been shown to influence development of mucosal 
and systemic immune tissues and immune cell populations (Maynard et al., 2012). It is thought 
that NK cells are central to RSV immunity in the early onset while CD8 T cells seem to enhance 
RSV pathology (Lambert et al., 2014). Antibiotic groups had significantly lower numbers of total 
and activated NK cells compared to controls at day 4 post-infection. Consequently, these mice 
were susceptible to RSV and had an impaired ability to clear the virus. Data shows that mice 
lacking in microbiota early in life accumulate an invariant natural killer T cell population in the 
lungs and intestines which increases their susceptibility to IBD and asthma (Olszak et al., 2012). 
Moreover, antibiotic treatment in adult mice has been shown to provide anti-inflammatory signals 
by dampening proinflammatory cytokine production (Culic et al., 2001), impairing neutrophil 
recruitment (Sugihara et al., 1997) and function and altering dendritic cell function (Ishida et al., 
2007). Consequently, it is reasonable that antibiotic driven changes in maternal microbiota 
impacted both numbers and function of infant NK cells following RSV challenge which led to 
poor viral control in our model. It is possible that reduction of microbial density and diversity 
among the offspring interfered with the viral recognition process by impairing early innate 
processes and dendritic cells critical for T cell priming. Importantly, we noted significantly lower 
microbial diversity (described in chapter 4) in the nursing group which may be a strong 
contributing factor to RSV susceptibility. Considering that an aberrant microbiome has been 
shown to impact on DC function at least in adult mice (Ishida et al., 2007), it is likely that infant 
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DC ability to process RSV was hindered. In our next experiments, we will co-culture lung DCs 
isolated from control or vancomycin-infant groups with T cells and monitor proliferation as well 
as ability of the DCs to deliver important TH1 polarizing signal necessary for RSV immunity. 
Collectively, these events may potentially lead to an impaired antigen presentation to T cells. Our 
study was tailored towards examining the impact of the intestinal gut commensals on RSV 
immunity. The microbiota at the site of infection, the lung, would most likely be critical in 
influencing host immune responses to RSV. The study of the human lung microbiome and the 
context of pulmonary disease and health is an area of emerging research and it is not clear when 
the respiratory microbiome is established. A recent report in humans found a diverse airway 
microbiome at birth regardless of gestational age but older preterm infants with chronic lung 
disease had a less diverse microbiota, suggesting that dysbiosis in the airway microbiome may set 
the stage for subsequent lung disease (Lal et al., 2016). A related murine study reported the ability 
of lung microbiota to promote tolerance to allergens in neonates via PD-1 (Gollwitzer et al., 2014). 
Therefore, it is conceivable that the lung microbiota may have an immuno-modulatory potential 
and dictate immunological responses, at least in the lung. Although most bacteria populating infant 
lung are derived from contact with the mother’s flora during delivery, the ability of bacteria to 
translocate from the infant’s own gut to the lung in a gut-lung axis cannot be ruled out. This implies 
that the less diverse microbiota of infants born to vancomycin treated dams may potentially find 
their way to the lung. Here, there is a possibility that the microbiota host cross talk makes the lung 
more susceptible to injury and inflammation and may provide justification for susceptibility to 
RSV in these pups.  Host-microbiota interactions may not be the only factor driving immune 
development in infants. However, they appear to play an essential role.  
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At the later stage of RSV, day 8, we think CD8 T cells and not NK cells contributed to viral control 
in the lung. When we analyzed only the vancomycin infant groups, we noted significant increases 
in proportions of CD8 T cells in both gestation and gestation plus nursing comparing means at day 
4 and day 8. However, the increase in nursing group was not significant which suggests a limited 
expansion of CD8 T cells in nursing group which are critical for viral control. Beyond expansion 
in the CD8 pool, neonatal CD8 T cells may already be biased in terms of phenotype differentiation 
and have been shown to expand rapidly and quickly become terminally differentiated (Smith et 
al., 2014). Gut dysbiosis in infants is likely to skew this CD8 phenomenon further. Although we 
did not find any differences in proportions of CD8 T cells at day 8 post RSV, It is likely that 
intestinal dysbiosis may have led to alteration of immune function in CD8 cells delaying viral 
clearance in susceptible infant pups.  The modulatory effect of gut dysbiosis on the central and 
effector memory T cells could have critical implications. Others have shown alveolar macrophages 
to be indispensable in RSV immunity and that interferon gamma stimulation of these cells 
attenuated weight loss and led to enhanced viral immunity (Eichinger et al., 2015; Empey et al., 
2012). We found no significant differences in both alveolar macrophages and concentrations of 
interferon gamma in our model on day 8 post challenge. The profound differences in immune 
response to RSV in maternal vancomycin-infants is associated with reduction of bacteria quantity 
and diversity as well as alteration of taxonomic composition in the gut.  
Furthermore, microbial derived metabolites have been shown to attenuate pathology associated 
with allergic airway indirectly by expanding the T regulatory pool (Zaiss et al., 2015). Infant 
dysbiotic microbiota in our model may have altered systemic metabolite profile which led to a 
diminished ability of infants to mount protective and regulatory immune responses to RSV. In 
addition, we observed microbiota changes unique to the nursing group that may have contributed 
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to the underlying immunological phenomena. For example, Erysipelotrichiales which have been 
shown to be highly immunogenic (Kaakoush, 2015) were significantly less abundant only in the 
nursing pups. In addition, Staphylococcus and Mucispirillum OTUs which are potentially 
pathogenic were predominant in the nursing pups at genus level (chapter 4). Although we did not 
investigate the direct effect of these taxa on immunity, the idea that they could be contributing to 
changes in immunity in these infants permitting effective RSV pathogenesis cannot be ruled out. 
Furthermore, functional changes because of these microbial biomarkers in this group could also 
be associated with observed phenotype.  
Our data introduce a new paradigm of the relationship between maternal gut microbiota during 
lactation and offspring immunity to RSV. This to our knowledge is the first time this kind of 
relationship has been demonstrated using experimental RSV infection in a maternal infant model. 
We are convinced that disrupting maternal gut microbiota has consequences on infant immunity 
to RSV. Most studies of this nature have largely been based on association in humans. Our data 
could provide some useful insights into how alteration of gut composition in human mothers could 
potentially impact immunity in infants. Future work will evaluate how maternal gut microbiota 
during pregnancy programs infant lung microbiota and how these microbiota influences infant 
immunity to RSV. 
5.4.2 Maternal PMB and infant N. brasiliensis model 
In this model, we show offspring born to mothers treated with PMB during gestation or gestation 
plus nursing to be susceptible to primary N. brasiliensis infection. Pups were infected at 21 days 
of age with Nb and killed 5 days after. It has previously been shown that intestinal nematode 
infection in mice is associated with increase in gram negative bacteria (Enterobacteriaceae and 
Prevotella) in the small intestinal tract as well as the parasite-free large intestines (Rausch et al., 
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2013). Moreover, Ramanan et al. showed that helminth infection protect against Crohn’s disease 
in mice by promoting colonization resistance by gram negative (Bacteroides vulgatus) bacteria 
(Ramanan et al., 2016). These studies guided our approach to test the Nb model on pups born to 
dams treated with PMB as the direct role of gram negative bacteria on host immunity to helminths, 
particularly in infants is not clear. We observed significantly higher worm burden in the gestation 
or gestation plus nursing pups compared to infected controls. N. brasiliensis is shortlived and 
induce a strong and protective TH2 response which is critical for parasite clearance (Lawrence et 
al., 1996; Mohrs et al., 2001). IL-4 and IL- 13 are signature cytokines involved in establishment 
of TH2 immune responses (McKenzie et al., 1998). Early reports revealed that IL-4Rα, IL-13, 
Stat6 but not IL-4 are required for host protection against Nb (Urban et al., 1998). These cytokines 
have been shown to act on non-bone marrow derived cells effectively orchestrating helminth 
immunity (Madden et al., 2002; Shea-Donohue et al., 2001). Importantly, IL-13 has been linked 
to mucus production which has been positively associated with enhanced expulsion of Nb 
(McKenzie et al., 1998). When we analyzed the proportions of CD4 T cells capable of producing 
IL-13 after non-specific stimulation, we observed a trend towards decreasing proportions of CD4 
T cells producing IL-13 in pups born to PMB treated dams. Similarly, we found significantly 
reduced numbers of CD3- cells that expressed IL-13 in gestation plus nursing pups with a trend 
towards a decrease in gestation pups compared to control pups. Furthermore, we noted 
significantly reduced concentrations of IL-13 in small intestinal homogenates in gestation or 
gestation plus nursing pups. Together, our IL-13 data corroborated the intestinal worm burden 
data, depicting why these infant groups were susceptible to Nb; they were unable to mount an 
effective TH2 immune response that’s imperative for parasite control. This to our knowledge is 
the first time the role of maternal microbiota during gestation in establishment of TH2 immunity 
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in infants has been defined. Analysis of taxonomic profiles across all groups showed 
Enterobacteriales to be significantly less abundant in gestation and gestation plus nursing groups 
(susceptible to Nb). Enterobacteriales have been shown to increase following helminth infection 
in murine models and to be positively associated with TH2 immunity (Rausch et al., 2013). 
Reduction in abundance of members in this taxon in susceptible groups could be associated with 
impaired TH2 immunity. In addition, Lactobacillus were significantly increased in gestation and 
gestation plus nursing pups (susceptible groups). Bacteria members in this genus have previously 
been shown to exhibit a mutualistic relationship with helminths where they support greater 
establishment of helminths in the gut (Reynolds et al., 2014).  Therefore, it is likely that the 
preponderance of Lactobacillus in the gut of susceptible offspring groups led to a receptive 
intestinal environment, further supporting pathogenesis of N. brasiliensis. Hayes et al described a 
similar phenomenon where bacteria taxa including Escherichia coli, Staphylococcus and 
Pseudomonas promoted hatching of Trichuris muris eggs (Hayes et al., 2010).  Others have 
demonstrated a central role of TH2 immunity in promoting colonization resistance and altering 
resident gut composition (Fricke et al., 2015; Ramanan et al., 2016). Our study adopted a different 
approach where changes in maternal gut bacteria were antibiotic mediated but not helminth driven. 
Secondly, we utilized a maternal infant model to examine the impact of an altered maternal gut on 
helminth immunity in offspring making our findings novel as far as infant TH2 immunity is 
concerned. Future experiments will focus on testing members of order Enterobacteriales in both 
mothers and offspring to farther our understanding of microbe host crosstalk that drive TH2 
immunity in infants. We will also investigate the role of the lung microbiota on helminth immunity 
and how this may impact other immune populations which are central to helminth immunity such 
as the innate lymphoid cells 2 (ILC2s) and alveolar macrophages 
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CHAPTER 6 
6.0 RESULTS SECTION III 
6.1 Influence of preconception helminth infection on infant gut microbiota and immunity 
6.1.1 Introduction 
Various factors that influence early gut colonization are derived from the mother (Koenig et al., 
2011). Maternal disease and infection status may impact offspring microbiota. For example, 
taxonomy analysis suggested that the overall bacteria content significantly differed between 
meconium from babies born to mothers with diabetes versus controls, where Bacteroidetes and 
Parabacteroides were enriched in meconium from diabetes group (Hu et al., 2013). Recently, 
maternal HIV infections have been shown to influence microbiota in HIV exposed but uninfected 
infants (Bender et al., 2016). Other maternal infections such as helminths may potentially have a 
similar impact on offspring gut microbial composition. Helminths are estimated to infect 2 billion 
people worldwide and susceptibility is increased during pregnancy (Woodburn et al., 2009; Yatich 
et al., 2009). Furthermore, helminth infections impact the microbiota. For instance, 
Heligmosomoides polygyrus (H. polygyrus) infection in mice led to an increased abundance of 
Lactobacillus and Enterobacterial loads in the gut (Rausch et al., 2013; Reynolds et al., 2014). 
Interestingly, a mutualistic relationship has been described between commensals and helminths. 
H. polygyrus infection led to an expansion of Lactobacillus taiwanensis which allowed for 
establishment of the parasite and survival in the gut (Reynolds et al., 2014). In addition, the 
microbiota has been shown to be essential in hatching of T. muris eggs (Hayes et al., 2010).  Yet 
whether the interaction between maternal gut bacteria and the intestinal helminths influences gut 
microbiota of the progeny remains unknown. Aside from maternal infection and disease status, 
diet is a key determinant of infant gut colonization postpartum (Mackie et al., 1999). Breastmilk 
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provides the first source of nutrition in infants and leads to transfer of bacteria which are thought 
to be key in the development of intestinal homeostasis (Beattie & Weaver, 2011). Furthermore, 
breastmilk helps in shaping the immune response in the progeny. For example, its role in 
prevention of diseases such as asthma has been elucidated (Verhasselt et al., 2008). Other 
components such as lactoferrins and defensins inhibit pathogens and further contribute to 
microbiota colonization. (Morrow & Rangel, 2004). Despite this, our understanding of the impact 
of maternal helminth infections on the microbial composition in breastmilk is not well developed. 
In this chapter, we explore the effect of preconception maternal helminth infection on maternal 
and infant gut microbiota using a mouse model of Nippostrongylus brasiliensis (Nb). We also 
examine how maternal helminth infections impact breastmilk microbiome  
6.1.2 RESULTS 
6.1.2.1 Preconception Nippostrongylus brasiliensis infection alters maternal intestinal 
microbiome during pregnancy. 
We infected seven 6-week-old female mice per group with 500Nb L3 subcutaneously, or left them 
uninfected. Seven days later, all mice were treated with Ivermectin for 7 days to clear the infection 
(although naturally an immunocompetent host clears Nb infections by day 9). Three weeks post 
infection, dams were mated and males removed from the cages 8 days after introduction. Eight 
days after males were isolated from the cages, maternal fecal microbiome during pregnancy was 
analyzed (Fig. 6.1A). We found significantly higher microbial diversity in pregnant previously 
infected (PI) dams compared to pregnant naïve dams (p=0.0185, ANOVA, Fig. 6.1B). Principal 
coordinate analysis of all samples revealed distinct clustering based on grouping. The largest 
variation was explained on PC1 (37%) and appeared to be driven by previous Nb infection (Fig. 
6.1C). 
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Figure 6.1: Preconception Nippostrongylus brasiliensis infection significantly increases 
microbial diversity in stool during pregnancy and result in distinct clustering according to 
beta diversity. (A) Female BALB/c mice were infected with 500Nb L3 and infection cleared 7 
days post infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice were 
mated. Fecal samples were collected from pregnant dams approximately 5 days prior to delivery 
for microbiome analysis. (B) Alpha diversity as measured by chao1. (C) Principal coordinate 
analysis showing bray curtis distances of maternal microbial communities. Data are representative 
of two independent experiments. PI – Previously infected. n=6-7 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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Figure 6.2: Preconception Nippostrongylus brasiliensis infection significantly impacts 
maternal stool microbiota during pregnancy. Female BALB/c mice were infected with 500Nb 
L3 and infection cleared 7 days post infection (p.i) by oral Ivermectin treatment for 7 days. 21d 
post infection, mice were mated. Fecal samples were collected from pregnant dams approximately 
5 days prior to delivery for microbiome analysis. Mean bacteria abundance at (A) Phylum level, 
(B) Class level and (C) Genus level. Analysis by ANOVA with FDR adjustment for multiple 
comparisons. Error bars show SEM. Data are representative of two independent experiments. PI – 
Previously infected. n=7-8 per group. *p<0.05, **p<0.01, ***p<0.001. 
 
 
At the phylum level, we reported significantly higher abundance of TM7 in pregnant PI dams 
compared to naïve pregnant dams (p=0.043, FDR=0.22). There was no difference in abundance of 
Bacteroidetes between the two dam groups (p=0.054, FDR=0.22, Fig. 6.2A). Our analyses at the 
family level showed Odoribacteraceae, F16 and Enterococcaceae to be significantly increased in 
pregnant PI dams compared to pregnant naïve dams (p=0.0092, 0.0055 and 0.0056, FDR=0.034, 
0.024 and 0.024 respectively). Prevotellaceae, Turicibacteraceae and Bacteroidaceae were 
predominant in pregnant naïve dams (Fig. 6.2B). At genus level, Oribacterium, Odoribacter and 
Enterococcus dominated fecal microbiota of pregnant PI dams while Turicibacter, Prevotella, 
Helicobacter and Bacteroides were enriched in naïve controls (Fig. 6.2C). Together, these data 
demonstrated that maternal N. brasiliensis infections alters maternal gut microbiota during 
pregnancy. This raises questions as to whether helminth driven modulations of intestinal 
microbiota during pregnancy potentially have repercussions on the offspring gut microbial 
colonization and immunity. 
 
 
 
134 
 
6.2 Influence of Nippostrongylus brasiliensis on breastmilk microbiota 
The human milk provides the first source of nutrition for the infant and contains optimal 
ingredients required for growth and development. In addition, breastmilk educates the developing 
immune system and confers a certain degree of protection against gastrointestinal and other 
infections. Therefore, we next asked if the impact of preconception helminth infections on the 
microbiota goes beyond the gut by examining the impact of helminth infections prior to pregnancy 
on breast milk microbiome. Given the difficulty in obtaining milk from female dams, we collected 
breast milk from the pup’s stomachs 14 days post-partum (Fig. 6.3A). At this time point, pups are 
still exclusively breastfeeding and are not taking any other solid food or liquids. When we analyzed 
breastmilk microbiota, we found no significant difference in alpha diversity between breastmilk 
obtained from naïve versus PI dams (p=0.62, ANOVA, Fig. 6.3B). However, there was distinct 
clustering of the OTUs in breast milk based on grouping. The highest variability of 42% was 
explained on PC1 and was associated with previous Nb infection in mothers (Fig. 6.3C). 
Proteobacteria were increased in milk from naïve dams compared to PI dams but the difference 
did not reach statistical significance (p=0.094, FDR=0.22). There was no significant difference in 
abundance of Actinobacteria, Bacteroidetes and Firmicutes (Fig. 6.4A). 
At the family level, we noted a significant increase in abundance of Paraprevotellaceae, S24-7, 
Rikenellaceae, Prevotellaceae, Erysipelotrichaceae, Enterobacteriaceae and Coriobacteriaceae in 
breastmilk obtained from PI dams compared to naïve dams. Other families including 
Corynebacteriaceae and Porphyromonadaceae were abundant in breastmilk from naïve dams (Fig. 
6.4B). Similarly, at genus level, Prevotella, Parabacteroides, Collinsella, CF231, Klebsiella and 
Allobaculum dominated breastmilk microbiome in PI dams while Sporosarcina, Porphyromonas 
and Corynebacterium were enriched in breastmilk from naïve (Fig. 6.4C). Altogether, we show 
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here that preconception Nb infections impact breastmilk microbiota and that these microbiota is 
unique from fecal microbiota. 
 
Figure 6.3: Preconception Nippostrongylus brasiliensis infection has no impact on microbial 
diversity in breastmilk but results in distinct clustering according to beta diversity. (A) 
Female BALB/c mice were infected with 500Nb L3 and infection cleared 7 days post infection 
(p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice were mated. 14days 
postpartum, pups were killed and breastmilk pellet collected from their stomach and used for 
microbiome analysis. (B) Alpha diversity in breastmilk microbiota measured by chao1. (C) 
Principal coordinate analysis by bray Curtis distance of breastmilk microbiota. Data representative 
of two independent experiments. PI – Previously infected. n=7-10 per group. *p<0.05, **p<0.01, 
***p<0.001. 
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Figure 6.4: Preconception Nippostrongylus brasiliensis infection impacts breastmilk 
microbiota. Female BALB/c mice were infected with 500Nb L3 and infection cleared 7 days post 
infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice were mated. 14days 
postpartum, pups were killed and breastmilk pellet collected from their stomach and used for 
microbiome analysis. Mean bacteria abundance at (A) Phylum level, (B) Class level and (C) Genus 
level. Analysis by ANOVA with FDR adjustment for multiple comparisons. Error bars show SEM. 
Data are representative of two independent experiments. PI – Previously infected. n=7-8 per group. 
*p<0.05, **p<0.01, ***p<0.001. 
 
6.3 Preconception Nippostrongylus brasiliensis infections influence offspring intestinal 
microbiota and immunity 
Having established that prior Nb infections alter both maternal intestinal microbiota during 
pregnancy as well as breast milk microbiota and that alterations were not similar in these sites, we 
sought to investigate whether changes in maternal microbiome in the two sites, influence gut 
colonization in her offspring. As before, female mice were infected with 500Nb L3. The control 
group was not infected. A week after the infection, all mice (infected and controls) were treated 
with Ivermectin in drinking water for 7 days to clear the infection (10mg/ml). Mice were rested 
for a week post Ivermectin treatment, after which they were mated. We analyzed fecal microbiota 
in pups born to previously helminth infected or naïve dams at day 14 of life (Fig. 6.5A). Fecal 
samples were collected from the colons of individual pups so as not to confuse maternal and pup 
stool, and microbiome analysis conducted using the 16S DNA sequencing approach as before. 
Throughout these experiments, parents were maintained on the same diet of normal chow. Hence 
any changes observed in offspring intestinal microbiota or immunity were solely because of 
preconception Nb infections in dams. We observed no significant difference in alpha diversity in 
pups born to previously infected (PI) mothers compared to controls (Fig. 6.5B). However, we 
noted distinct clusters between the two groups as revealed by principal coordinate analysis of 
infant fecal microbiota at day 14 suggesting profound differences in the microbiota (Fig. 6.5C). 
Indeed 37% of total variability was explained by PC1 and could be attributed partly to previous 
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maternal infections. At phylum level, we found a trend towards higher abundance of Bacteroidetes 
in offspring born to PI dams while Firmicutes were reduced but these differences did not reach 
statistical significance (Fig. 6.6A). Analysis of predominant bacteria taxa at family displayed 
significantly higher abundance of Mycoplasmataceae, Micrococcaceae and Coriobacteriaceae in 
pups born to PI dams (p=0.035, 0.0012 and 0.046, FDR=0.091, 0.016 and 0.11 respectively, Fig. 
6.6B). At genus level, Adlercreutzia and Arthrobacter were enriched in pups born to PI dams while 
Streptococcus, Ruminococcus, Blautia and Corynebacterium were predominant in pups born to 
naïve dams (Fig. 6.6C). In a separate experiment to investigate the period in which microbiota 
transfer occurs from mother to offspring, we transferred pups born to PI dams to be nursed by 
lactating naïve mothers and those born to naïve dams to lactating PI mothers, 3 days after delivery. 
We analyzed stool microbiota at 14 days as before. Principal coordinate analysis demonstrated that 
microbiota from PI dams to their offspring were transferred both transplacentally and while 
breastfeeding (Appendix C, Fig. C1).  The key microbiota altered in maternal gut, breastmilk and 
offspring following maternal Nb infection are summarized in table C2, Appendix C. Taken 
together, we show that preconception N. brasiliensis infections impacted composition of bacteria 
colonizing the infant gut. This can be attributed at least, in part to the impact of helminth infection 
on both maternal gut and breastmilk microbiome.  To our knowledge, this is the first time the 
relationship between preconception helminth infections and offspring gut microbiota has been 
described. 
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Figure 6.5: Preconception Nippostrongylus brasiliensis infection has no impact on offspring 
stool microbial diversity but leads to distinct clustering by grouping according to beta 
diversity. (A) Female BALB/c mice were infected with 500Nb L3 and infection cleared 7 days 
post infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice were mated. 
14days postpartum, pups were killed and fecal samples collected from their colons for microbiome 
analysis. (B) Chao1 alpha diversity of infant microbiota. (C) Principal coordinate analysis of infant 
microbiota by bray curtis distance. Data are representative of two independent experiments. PI-
Previously infected. n=10 per group. *p<0.05, **p<0.01. 
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Figure 6.6: Preconception Nippostrongylus brasiliensis infection impacts gut microbiota in 
infant 14 days postpartum. Female BALB/c mice were infected with 500Nb L3 and infection 
cleared 7 days post infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice 
were mated. 14days postpartum, pups were killed and fecal samples collected from their colons 
for microbiome analysis. Mean bacteria abundance at (A) Phylum level, (B) Family level and (C) 
Genus level. Analysis by ANOVA with FDR adjustment for multiple comparisons. Error bars 
show SEM. Data are representative of two independent experiments. PI – Previously infected. 
n=10 per group. *p<0.05, **p<0.01, ***p<0.001. 
 
Since microbial colonization of the infant gut is crucial for immune development, we also analyzed 
pup immunity. We set up the experiment as before and examined cells in the spleen and mesenteric 
lymph node (MLNs) 14 days postpartum (Fig. 6.7A). There were significantly higher total cell 
numbers in spleens of pups born to PI dams (Fig. 6.7B). Moreover, we found significantly higher 
total numbers of CD3+CD4 cells, activated CD4 T (CD3+CD4+CD44hi) cells as well as T 
regulatory cells (CD3+CD4+FoxP3+) (Fig. 6.7C, D and E). When we stimulated total cells with 
PMA and Ionomycin, we noted a significantly higher proportion of CD4+ T cells expressing IL-
13 in offspring born to PI mothers when compared to those born to naïve mothers (Fig. 6.7F). 
Similarly, total B cells were significantly higher in offspring born to PI dams when compared to 
naïve dams (Fig. 6.7G). Unexpectedly, we did not find any difference in the proportion and total 
numbers of cellular populations in the MLNs (Fig. 6.8). Altogether, our immunological data 
provides evidence of early activation of adaptive immunity in the spleens of pups born to PI dams. 
These pups also have unique microbiota compared to those born to naive dams which raises the 
possibility of microbiome involvement either directly or indirectly in the early changes in 
immunity. 
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Figure 6.7: Preconception Nippostrongylus brasiliensis infection alter spleen immune 
populations in infants. (A) Female BALB/c mice were infected with 500Nb L3 and infection 
cleared 7 days post infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice 
were mated. 14days postpartum, pups were killed. Spleens were collected and immune populations 
characterized by FACS. (B) Total cell counts in spleen, (C) CD4 T cells (CD3+CD4+), (D) 
Activated CD4 T cells (CD4+CD44hi), (E) T regulatory cells (CD3+CD4+FOXP3+), (F) CD4 T 
cells expressing IL-13 following PMA/Ionomycin stimulation for 4 hours and (G) Total B cells 
(CD19+B220+). Graphs are shown as mean ± SEM and analyzed by Mann Whitney U test. Data 
are representative of two independent experiments. n=5-6 per group. PI- previously infected. 
*p<0.05, **p<0.01. 
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Figure 6.8: Preconception Nippostrongylus brasiliensis infections does not significantly alter 
immune populations in MLNs in the offspring. Female BALB/c mice were infected with 500Nb 
L3 and infection cleared 7 days post infection (p.i) by oral Ivermectin treatment for 7 days. 21d 
post infection, mice were mated. 14days postpartum, pups were killed. Mesenteric lymph nodes 
were collected and immune populations characterized by FACS. (A) Total cell counts in MLNs, 
(B) CD4 T cells (CD3+CD4+), (C) Activated CD4 T cells (CD4+CD44hi), (D) T regulatory cells 
(CD3+CD4+FOXP3+), (E) Total B cells (CD19+B220+). Graphs are shown as mean ± SEM and 
analyzed by Mann Whitney U test. Data are representative of two independent experiments. n=5-
6 per group. PI- previously infected. 
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6.4 Discussion 
In this chapter, we have characterized how preconception helminth infections impact intestinal 
microbiota of dams and pups using a murine model of Nippostrongylus brasiliensis. Although we 
treated both control and experimental mice with Ivermectin 7 days post infection, we were still 
able to pick up differences in maternal microbiota during pregnancy suggesting that helminths 
induce immediate and lasting changes in resident bacteria community in the gut. By the time of 
mating, dams presumably had no worms residing in their gut, yet likely had Th2 immune memory 
to Nb infection. Previous studies have reported an impact of helminth infections on microbiota in 
both murine and human subjects (Cooper et al., 2013; Fricke et al., 2015; Lee et al., 2014; Rausch 
et al., 2013; Reynolds et al., 2014).  
However, to our knowledge, this is the first report that investigates the impact of helminth 
infections on microbiota during pregnancy. In terms of compositional changes, we observed trends 
towards a decrease in abundance of Firmicutes, Bacteroidetes and Actinobacteria in pregnant PI 
dams. These findings contradict those of Fricke and colleagues who observed an increased 
abundance of Bacteroidetes and Actinobacteria in N. brasiliensis infected mice (Fricke et al., 
2015). Considering that N. brasiliensis was used in both studies, it is possible that the timing of 
microbiota analysis could have driven these changes. While we analyzed the microbiota in 
pregnant dams, Fricke et al. monitored microbiota in non-pregnant mice. Indeed data shows that 
the microbiota undergoes profound changes during pregnancy (Koren et al., 2012). It is possible 
that changes in PI dams occurred as a result of hormonal changes during pregnancy.  
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When we analyzed breast milk microbiota, we noted a significantly higher abundance of 
Paraprevotellaceae and Prevotellaceae in dams that were PI compared to naïve dams. However, 
these families were significantly reduced in the gut of these dams during pregnancy. This suggests 
that the gut microbiota during pregnancy does not necessarily mirror breastmilk microbiota and 
that some Nb driven changes could be partly site specific. Conversely, we noted significantly less 
abundance of Porphyromonadaceae in both the gut during pregnancy of PI dams and breastmilk 
from the same group indicating that some taxa were present in similar levels at both sites. This 
could further point to the existence of a gut-breastmilk microbiome axis, whereby alterations in 
the gut lead to alterations in breastmilk microbiome. Breastfeeding has been shown to be critical 
in primary prevention of asthma and allergic diseases (Friedman & Zeiger, 2005). In addition, 
helminth infections modulate allergic inflammation by regulating Th2 responses (Zaiss et al., 
2015). It is possible that helminth driven changes of breastmilk microbiota lead to transfer of 
regulatory immune components which dampens excessive Th2 responses associated with allergy 
in infants. 
There is growing appreciation that commensal microbes may contribute fundamentally to the 
growth, development and immune maturation of infants and may have lasting consequences (Cox 
et al., 2014; Hong et al., 2010; Nobel et al., 2015; Sjögren et al., 2009). Emerging studies have 
challenged the dogma of a sterile uterine environment and demonstrated presence of bacteria in 
fetal membranes (Jones et al., 2009), amniotic fluid (DiGiulio et al., 2008), meconium (Hu et al., 
2013) and recently the placenta (Aagaard et al., 2014; Collado et al., 2016) suggesting that 
microbial colonization may occur prior to delivery. Previous reports revealed that maternal 
diabetes impacted the microbial composition in meconium, suggesting that maternal disease and 
infection could impact bacterial composition in her offspring (Hu et al., 2013). We used a similar 
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approach to analyze the impact of helminth infections prior to pregnancy on offspring gut 
microbiota. We noted dramatic differences in offspring gut microbiota in infants born to PI dams 
compared to uninfected dams. Arthrobacter and Adlercreutzia were significantly elevated in pups 
born to PI dams. These genera were not detected in maternal gut or breastmilk indicating the 
existence of other sources of microbiota colonisation in infants. Moreover, Odoribacter, 
Oribacterium and Enterococcus were predominant in the maternal gut of PI dams but these were 
undetected in the offspring gut. We observed a similar phenomenon with Klebsiella, Collinsella 
and Allobaculum which were enriched in breastmilk microbiota of PI dams. These trends and 
associations suggest that gut colonization in offspring following preconception helminth infections 
does not necessarily mirror maternal gut or breast milk microbiome. Our microbiome data in 
chapter 4 where we looked at trends in gut bacteria in offspring having treated parents with 
antibiotics also revealed a consistent phenomenon. When we analyzed the period in which most 
microbiota are transferred to offspring, PCA analysis revealed that both in utero and nursing were 
important phases for microbiome transfer suggesting that microbiota-dependent helminth immune 
modulation may begin in utero and continue while breastfeeding. Our next experiments will 
investigate whether Nb induced changes in maternal microbiome can be transferred by cohousing 
and if this Nb-induced microbiota has a role in infant immunity to helminths. Others have shown 
that H. polygyrus induced changes in intestinal microbiota protect against allergy and transfer of 
H. polygyrus-modified microbiota alone by cohousing was sufficient to mediate protection against 
allergic asthma (Zaiss et al., 2015). Analysis of offspring immunity in the spleens revealed early 
activation of adaptive immune system in offspring born to infected dams. We noted significantly 
increased total numbers of CD4+ T cells, activated CD4+ T cells (CD4+CD44hiCD62Llo), T 
regulatory cells (CD4+FoxP3+) as well as B cells in spleens. Our data is consistent with 
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unpublished work from the Horsnell’s lab that has observed a similar phenomenon in offspring 
born to Nb infected mothers. Although our analysis is based on association, we think that Nb driven 
changes in maternal microbiota, which are transferred to offspring during delivery and lactation, 
could be involved in early induction of adaptive immunity and aid in establishment of anti-
helminth immunity among her progeny. It is also possible that microbiota changes in offspring as 
a result of maternal helminth infections could be involved in early immune programming. Our 
future studies will investigate this hypothesis further in causality models. We will utilize 
gnotobiotic models to examine the immune impact of Adlercreutzia and Arthrobacter which we 
have identified as microbial markers for offspring born to PI dams.  
Overall, our data describes in detail for the first time, changes in gut microbiota in dams during 
pregnancy and associated outcomes in offspring microbiota. We show conclusively that maternal 
infections with Nb prior to pregnancy alters gut microbiome and diversity in dams. Beyond the 
gut, Nb infections also impact breast milk microbiota. Moreover, preconception Nb infections 
influence gut composition in offspring at 14 days of life at least in murine hosts. 
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CHAPTER 7 
7.0 Conclusion and future work 
7.1 Summary of results 
The gut microbiota plays a significant role in maintaining immune homeostasis and ability to 
combat disease by programming the immune system (Atarashi et al., 2011; Nistal et al., 2012; 
Nylund et al., 2014). The composition of early bacteria colonizing the infant gut is largely 
dependent on the maternal-offspring transfer of microbiota. It has historically been assumed that 
the fetus is sterile and that colonization of the infant gut only begins after delivery. However, recent 
studies have identified bacteria in fetal membranes (Jones et al., 2009) and placenta of healthy 
pregnancies (Aagaard et al., 2014) suggesting that gut colonization could begin prior to delivery. 
Regardless of in utero exposure, massive bacterial colonization begin at birth upon exposure to 
vaginal, skin or environmental microbiota (Dominguez-Bello et al., 2010). Some of the factors 
that drive profound shifts in offspring microbiota include C-section delivery, formula feeding and 
antibiotic use.  
Antibiotic driven insults on the maternal microbiota during pregnancy may increase offspring risk 
of obesity (Mueller et al., 2015) and asthma (Metsälä et al., 2015). Other factors that may alter 
bacteria composition in offspring include maternal infections or disease status. For example, 
maternal diabetes leads to diversified microbiota in the meconium (Hu et al., 2013). Furthermore, 
maternal infections, such as HIV, alter infant gut microbiota (Bender et al., 2016). In our first set 
of experiments, we investigated the impact of maternal intestinal microbiota during gestation or 
lactation on offspring gut colonization and immune development. The second aspect of our work 
delved into the influence of preconception helminth infections on offspring gut bacteria as well as 
immunity. These aspects were independent of each other but both examined the effects of maternal 
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events on infant gut microbial colonization and added novel insights to the existing body of work 
on this topic.  
Treatment of dams with vancomycin during gestation or lactation led to profound differences in 
offspring growth, microbiota and immunity. Pups born to dams treated with vancomycin only 
while nursing had significantly higher body weight, and although not significant, vancomycin 
treatment during gestation also led to increased weight in pups.  Administration of vancomycin 5 
days prior to delivery through 14 days of nursing did not cause alterations in pup weight. Moreover, 
offspring born to antibiotic treated dams regardless of timing of treatment had significantly higher 
total spleen cells but the splenic weights were not different. Polymyxin B maternal treatment, also 
impacted offspring body weight. Pups born to dams treated with polymyxin B during gestation or 
nursing had significantly higher body weight while prolonged polymyxin B modulation of 
maternal microbiota had a non-significant impact on offspring weights. There were no differences 
in the spleen weights but total immune cells were significantly lower in all antibiotic infant groups. 
When the two antibiotics were used in combination, we observed trends similar to effects driven 
by vancomycin only administration in terms of offspring body weights, spleen weights and total 
cell numbers. Although we did not examine maternal glucose tolerance or other metabolic 
consequences in the mother, these data have implications on potential alteration of maternal 
microbiota on infant growth. 
Manipulating maternal gut microbiome using vancomycin significantly impacted the gut microbial 
community in offspring. Treating dams with vancomycin 5 days prior to delivery led to a distinct 
microbiota in the offspring, which was unique from control pups and from the nursing treatment 
pups, indicating that colonization begins prior to delivery and that maternal microbiota during 
pregnancy influences early infant gut composition. Further, offspring born to vancomycin breeders 
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had reduced microbial diversity in their gut and an abundance of Proteobacteria, which are features 
of chronic gut inflammation. Moreover, Bacteroidetes were significantly less abundant in the 
antibiotic groups versus control pups. Since Vancomycin has no spectral activity against 
Bacteroidetes, this supports existence of an indirect mechanism by which vancomycin treatment 
in dams mediates gut microbial alterations in offspring. This was confirmed by the lack of 
detectable Vancomycin in the plasma of dams and pups, and will be a subject for our future studies. 
Polymyxin B driven insults on gut microbiota in dams led to reduced abundance of Proteobacteria 
and Deferribacteres across all antibiotic infant groups. Principal component analysis revealed 
unique clusters in the various groups suggesting distinct microbiomes are developed during 
different periods of maternal exposure, although the impact was not as drastic as what we observed 
by vancomycin treatment and there was some overlap between G and GN groups. Interestingly, 
although maternal microbiota is critical in determining the initial bacteria colonizing the offspring, 
our data shows that offspring microbiota in all groups was distinct from that of the mother. 
Administration of vancomycin, polymyxin B or a mixture of the two antibiotics profoundly 
impacted on offspring peripheral immunity in the spleens in terms of proportions of T and B cells 
and their subsets. Maternal oral vancomycin led to significant reduction in infant central memory 
CD4+ T cells (CD3+CD4+CD44hiCD62Lhi) regardless of antibiotic timing. We observed 
significantly lower proportions of CD4+ T cells in offspring born to dams treated with polymyxin 
B. Administering polymyxin B to mothers while nursing led to significantly reduced proportions 
of effector memory CD4+ T cells (CD3+CD4+CD44hiCD62Llo) while treatment during gestation 
or gestation plus nursing significantly increased proportions of central memory CD4+ T cells in 
offspring. Beyond T cells, we also reported significant alterations in offspring B cell compartment. 
Pups born to dams treated with vancomycin while nursing or gestation plus nursing had 
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significantly reduced proportions of B cells (CD19+B220+), follicular B cells (CD19+CD23+) 
and marginal zone B cells (CD19+CD21+) compared to control pups. Maternal PMB treatment 
during nursing or gestation plus nursing led to a significant increase in proportions of follicular B 
cells among her offspring. Administering a mixture of vancomycin and PMB also impacted B cells 
in a manner similar to vancomycin alone. 
Upon infection with RSV intranasally at 3 weeks of age, offspring born to vancomycin breeders 
were more susceptible to disease in the early stage of the infection (day 4 post RSV). This was 
demonstrated by significantly reduced rate of growth and significantly lower weights versus 
controls in the early stage of the disease. Further, offspring born to vancomycin treated dams had 
higher viral load burdens in their lungs compared to controls, indicating the microbiota had a role 
to play in viral immunity. Indeed, vancomycin treatment only while nursing resulted in a RSV 
susceptible phenotype throughout the experiments whereas the other antibiotic groups recovered 
between day 5 and 7. Our helminth model also supports these results where we subjected offspring 
born to polymyxin B breeders to Nippostrongylus brasiliensis infection to test the Th2 arm of 
immunity. We found significantly higher worm burden in the intestines in offspring born to dams 
treated with polymyxin B during gestation or gestation plus nursing compared to controls. These 
data are corroborated by the IL-13 cytokine levels, which were significantly lower in the 
aforementioned groups, which explains why these pups were unable to clear the infection. Similar 
to the effect we observed of microbiota on RSV immunity, our helminth data extends this dogma 
and shows that maternal microbiota during pregnancy has a role to play in the establishment of 
optimal Th2 immunity in offspring.  
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In the final results chapter, we show that preconception infection with the rodent nematode; N. 
brasiliensis impacts maternal microbiota during pregnancy. Preconception Nb infections 
significantly increased microbial diversity during pregnancy. In addition, PI dams had significantly 
higher abundance of Enterococcaceae, F16 and Odoribacteraceae during pregnancy. Further, 
preconception Nb infections altered breastmilk microbiota. At the family level, there was an 
increase in Paraprevotellaceae, Prevotellaceae, Enterobacteriaceae, Coriobacteriaceae and S24-7 
families in the milk of previously infected dams. However, Nb infections significantly reduced 
Porphyromonadaceae and Corynebacteriaceae in breastmilk. Changes in microbiota were also 
reflected in their offspring and these did not always mirror maternal microbiota. We found 
dramatic differences in gut microbiota in offspring born to previously Nb infected dams compared 
to offspring born to naïve dams. 
Taken together, our data shows that manipulating maternal gut microbiota during gestation and or 
lactation profoundly impacts offspring growth, intestinal microbiota and peripheral immunity. 
Moreover, offspring born to antibiotic breeders are susceptible to both RSV and Nb infections 
indicating a critical role of maternal microbiota during pregnancy and lactation in influencing 
immune development in her young ones. Further, helminth infections prior to pregnancy impact 
murine gut microbiota during pregnancy and consequently alter offspring microbiota, which may 
be associated with early immune activation in infant mice. 
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7.2 Future work 
While we have generated a significant body of work in the field of infant microbiome and 
immunity as well as the role of maternal gut microbiome in programming offspring immunity, 
several questions remain unanswered. We have shown from our maternal antibiotics experiments 
that altering the maternal gut during gestation or lactation profoundly impacts body weight and 
development in offspring. While it is clear, the microbiome is involved in driving metabolic 
changes in the mothers, which then impact the offspring, the exact mechanism of these biological 
occurrences is unknown. Various scenarios are likely including epigenetic changes that could 
begin in utero or transfer of microbiota with an altered energy harvest capability. An additional 
explanation could be local generation of bacterial metabolites which translocate to the offspring in 
utero or during breastfeeding. To further delineate this, follow-up experiments could include 
determination of breastmilk and serum levels of short chain fatty acids in mothers and offspring 
respectively. We will utilize mouse models deficient in short chain fatty acid receptors: Free Fatty 
Acid receptor 2 and 3 (FFA2 and FFA3) to further understand the role of SCFAs in conferring 
metabolic phenotypes in offspring. 
Moreover, we observed profound changes in offspring gut microbiota in pups born to vancomycin 
breeders. These changes were only as a result of direct intervention in maternal gut since 
vancomycin was not absorbed and we did not detect it in maternal and offspring serum. Part of the 
mechanism which drove changes in offspring intestinal microbiota could include bacteria 
translocation to the placenta. However, it is also possible that vancomycin in dams could indirectly 
alter microbiota in other sites such as breastmilk and the genital tract which consequently would 
influence infant microbiota. In our next experiments, we will analyze breastmilk as well as genital 
tract microbiome in dams fed on vancomycin versus controls. This will further our understanding 
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of how vancomycin impacts maternal microbiota and shed light on mechanisms by which 
alterations in infant microbiota occur. 
Most importantly, we present findings that an altered maternal microbiota during gestation or 
lactation has health consequences for the offspring, including altered immune development. This 
indicates that microbial signals from the dams during this unique period are critical for optimal 
development of offspring immunity. We observed drastic changes both T and B cell compartments 
when pups are born to dams treated with antibiotics. Next, we will investigate functionality of 
these cells (T and B), studying the cytokine profiles and ability to produce antibody. In addition, 
for maternal vancomycin experiments will analyze maternal microbiota during pregnancy. We will 
then gavage fecal material obtained from SPF mice during pregnancy to pregnant germ free mice 
and investigate the effect on inherent B cells in offspring. Furthermore, we will isolate individual 
bacteria from the fecal material and mono-colonize pregnant germ free mice to determine 
individual bacteria with a significant effect on offspring B cell compartment. 
Moreover, when we challenged offspring born to antibiotic breeders either with RSV or Nb, we 
noted that antibiotic treatment in dams rendered the offspring susceptible. This introduced a novel 
conceptual framework showing rather unappreciated players in shaping both Th1 and Th2 
immunity in infants. While our findings clearly show that microbes were necessary for optimal 
immunity to these pathogens which tested various arms of cellular immunity, we were not able to 
link specific microbes to these functions. Our next experiments will test individual effects of the 
abundant bacterial taxa on immunity using germ free models. Further, although our intervention 
was directed at the maternal gut, we showed that these changes altered respiratory immunity in 
offspring which raises interesting questions as to how the gut could be interacting with immune 
cells in the lung of the offspring which will also be a subject of further investigation. 
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Our findings in the last chapter show that preconception Nb infections alter not only maternal gut 
microbiota during pregnancy but also the offspring microbiota. Although we treated dams with 
Ivermectin to clear the Nb antigen from the host, we detected changes in microbiota during 
pregnancy suggesting that Nb modulated alterations of microbiota were lasting beyond the active 
infection. Alterations in the gut community were also revealed in their offspring at 14 days of life, 
implying long-lasting effects on pup gut microbiota, likely mediated by alterations in breastmilk 
microbial makeup Apart from the changes in microbiota, we also noted early activation of the 
adaptive immune system in offspring born to infected dams. Although we show that changes in 
offspring microbiota are associated with changes in the immune system, our data does not prove a 
causal relationship. Having shown that maternal antibiotics during pregnancy altered offspring 
immunity to Nb whether administered during gestation or gestation plus nursing, we are also 
convinced that the Nb driven changes in maternal microbiota during pregnancy could be associated 
with protection in offspring. Our collaborators (Horsnell lab) have shown that pups born to Nb 
infected dams are protected against the infection as revealed by lower worm burdens compared to 
controls. We are currently conducting these experiments with the aim of investigating whether the 
changes introduced by Nb during pregnancy have any role to play in protecting their offspring 
from Nb infections. 
Overall, our data reveals the impact of maternal antibiotics prior to delivery and during lactation 
on offspring intestinal microbiota and immunity to various pathogens. Also, we show that maternal 
infections impact offspring microbiota. Combining the maternal infant model with 16S rRNA 
profiling, we have identified key microbiota altered in offspring following antibiotic treatment or 
helminth infections in their mothers. However, there exist several factors that differentiate mice 
and humans that could contribute to different microbiota profiles. Experimental mice have 
156 
 
restricted diet and are of an inbred strain minimizing any genetic factors that may impact 
microbiota while humans have greater dietary and lifestyle variations.  Together, these factors limit 
our ability to generalize the relevance of these data in a clinical setting. Further studies are needed 
to determine specific microbiota impacted early in life following maternal antibiotic exposure or 
maternal infections and the relevance on infant immunity and response to vaccines.  
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Appendices 
Appendix A: Influence of maternal antibiotics on offspring gut microbiome and immunity
 
Table A1: Vancomycin levels in serum. Vancomycin levels were measured in serum 
collected from both dams treated with vancomycin or their offspring. Levels were 
measured using the Abbott Architect ELISA technique and levels were all below the 
detection limit of 3mg/L. 
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Appendix B: CD8 T lymphocytes pool expands following RSV infection in infant pups 
 
 
Figure B1: CD8 T cells significantly increase at day 8 post RSV infection in infants among 
gestation and gestation plus nursing pups. Data are representative of two experiments. n=4-6 
pups per group per time point. 
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Appendix C: Microbiota transfer to offspring following maternal Nb exposure occurs in 
utero and while breastfeeding 
 
 
Figure C1: Microbiota transfer to pups after maternal Nb infection occurs both in utero and 
while nursing. Female BALB/c mice were infected with 500Nb L3 and infection cleared 7 days 
post infection (p.i) by oral Ivermectin treatment for 7 days. 21d post infection, mice were mated. 
3 days after delivery, pups born to previously infected (PI) dams were transferred and nursed by 
naïve lactating mothers while those born to naïve dams were transferred and nursed by lactating 
PI mothers. Two weeks postpartum, infant stool microbiota was analyzed. Principal coordinate 
analysis showing bray-curtis distance of infant stool microbial communities. PI-Previously 
infected. n= 6-10 per group. 
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Table C2: Summary table showing changes in microbiota in both dams (stool and breastmilk) 
and offspring (stool 14 days postpartum) following preconception N. brasiliensis infection. 
Bacteria (Taxa) Significantly 
differentially 
abundant in stool 
from pregnant PI 
dams 
Significantly 
differentially 
abundant in 
breastmilk from PI 
dams 
Significantly 
differentially 
abundant in pups 
born and 
breastfed by PI 
dams 
Phylum TM7 - - 
Family Odoribacteraceae 
F16 
Enterococcaceae 
S24-7 
Rikenellaceae 
Prevotellaceae 
Erysipelotrichaceae 
Enterobacteriaceae 
Coriobacteriaceae 
Mycoplasmataceae 
Micrococcaceae 
Coriobacteriaceae 
Genus Oribacterium 
Odoribacter 
Enterococcus 
Prevotella 
Parabacteroides 
Micrococcus 
Klebsiella 
Collinsella 
CF231 
Allobaculum 
Arthrobacter 
Adlercreutzia 
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General buffer recipes 
ELISA Blocking buffer 
40g BSA 
Dissolve in a final volume of 1000ml 1XPBS and store at 4° C 
 
ELISA Dilution Buffer 
10g BSA 
Dissolve in a final volume of 1000ml of 1XPBS and store at 4° C 
 
ELISA Washing Buffer 
20g KCI 
20g KH2HPO4.2H2O 
800g NaCl 
50ml Tween-20 
100ml 10% NaN3 
Make up to 5L with ddH20 and store at room temperature. Use at 1.20 in ddH20 
 
 
ELISA Substrate Buffer (horseradish peroxidase conjugates) 
Peroxidase Substrate Solution B (Roche Diagnostics GmbH, Mannheim, Germany) 
TMB Peroxidase Substrate Solution A (Roche Diagnostics GmbH) 
Before use, mix equal volumes of TMB Peroxidase Substrate (Soln A) with Peroxidase Substrate 
(Soln B) 
 
Complete media (Iscove’s Modified Dulbeco’s Medium, IMDM) 
1 tube IMDM (Gibco) 
50ml Fetal Bovine Serum (10% FBS) 
5ml Penicillin/Streptomycin (1X) (5% PenStrep). 
Mix contents and filter sterilize and store at 4° C 
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MACS Buffer 
2mM EDTA 
0.5% BSA 
Dissolve contents in a final volume of 1000ml of 1XPBS and store at 4° C 
 
Red Cell Lysis Buffer 
8.34g NH4Cl 
0.037g EDTA 
1g NAHCO3 
Dissolve reagents in 1000ml ddH20. Filter sterilize (0.22μm) and store at 4° C or 25° C 
 
Lung Digestion Buffer 
0.002g DNase I (Roche Germany) 
0.02g Collagenase Type I (Gibco-Invitrogen) 
Dissolve reagents in 150ml DMEM (containing 100U/ml penicillin G, 100μg/ml streptomycin). 
Filter sterilize with a 0.22μm filter and store at 4° C for up to 7 days. 
 
 
 
 
 
 
 
 
 
 
 
 
163 
 
References 
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014). The 
placenta harbors a unique microbiome. Science Translational Medicine, 6(237), 237-65.  
Achary, K. G., Mandal, N. N., Mishra, S., Sarangi, S. S., Kar, S. K., Satapathy, A. K., & Bal, M. 
S. (2013). Maternal filarial infection: association of anti-sheath antibody responses with 
plasma levels of IFN-gamma and IL-10. Parasitology, 140(5), 598–603.  
Alakomi, H. L., Skyttä, E., Saarela, M., Mattila-Sandholm, T., Latva-Kala, K., & Helander, I. M. 
(2000). Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. 
Applied and Environmental Microbiology, 66(5), 2001–2005.  
Alderete, T. L., Autran, C., Brekke, B. E., Knight, R., Bode, L., Goran, M. I., & Fields, D. a. 
(2015). Associations between human milk oligosaccharides and infant body composition in 
the first 6 mo of life 1 , 2, (C), 1–8. 
Alugupalli, K. R., Leong, J. M., Woodland, R. T., Muramatsu, M., Honjo, T., & Gerstein, R. M. 
(2004). B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity. Immunity, 
21(3), 379–390.  
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., … Koga, Y. (2017). A 
proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of 
metabolic disorders via microbiota modulation and acetate elevation. Scientific Reports, 
7(July 2016), 43522.  
Ardissone, A. N., De La Cruz, D. M., Davis-Richardson, A. G., Rechcigl, K. T., Li, N., Drew, J. 
C., … Neu, J. (2014). Meconium microbiome analysis identifies bacteria correlated with 
premature birth. PLoS ONE, 9(3), 1–8.  
Armitage, G. C. (2013). Bi-directional relationship between pregnancy and periodontal disease. 
Periodontology 2000, 61(1), 160–176.  
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., … Rudensky, A. Y. 
(2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell 
generation. Nature, 504(7480), 451–5.  
Arrieta, M., Stiemsma, L. T., Dimitriu, P. a, Thorson, L., Russell, S., Yurist-doutsch, S., … 
Finlay, B. B. (2015). Early infancy microbial and metabolic alterations affect risk of 
childhood asthma, 7(307).  
Arthur, J. C., Perez-chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T., … Jobin, 
C. (2012). Intestinal inflammation targets cancer-inducing activity of the microbiota. 
Science, 338(6103), 120–123.  
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., … Honda, K. 
(2013). Treg induction by a rationally selected mixture of Clostridia strains from the human 
microbiota. Nature, 500(7461), 232–6.  
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., … Honda, K. 
(2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science 
(New York, N.Y.), 331(6015), 337–41. 
164 
 
Avershina, E., Storrø, O., Øien, T., Johnsen, R., Pope, P., & Rudi, K. (2014). Major faecal 
microbiota shifts in composition and diversity with age in a geographically restricted cohort 
of mothers and their children. FEMS Microbiology Ecology, 87(1), 280–290.  
Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., … Jun, W. 
(2015). Dynamics and stabilization of the human gut microbiome during the first year of 
life. Cell Host and Microbe, 17(5), 690–703.  
Basha, S., Surendran, N., & Pichichero, M. E. (2014). Immune responses in neonates. Expert 
Reviews in Clinical Immunology, 10(9), 1171–1184.  
Beattie, L. M., & Weaver, L. T. (2011). Mothers, babies and friendly bacteria. Archives of 
Disease in Childhood. Fetal and Neonatal Edition, 96(3), F160–F163.  
Bellei G, Harslberger, A. (2012). DIETARY FIBRE. Nutritional Bulletin, 14(4), 15–17. 
Bender, J. M., Li, F., Martelly, S., Byrt, E., Rouzier, V., Leo, M., … Aldrovandi, G. M. (2016). 
Maternal HIV infection influences the microbiome of HIV-uninfected infants. Science 
Translational Medicine, 8(349), 349-100.  
Berger, M., Gray, J. A., & Roth, B. L. (2009). The Expanded Biology of Serotonin. Annual 
Review of Medicine, 60(1), 355–366.  
Bergmann, R. L., Edenharter, G., Bergmann, K. E., Guggenmoos-Holzmann, I., Forster, J., 
Bauer, C. P., … Wahn, U. (1997). Predictability of early atopy by cord blood-IgE and 
parental history. Clinical and Experimental Allergy : Journal of the British Society for 
Allergy and Clinical Immunology, 27(7), 752–60.  
Bezirtzoglou, E., Tsiotsias, A., & Welling, G. W. (2011). Microbiota profile in feces of breast- 
and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe, 
17(6), 478–82.  
Borgella, S., Fievet, N., Huynh, B. T., Ibitokou, S., Hounguevou, G., Affedjou, J., … Deloron, P. 
(2013). Impact of pregnancy-associated malaria on infant malaria infection in southern 
Benin. PLoS ONE, 8(11), 1–10.  
Bouskra, D., Brézillon, C., Bérard, M., Werts, C., Varona, R., Boneca, I. G., & Eberl, G. (2008). 
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal 
homeostasis. Nature, 456(7221), 507–10.  
Brandt, C., Power, U. F., Plotnicky-Gilquin, H., Huss, T., Nguyen, T., Lambert, P. H., … 
Siegrist, C. a. (1997). Protective immunity against respiratory syncytial virus in early life 
after murine maternal or neonatal vaccination with the recombinant G fusion protein 
BBG2Na. The Journal of Infectious Diseases, 176(4), 884–891. 
Broadhurst, M. J., Ardeshir, A., Kanwar, B., Mirpuri, J., Gundra, U. M., Leung, J. M., … Loke, 
P. (2012). Therapeutic helminth infection of macaques with idiopathic chronic diarrhea 
alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathogens, 
8(11), e1003000.  
 
165 
 
Burt, T. D. (2013). Fetal regulatory T cells and peripheral immune tolerance in utero: 
implications for development and disease. American Journal of Reproductive Immunology 
(New York, N.Y. : 1989), 69(4), 346–58.  
Canani, R. B., Costanzo, M. Di, Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). 
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World 
Journal of Gastroenterology, 17(12), 1519–1528.  
Candon, S., Perez-Arroyo, A., Marquet, C., Valette, F., Foray, A.-P., Pelletier, B., … Chatenoud, 
L. (2015). Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease 
Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes. 
Plos One, 10(5), e0125448.  
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., … 
Knight, R. (2012). Ultra-high-throughput microbial community analysis on the Illumina 
HiSeq and MiSeq platforms. The ISME Journal, 6(8), 1621–1624.  
Caporaso, J. G., Lauber, C. L., Walters, W. a, Berg-Lyons, D., Lozupone, C. a, Turnbaugh, P. J., 
… Knight, R. (2011). Global patterns of 16S rRNA diversity at a depth of millions of 
sequences per sample. Proceedings of the National Academy of Sciences of the United 
States of America, 108 Suppl, 4516–4522.  
Carroll, M. C. (2008). Complement and Humoral Immunity Michael. Vaccine, 141(4), 520–529.  
Cd, I. T., Foxp, C. D., & Chatenoud, L. (2011). Suppression and Regulation of Immune 
Responses, 677, 3–13.  
Cebula, A., Seweryn, M., Rempala, G. a, Pabla, S. S., Mcindoe, A., Denning, T. L., … Kisielow, 
P. (2013). Thymus-derived regulatory T cells control tolerance to commensal microbiota 
Anna, 497(7448), 258–262.  
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014). The microbial metabolite 
butyrate regulates intestinal macrophage function via histone deacetylase inhibition. 
Proceedings of the National Academy of Sciences, 111(6), 2247–2252.  
Chaplin, D. D. (2010). Overview of the immune response. Journal of Allergy and Clinical 
Immunology, 125(2 SUPPL. 2).  
Chassaing, B., Ley, R. E., & Gewirtz, A. T. (2014). Intestinal Epithelial Cell Toll-like Receptor 5 
Regulates the Intestinal Microbiota to Prevent Low-Grade Inflammation and Metabolic 
Syndrome in Mice. Gastroenterology, 147(6), 1363–1377.e17.  
Chen, J., He, X., & Huang, J. (2014). Diet Effects in Gut Microbiome and Obesity. Journal of 
Food Science, 0(0).  
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012). Human intestinal lumen and mucosa-
associated microbiota in patients with colorectal cancer. PLoS ONE, 7(6).  
Cherrier, M., Ohnmacht, C., Cording, S., & Eberl, G. (2012). Development and function of 
intestinal innate lymphoid cells. Current Opinion in Immunology, 24(3), 277–283.  
 
166 
 
Chiller, K., Selkin, B. a, & Murakawa, G. J. (2001). Skin microflora and bacterial infections of 
the skin. The Journal of Investigative Dermatology. Symposium Proceedings / the Society 
for Investigative Dermatology, Inc. [and] European Society for Dermatological Research, 
6(3), 170–174. 
Cho, I., Yamanishi, S., Cox, L., Methé, B. a, Zavadil, J., Gao, Z., … Alexander, V. (2012). 
Antibiotics in early life alter the murine colonic microbiome and adiposity, 488(7413), 621–
626.  
Claesson, M. J., Cusack, S., O’Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., … 
O’Toole, P. W. (2011). Composition, variability, and temporal stability of the intestinal 
microbiota of the elderly. Proceedings of the National Academy of Sciences of the United 
States of America, 108 Suppl, 4586–91.  
Collado, M. C., Rautava, S., Aakko, J., Isolauri, E., & Salminen, S. (2016). Human gut 
colonisation may be initiated in utero by distinct microbial communities in the placenta and 
amniotic fluid. Scientific Reports, 6(October 2015), 23129.  
Cooper, P., Walker, A. W., Reyes, J., Chico, M., Salter, S. J., Vaca, M., & Parkhill, J. (2013). 
Patent human infections with the whipworm, Trichuris trichiura, are not associated with 
alterations in the faecal microbiota. PloS One, 8(10), e76573.  
Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V, Leung, J. M., Cho, I., … Blaser, M. J. 
(2014). Altering the Intestinal Microbiota during a Critical Developmental Window Has 
Lasting Metabolic Consequences. Cell, 705–721.  
Culley, F. J. (2009). Natural killer cells in infection and inflammation of the lung. Immunology, 
128(2), 151–163. 
Culley, F. J., Pollott, J., & Openshaw, P. J. M. (2002). Age at first viral infection determines the 
pattern of T cell-mediated disease during reinfection in adulthood. The Journal of 
Experimental Medicine, 196(10), 1381–1386.  
Cultural, P., & Lloreda, E. F. (2011). Disparate CD4+ lamina propria (LP) lymphokine secretion 
profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased 
secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of 
IL-5. American Archaeology.  
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009). Natural and Adaptive Foxp3+ Regulatory T 
Cells: More of the Same or a Division of Labor? Immunity, 30(5), 626–635.  
D.W. T. Crompton, M. C. N. (2002). NUTRITIONAL IMPACTOF INTESTINAL 
HELMINTHIASISDURINGTHEHUMAN LIFECYCLE. Annual Review of Immunology, 
20(1), 669–707.  
Dalle, J. H., Menezes, J., Wagner, É., Blagdon, M., Champagne, J., Champagne, M. A., & 
Duval, M. (2005). Characterization of cord blood natural killer cells: Implications for 
transplantation and neonatal infections. Pediatric Research, 57(5 I), 649–655.  
David, L. a, Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., … 
Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. 
Nature, 505(7484), 559–63.  
167 
 
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., … 
Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative 
study in children from Europe and rural Africa. Proceedings of the National Academy of 
Sciences of the United States of America, 107(33), 14691–6.  
De Meer, G., Janssen, N. A. H., & Brunekreef, B. (2005). Early childhood environment related 
to microbial exposure and the occurrence of atopic disease at school age. Allergy: European 
Journal of Allergy and Clinical Immunology, 60(5), 619–625.  
de Silva, N. R., Brooker, S., Hotez, P. J., Montresor, A., Engels, D., & Savioli, L. (2003). Soil-
transmitted helminth infections: updating the global picture. Trends in Parasitology, 19(12), 
547–51.  
Delespesse, G., Yang, L. P., Ohshima, Y., Demeure, C., Shu, U., Byun, D. G., & Sarfati, M. 
(1998). Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 
effectors. Vaccine, 16(14–15), 1415–1419.  
Dethlefsen, L., & Relman, D. A. (2011). Incomplete recovery and individualized responses of 
the human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the 
National Academy of Sciences, 108, 4554–4561.  
Dey, N., Soergel, D. A., Repo, S., & Brenner, S. E. (2013). Association of gut microbiota with 
post-operative clinical course in Crohn’s disease. BMC Gastroenterology, 13(1), 131.  
DiGiulio, D. B., Romero, R., Amogan, H. P., Kusanovic, J. P., Bik, E. M., Gotsch, F., … 
Relman, D. A. (2008). Microbial prevalence, diversity and abundance in amniotic fluid 
during preterm labor: A molecular and culture-based investigation. PLoS ONE, 3(8), 1–10.  
Domachowske, J. B., & Rosenberg, H. F. (1999). Respiratory syncytial virus infection: immune 
response, immunopathogenesis, and treatment. Clinical Microbiology Reviews, 12(2), 298–
309. 
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & 
Knight, R. (2010). Delivery mode shapes the acquisition and structure of the initial 
microbiota across multiple body habitats in newborns. Proceedings of the National 
Academy of Sciences of the United States of America, 107(26), 11971–5.  
Dong, P., Yang, Y., & Wang, W. (2010). The role of intestinal bifidobacteria on immune system 
development in young rats. Early Human Development, 86(1), 51–58.  
Eberl, G., Colonna, M., Di Santo, J. P., & McKenzie, A. N. J. (2015). Innate lymphoid cells: A 
new paradigm in immunology. Science, 348(6237), aaa6566.  
Edwards, K. M. (2015). Maternal antibodies and infant immune responses to vaccines. Vaccine, 
33(47), 6469–6472.  
Ege, M. J., Bieli, C., Frei, R., van Strien, R. T., Riedler, J., Ublagger, E., … Braun-Fahrländer, 
C. (2006). Prenatal farm exposure is related to the expression of receptors of the innate 
immunity and to atopic sensitization in school-age children. The Journal of Allergy and 
Clinical Immunology, 117(4), 817–23.  
 
168 
 
Eichinger, K. M., Egaña, L., Orend, J. G., Resetar, E., Anderson, K. B., Patel, R., & Empey, K. 
M. (2015). Alveolar macrophages support interferon gamma-mediated viral clearance in 
RSV-infected neonatal mice. Respiratory Research, 16(1), 122.  
Else, K. ., & Finkelman, F. D. (1998). Invited review Intestinal nematode parasites, cytokines 
and effector mechanisms. International Journal for Parasitology, 28(8), 1145–1158.  
Empey, K. M., Orend, J. G., Peebles, R. S., Ega??a, L., Norris, K. A., Oury, T. D., & Kolls, J. K. 
(2012). Stimulation of immature lung macrophages with intranasal interferon gamma in a 
novel neonatal mouse model of respiratory syncytial virus infection. PLoS ONE, 7(7).  
Ericsson, A. C., Hagan, C. E., Davis, D. J., & Franklin, C. L. (2014). Segmented filamentous 
bacteria: Commensal microbes with potential effects on research. Comparative Medicine, 
64(2), 90–98. 
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., … Prinz, 
M. (2015). Host microbiota constantly control maturation and function of microglia in the 
CNS. Nature Neuroscience, 18(7), 965–977.  
Fallani, M., Amarri, S., Uusijarvi, A., Adam, R., Khanna, S., Aguilera, M., … Edwards, C. A. 
(2011). Determinants of the human infant intestinal microbiota after the introduction of first 
complementary foods in infant samples from five European centres. Microbiology, 157(5), 
1385–1392.  
Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014). Human memory T cells: generation, 
compartmentalization and homeostasis. Nature Reviews Immunology, 6(9), 2166–2171.  
Favier, C. F., Vaughan, E. E., Vos, W. M. De, & Akkermans, A. D. L. (2002). Molecular 
Monitoring of Succession of Bacterial Communities in Human Neonates Molecular 
Monitoring of Succession of Bacterial Communities in Human Neonates. Applied and 
Environmental Microbiology, 68(1), 219–226. 
Fernandez, L., Langa, S., Martin, V., Maldonado, A., Jimenez, E., Martin, R., & Rodriguez, J. 
M. (2013). The human milk microbiota: Origin and potential roles in health and disease. 
Pharmacological Research, 69(1), 1–10.  
Fink, P. J. (2013). The Biology of Recent Thymic Emigrants. Annual Review of Immunology, 
31(1), 31–50.  
Finkelman, F. D., Shea-Donohue, T., Morris, S. C., Gildea, L., Strait, R., Madden, K. B., … 
Urban, J. F. (2004). Interleukin-4- and interleukin-13-mediated host protection against 
intestinal nematode parasites. Immunological Reviews, 201, 139–155.  
Finlay, C. M., Walsh, K. P., & Mills, K. H. G. (2014). Induction of regulatory cells by helminth 
parasites: Exploitation for the treatment of inflammatory diseases. Immunological Reviews, 
259(1), 206–230.  
Fisher, R. E., Steele, M., & Karrow, N. A. (2012). Fetal programming of the neuroendocrine-
immune system and metabolic disease. Journal of Pregnancy, 2012.  
 
169 
 
Foliaki, S., Pearce, N., Björkstén, B., Mallol, J., Montefort, S., & von Mutius, E. (2009). 
Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in 
children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase 
III. The Journal of Allergy and Clinical Immunology, 124(5), 982–9.  
Franzosa, E. a., Hsu, T., Sirota-Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X. C., & 
Huttenhower, C. (2015). Sequencing and beyond: integrating molecular “omics” for 
microbial community profiling. Nature Reviews. Microbiology, 13(6), 360–72.  
Fricke, W. F., Song, Y., Wang, A., Smith, A., Grinchuk, V., Pei, C., … Zhao, A. (2015). Type 2 
immunity-dependent reduction of segmented filamentous bacteria in mice infected with the 
helminthic parasite Nippostrongylus brasiliensis. Microbiome, 1–12.  
Friedman, N. J., & Zeiger, R. S. (2005). The role of breast-feeding in the development of 
allergies and asthma. Journal of Allergy and Clinical Immunology, 115(6), 1238–1248.  
Fu, Y. R., Yi, Z. J., Pei, J. L., & Guan, S. (2010). Effects of Bifidobacterium bifidum on adaptive 
immune senescence in aging mice. Microbiology and Immunology, 54(10), 578–583.  
Fujimura, Kei, E., Slusher, Nicole, A., Cabana, Michael, D., & Lynch, Susan, V. (2010). Role of 
the gut microbiota in defining human health. Expert Rev Anti Infect Ther, 8(4), 435–454.  
Fujino, S., Andoh,  a, Bamba, S., Ogawa,  a, Hata, K., Araki, Y., … Fujiyama, Y. (2003). 
Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 52(1), 65–70.  
Galindo-Albarran, A. O., Lopez-Portales, O. H., Guti??rrez-Reyna, D. Y., Rodriguez-Jorge, O., 
Sanchez-Villanueva, Jose, A., Ramirez-Pliego, O., … Santana, M. A. (2016). CD8+ T Cells 
from Human Neonates Are Biased toward an Innate Immune Response. Cell Reports, 17(8), 
2151–2160.  
Gebreegziabiher, D., Desta, K., Desalegn, G., Howe, R., & Abebe, M. (2014). The effect of 
maternal helminth infection on maternal and neonatal immune function and immunity to 
tuberculosis. PLoS ONE, 9(4), 1–7. 
Ghosn, E. E. B., Yang, Y., Tung, J., Herzenberg, L. a, & Herzenberg, L. a. (2008). CD11b 
expression distinguishes sequential stages of peritoneal B-1 development. Proceedings of 
the National Academy of Sciences of the United States of America, 105(13), 5195–5200.  
Gluckman, P. D. (2008). Effect of In Utero and Early Life Conditions on Adult Health and 
Disease. The New England Journal of Medicine, 359(1), 61–73.  
Gollwitzer, E. S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K. D., … 
Marsland, B. J. (2014). Lung microbiota promotes tolerance to allergens in neonates via 
PD-L1. Nature Medicine, (May). 
Gonzalez-Perez, G., Hicks, A. L., Tekieli, T. M., Radens, C. M., Williams, B. L., & Lamouse-
Smith, E. S. N. (2016). Maternal Antibiotic Treatment Impacts Development of the 
Neonatal Intestinal Microbiome and Antiviral Immunity. The Journal of Immunology.  
Goodrich, J. K., Di Rienzi, S. C., Poole, A. C., Koren, O., Walters, W. A., Caporaso, J. G., … 
Ley, R. E. (2014). Conducting a Microbiome Study. Cell, 158(2), 250–262.  
170 
 
Gori, A., Tincati, C., Rizzardini, G., Torti, C., Quirino, T., Haarman, M., … Clerici, M. (2008). 
Early impairment of gut function and gut flora supporting a role for alteration of 
gastrointestinal mucosa in human immunodeficiency virus pathogenesis. Journal of Clinical 
Microbiology, 46(2), 757–758.  
Greenfeder, S., Umland, S. P., Cuss, F. M., Chapman, R. W., & Egan, R. W. (2001). Th2 
cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respiratory 
Research, 2(2), 71–79. 
Guillemard, E., Tondu, F., Lacoin, F., & Schrezenmeir, J. (2010). Consumption of a fermented 
dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration 
of respiratory infections in the elderly in a randomised controlled trial. The British Journal 
of Nutrition, 103(1), 58–68. 
Guilmot, A., Hermann, E., Braud, V. M., Carlier, Y., & Truyens, C. (2011). Natural killer cell 
responses to infections in early life. Journal of Innate Immunity, 3(3), 280–288.  
Guzman Sanchez-Schmitz, O. L. (2011). Development of Newborn and Infant Vaccines, 72(2), 
181–204.  
Hall, C. B., Weinberg, G. A., Poehling, K. A., Erdman, D., Grijalva, C. G., & Zhu, Y. (2012). 
The Burden of Respiratory Syncytial Virus Infection in Young Children. 
Hand, T. W., Santos, L. M. Dos, Bouladoux, N., Molloy, M. J., Pagán, A. J., Pepper, M., … Iii, 
C. O. E. (2012). Acute Gastrointestinal Infection Induces Long-Lived Microbiota- Specific 
T Cell Responses. Science, 337(6101), 1553–1556.  
Hand, Y. B. and T. (2014). Role of the Microbiota in Immunity and inflammation. October, 
141(4), 520–529.  
Harker, J. a, Yamaguchi, Y., Culley, F. J., Tregoning, J. S., & Openshaw, P. J. M. (2014). 
Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of 
the innate immune system. Journal of Virology, 88(1), 604–11.  
Hauth, J. C., Goldenberg, R. L., Andrews, W. W., DuBard, M. B., & Copper, R. L. (1995). 
Erythromycin in Women With Bacterial Vaginosis. New England Journal of Medicine, 333, 
1732–1736. 
Hayes, K. S., Bancroft, A. J., Goldrick, M., Portsmouth, C., Roberts, I. S., & Grencis, R. K. 
(2010). Europe PMC Funders Group Exploitation of the Intestinal Microflora by the 
Parasitic Nematode Trichuris muris. Science, 328(5984), 1391–1394.  
Hickson, M. (2011). Probiotics in the prevention of antibiotic-associated diarrhoea and 
Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 4(3), 185–97.  
Hodgins, D. C., & Shewen, P. E. (2012). Vaccination of neonates: problem and issues. Vaccine, 
30(9), 1541–59. 
Holzscheiter, M., Layland, L. E., Loffredo-Verde, E., Mair, K., Vogelmann, R., Langer, R., … 
Prazeres da Costa, C. (2014). Lack of host gut microbiota alters immune responses and 
intestinal granuloma formation during schistosomiasis. Clinical and Experimental 
Immunology, 175(2), 246–57.  
171 
 
Hong, P. Y., Lee, B. W., Aw, M., Shek, L. P. C., Yap, G. C., Chua, K. Y., & Liu, W. T. (2010). 
Comparative analysis of fecal microbiota in infants with and without eczema. PLoS ONE, 
5(4).  
Hotez, P. J., Brindley, P. J., Bethony, J. M., King, C. H., Pearce, E. J., & Jacobson, J. (2008). 
Review series Helminth infections : the great neglected tropical diseases. Journal of 
Clinical Investigation, 118(4), 1311–1321.  
Hotez, P. J., & Kamath, A. (2009). Neglected tropical diseases in sub-Saharan Africa: Review of 
their prevalence, distribution, and disease burden. PLoS Neglected Tropical Diseases, 3(8), 
2–11. 
Hovdenak, N., & Haram, K. (2012). Influence of mineral and vitamin supplements on pregnancy 
outcome. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 164(2), 
127–32.  
Howard, T. H., & Meyer, W. H. (1984). Chemotactic peptide modulation of actin assembly and 
locomotion in neutrophils. Journal of Cell Biology, 98(4), 1265–1271.  
Hoyo, C., Murtha, A. P., Schildkraut, J. M., Jirtle, R., Demark-Wahnefried, W., Forman, M. R., 
… Murphy, S. K. (2011). Methylation variation at IGF2 differentially methylated regions 
and maternal folic acid use before and during pregnancy. Epigenetics, 6(7), 928–936.  
Hu, J., Nomura, Y., Bashir, A., Fernandez-Hernandez, H., Itzkowitz, S., Pei, Z., … Peter, I. 
(2013). Diversified microbiota of meconium is affected by maternal diabetes status. PloS 
One, 8(11), e78257.  
Huntington, N. D. (2014). NK cell recognition of unconventional ligands. Immunology and Cell 
Biology, 92(3), 208–9.  
Hurt, R. A., Qiu, X., Wu, L., Roh, Y., Palumbo, A. V, Tiedje, J. M., & Zhou, J. (2001). 
Simultaneous Recovery of RNA and DNA from Soils and Sediments Simultaneous 
Recovery of RNA and DNA from Soils and Sediments. Applied and Environmental 
Microbiology, 67(10), 4495–4503.  
Hwang, Y. Y., & Mckenzie, A. N. J. (2013). Crossroads Between Innate and Adaptive Immunity 
IV, 785. 
Iris K. Pang and Akiko Iwasaki. (2012). Control of antiviral immunity by pattern recognition and 
the microbiome. Changes, 29(6), 997–1003.  
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Karaoz, U., Wei, D., … Littman, D. R. 
(2009). Induction of intestinal TH17 cells by segmented filamentous bacteria. Elsevier, 
139(3), 485–498.  
Iwasaki, A., Medzhitov, R., & Haven, N. (2015). Control of adaptive immunity by the innate 
immune system, 16(4), 343–353.  
Jakobsson, H. E., Abrahamsson, T. R., Jenmalm, M. C., Harris, K., Quince, C., Jernberg, C., … 
Andersson, A. F. (2014). Decreased gut microbiota diversity, delayed Bacteroidetes 
colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut, 63, 
559–66. 
172 
 
Janeway, C. A. (2001). How the immune system protects the host from infection. Microbes and 
Infection, 3(13), 1167–1171.  
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2007). Long-term ecological impacts of 
antibiotic administration on the human intestinal microbiota. The ISME Journal, 1(1), 56–
66.  
Jeurink, P. V., van Bergenhenegouwen, J., Jiménez, E., Knippels, L. M. J., Fernández, L., 
Garssen, J., … Martín, R. (2013). Human milk: A source of more life than we imagine. 
Beneficial Microbes, 4(1), 17–30. 
Jiang, W., Wang, X., Zeng, B., Liu, L., Tardivel, A., Wei, H., … Zhou, R. (2013). Recognition 
of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial 
lymphocytes. The Journal of Experimental Medicine, 210(11), 2465–76.  
Jimenez, E., Fernandez, L., Marin, M. L., Martin, R., Odriozola, J. M., Nueno-Palop, C., … 
Rodriguez, J. M. (2005). Isolation of commensal bacteria from umbilical cord blood of 
healthy neonates born by cesarean section. Current Microbiology, 51(4), 270–274.  
Jiménez, E., Marín, M. L., Martín, R., Odriozola, J. M., Olivares, M., Xaus, J., … Rodríguez, J. 
M. (2008). Is meconium from healthy newborns actually sterile? Research in Microbiology, 
159(3), 187–193. 
John Nicholas Melvan, Gregory J. Bagby, David A. Welsh, Steve Nelson,  and P. Z. (2011). 
Neonatal Sepsis and Neutrophil Insufficiencies, 29(3), 1–24.  
Johnson‐Henry, K. C., Nadjafi, M., Avitzur, Y., Mitchell, D. J., Ngan, B., Galindo‐Mata, E., … 
Sherman, P. M. (2005). Amelioration of the Effects of Citrobacter rodentium Infection in 
Mice by Pretreatment with Probiotics. The Journal of Infectious Diseases, 191(12), 2106–
2117. 
Johnson, J. E., Gonzales, R. a, Olson, S. J., Wright, P. F., & Graham, B. S. (2007). The 
histopathology of fatal untreated human respiratory syncytial virus infection. Modern 
Pathology, 20(1), 108–119.  
Jones, C. A., Holloway, J. A., & Warner, J. O. (2002). Phenotype of fetal monocytes and B 
lymphocytes during the third trimester of pregnancy. Journal of Reproductive Immunology, 
56(1–2), 45–60. 
Jones, H. E., Harris, K. A., Azizia, M., Bank, L., Carpenter, B., Hartley, J. C., … Peebles, D. 
(2009). Differing prevalence and diversity of bacterial species in fetal membranes from very 
preterm and term labor. PLoS ONE, 4(12).  
Kaakoush, N. O. (2015). Insights into the Role of Erysipelotrichaceae in the Human Host. 
Frontiers in Cellular and Infection Microbiology, 5(November), 84.  
Kabata, H., Moro, K., Koyasu, S., & Asano, K. (2015). Group 2 innate lymphoid cells and 
asthma. Allergology International : Official Journal of the Japanese Society of Allergology, 
64(3), 227–34.  
 
173 
 
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996). Stat6 is required for 
mediating responses to IL-4 and for the development of Th2 cells. Immunity, 4(3), 313–319.  
Kerry S. Campbell, J. H. (2013). NK cell biology: An update and future directions, 132(3), 536–
544.  
Khan, W. N. (2009). B cell receptor and BAFF receptor signaling regulation of B cell 
homeostasis. Journal of Immunology (Baltimore, Md. : 1950), 183, 3561–3567.  
Khoruts, A. (2016). First microbial encounters. Nature Medicine, 22(3), 231–232.  
Kida, Y., Shimizu, T., & Kuwano, K. (2006). Sodium butyrate up-regulates cathelicidin gene 
expression via activator protein-1 and histone acetylation at the promoter region in a human 
lung epithelial cell line, EBC-1. Molecular Immunology, 43(12), 1972–81.  
Kidzeru, E. B., Hesseling, A. C., Passmore, J.-A. S., , Landon Myere, H. G., Christophe Toukam 
Tchakoute, C. M. G., Donald L. Sodora, A., & Heather B. Jaspana. (2014). In-utero 
exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-
uninfected infants, 19(2), 161–169.  
Kleessen, B., Schwarz, S., Boehm, A., Fuhrmann, H., Richter, A., Henle, T., & Krueger, M. 
(2007). Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota 
of healthy volunteers. The British Journal of Nutrition, 98(3), 540–9.  
Klein Klouwenberg, P., & Bont, L. (2008). Neonatal and infantile immune responses to 
encapsulated bacteria and conjugate vaccines. Clinical and Developmental Immunology, 
2008.  
Klose, C. S. N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., … Diefenbach, A. 
(2014). Differentiation of type 1 ILCs from a common progenitor to all helper-like innate 
lymphoid cell lineages. Cell, 157(2), 340–356.  
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., … Ley, R. E. 
(2011). Succession of microbial consortia in the developing infant gut microbiome. 
Proceedings of the National Academy of Sciences of the United States of America, 108 
Suppl, 4578–4585.  
Kolli, D., Velayutham, T. S., & Casola, A. (2013). Host-Viral Interactions: Role of Pattern 
Recognition Receptors (PRRs) in Human Pneumovirus Infections. Pathogens, 2(2), 232–
263.  
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Bäckhed, H. K., … Ley, R. 
E. (2012). Host remodeling of the gut microbiome and metabolic changes during 
pregnancy. Cell, 150(3), 470–80. 
Kristensen, J., Vestergaard, M., Wisborg, K., Kesmodel, U., & Secher, N. J. (2005). Pre-
pregnancy weight and the risk of stillbirth and neonatal death. BJOG: An International 
Journal of Obstetrics and Gynaecology, 112(4), 403–408. 
Kumagai, M., Kimura, A., Takei, H., Kurosawa, T., Aoki, K., Inokuchi, T., & Matsuishi, T. 
(2007). Perinatal bile acid metabolism: Bile acid analysis of meconium of preterm and full-
term infants. Journal of Gastroenterology, 42(11), 904–910.  
174 
 
Labeaud,  a D., Malhotra, I., King, M. J., King, C. L., & King, C. H. (2009). Do antenatal 
parasite infections devalue childhood vaccination? PLoS Neglected Tropical Diseases, 3(5), 
e442.  
Lal, C. V., Travers, C., Aghai, Z. H., Eipers, P., Jilling, T., Halloran, B., … Ambalavanan, N. 
(2016). The Airway Microbiome at Birth. Scientific Reports, 6, 31023.  
Lambert, L., Sagfors, A. M., Openshaw, P. J. M., & Culley, F. J. (2014). Immunity to RSV in 
early-life, 5(September), 1–14.  
Lauren H Jaeger, Sheila M.F.M. de Souza, Ondemar F. Dias, A. M. I. (2013). Treatment of 
listeriosis in first trimester of pregnancy. Emerging Infectious Diseases, 19(5), 839–841.  
Lawrence, R. A., Gray, C. A., Osborne, J., & Maizels, R. M. (1996). Nippostrongylus 
brasiliensis: cytokine responses and nematode expulsion in normal and IL-4-deficient mice. 
Experimental Parasitology, 84(1), 65–73.  
Lee, H.-Y., Park, J.-H., Seok, S.-H., Baek, M.-W., Kim, D.-J., Lee, K.-E., … Park, J.-H. (2006). 
Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic 
acid and show anti-obesity effects in diet-induced obese mice. Biochimica et Biophysica 
Acta, 1761(7), 736–44.  
Lee, S. C., Tang, M. S., Lim, Y. a L., Choy, S. H., Kurtz, Z. D., Cox, L. M., … Loke, P. (2014). 
Helminth colonization is associated with increased diversity of the gut microbiota. PLoS 
Neglected Tropical Diseases, 8(5), e2880.  
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. a, Knight, R. D., & Gordon, J. I. (2005). 
Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of 
the United States of America, 102(31), 11070–5. 
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006a). Ecological and evolutionary forces shaping 
microbial diversity in the human intestine. Cell, 124(4), 837–48.  
Ley, R. E., Peterson, D. a, & Gordon, J. I. (2006b). Ecological and evolutionary forces shaping 
microbial diversity in the human intestine. Cell, 124(4), 837–48.  
Luckheeram, R. V., Zhou, R., Verma, A. D., & Xia, B. (2012). CD4+T Cells: Differentiation and 
Functions. Clinical and Developmental Immunology, 2012, 1–12.  
Macfarlane, S., & Dillon, J. F. (2007). Microbial biofilms in the human gastrointestinal tract. 
Journal of Applied Microbiology, 102(5), 1187–1196.  
Mackie, R. I., Sghir, A., & Gaskins, H. R. (1999). Developmental microbial ecology of the 
neonatal gastrointestinal tract. The American Journal of Clinical Nutrition, 69(5), 1035S–
1045S. 
Madden, K. B., Whitman, L., Sullivan, C., Gause, W. C., Urban, J. F., Katona, I. M., … Shea-
Donohue, T. (2002). Role of STAT6 and Mast Cells in IL-4- and IL-13-Induced Alterations 
in Murine Intestinal Epithelial Cell Function. The Journal of Immunology, 169(8), 4417–
4422.  
 
175 
 
Maizels, R. M., Balic, A., Gomez-Escobar, N., Nair, M., Taylor, M. D., & Allen, J. E. (2004). 
Helminth parasites &#x2013; masters of regulation. Immunological Reviews, 201(1), 89–
116.  
Maizels, R. M., Hewitson, J. P., & Smith, K. A. (2012). Susceptibility and immunity to helminth 
parasites. Current Opinion in Immunology, 24(4), 459–66.  
Mandal, A., & Viswanathan, C. (2015). Natural killer cells: In health and disease. 
Hematology/Oncology and Stem Cell Therapy, 8(2), 47–55.  
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., … Dore, J. 
(2006). Reduced diversity of faecal microbiota in Crohn’s disease revealed by a 
metagenomic approach. Gut, 55(2), 205–11.  
Marcobal, A., Kashyap, P. C., Nelson, T. A., Aronov, P. A., Donia, M. S., Spormann, A., … 
Sonnenburg, J. L. (2013). A metabolomic view of how the human gut microbiota impacts 
the host metabolome using humanized and gnotobiotic mice. The ISME Journal, 7(10), 
1933–1943. 
Marques, T. M., Wall, R., Ross, R. P., Fitzgerald, G. F., Ryan, C. A., & Stanton, C. (2010). 
Programming infant gut microbiota: influence of dietary and environmental factors. Current 
Opinion in Biotechnology, 21(2), 149–56.  
Martin, C. R., & Walker, W. A. (2008). Probiotics: role in pathophysiology and prevention in 
necrotizing enterocolitis. Seminars in Perinatology, 32(2), 127–37.  
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., … Mackay, C. R. 
(2009). Regulation of inflammatory responses by gut microbiota and chemoattractant 
receptor GPR43. Nature, 461(7268), 1282–6.  
Matsuse, H., Behera,  a K., Kumar, M., Rabb, H., Lockey, R. F., & Mohapatra, S. S. (2000). 
Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent 
airway inflammation and hyperresponsiveness. Journal of Immunology (Baltimore, Md. : 
1950), 164(12), 6583–6592.  
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012). Reciprocal interactions of 
the intestinal microbiota and immune system. Nature, 489(7415), 231–41.  
McCarron, M. J., & Reen, D. J. (2010). Neonatal CD8+ T-cell differentiation is dependent on 
interleukin-12. Human Immunology, 71(12), 1172–9.  
McDonald, D., Price, M. N., Goodrich, J., Nawrocki, E. P., DeSantis, T. Z., Probst, A., … 
Hugenholtz, P. (2012). An improved Greengenes taxonomy with explicit ranks for 
ecological and evolutionary analyses of bacteria and archaea. The ISME Journal, 6(3), 610–
618. 
McFarland, L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated 
diarrhea and the treatment of Clostridium difficile disease. American Journal of 
Gastroenterology, 101(4), 812–822.  
 
176 
 
McFarlane, A. J., McSorley, H. J., Davidson, D. J., Fitch, P. M., Errington, C., Mackenzie, K. J., 
… Schwarze, J. (2017). Enteric helminth-induced type-I interferon signalling protects 
against pulmonary virus infection through interaction with the microbiota. Journal of 
Allergy and Clinical Immunology.  
McKenzie, G. J., Bancroft, A., Grencis, R. K., & McKenzie, A. N. J. (1998). A distinct role for 
interleukin-13 in Th2-cell-mediated immune responses. Current Biology, 8(6), 339–342.  
McKenzie, G. J., Emson, C. L., Bell, S. E., Anderson, S., Fallon, P., Zurawski, G., … McKenzie, 
A. N. . (1998). Impaired Development of Th2 Cells in IL-13-Deficient Mice. Immunity, 
9(3), 423–432.  
Mcnamara, P. S., & Smyth, R. L. (2002). The pathogenesis of respiratory syncytial virus disease 
in childhood, 13–28. 
Medzhitov, R., & Janeway, Jr, C. (2000). The Toll receptor family and microbial recognition. 
Trends in Microbiology, 8(10), 452–456.  
Mercedes Gomez de Agüero, Stephanie C. Ganal-Vonarburg, Tobias Fuhrer, Sandra Rupp, 
Yasuhiro Uchimura, Hai Li, Anna Steinert, Mathias Heikenwalder, Siegfried Hapfelmeier, 
Uwe Sauer, Kathy D.McCoy, A. J. M. (2016). The maternal microbiota drives early 
postnatal innate immune development. Science Translational Medicine, 351(6279), 35313–
35319.  
Metsälä, J., Lundqvist,  a., Virta, L. J., Kaila, M., Gissler, M., & Virtanen, S. M. (2015). Prenatal 
and post-natal exposure to antibiotics and risk of asthma in childhood. Clinical & 
Experimental Allergy, 45(1), 137–145.  
Mirpuri, J., Raetz, M., Sturge, C. R., Wilhelm, C. L., Benson, A., Savani, R. C., … Yarovinsky, 
F. (2014). Proteobacteria-specific IgA regulates maturation of the intestinal microbiota © 
2014 Landes Bioscience . Do not distribute © 2014 Landes Bioscience . Do not distribute, 
5(1), 28–39.  
Moens, E., Brouwer, M., Dimova, T., Goldman, M., Willems, F., & Vermijlen, D. (2011). IL-
23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells 
expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. 
Journal of Leukocyte Biology, 89(5), 743–752.  
Mohrs, M., Shinkai, K., Mohrs, K., & Locksley, R. M. (2001). Analysis of Type 2 Immunity In 
Vivo with a Bicistronic IL-4 Reporter. Immunity, 15(2), 303–311.  
Mold, J. E., Michaëlsson, J., Burt, T. D., Muench, M. O., Karen, P., Busch, M. P., … Joseph, M. 
(2008). Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T 
Cells in Utero. Science, 322(5907), 1562–1565.  
Moles, L., G??mez, M., Heilig, H., Bustos, G., Fuentes, S., de Vos, W., … Jim??nez, E. (2013). 
Bacterial Diversity in Meconium of Preterm Neonates and Evolution of Their Fecal 
Microbiota during the First Month of Life. PLoS ONE, 8(6).  
Morein, B., Blomqvist, G., & Hu, K. (2007). Immune responsiveness in the neonatal period. 
Journal of Comparative Pathology, 137 Suppl, S27-31.  
177 
 
Morelli, L. (2008). Postnatal development of intestinal microflora as influenced by infant 
nutrition. The Journal of Nutrition, 138(9), 1791S–1795S. Retrieved from  
Morrow, A. L., & Rangel, J. M. (2004). Human milk protection against infectious diarrhea: 
Implications for prevention and clinical care. Seminars in Pediatric Infectious Diseases, 
15(4), 221–228.  
Mpairwe, H., Tweyongyere, R., & Elliott, A. (2014). Pregnancy and helminth infections. 
Parasite Immunology, 36(8), 328–337.  
Mueller, N. T., Whyatt, R., Hoepner, L., Oberfield, S., Dominguez-Bello, M. G., Widen, E., … 
Rundle, A. (2015). Prenatal exposure to antibiotics, cesarean section and risk of childhood 
obesity. International Journal of Obesity, 39(4), 665–670.  
Murawski, M. R., Bowen, G. N., Cerny, A. M., Anderson, L. J., Haynes, L. M., Tripp, R. A., … 
Finberg, R. W. (2009). Respiratory syncytial virus activates innate immunity through Toll-
like receptor 2. Journal of Virology, 83(3), 1492–500.  
Murk, W., Risnes, K. R., & Bracken, M. B. (2011). Prenatal or early-life exposure to antibiotics 
and risk of childhood asthma: a systematic review. Pediatrics, 127(6), 1125–38.  
Myles, I. a, Fontecilla, N. M., Janelsins, B. M., Vithayathil, P. J., Segre, J. a, & Datta, S. K. 
(2013). Parental dietary fat intake alters offspring microbiome and immunity. Journal of 
Immunology (Baltimore, Md. : 1950), 191(6), 3200–9.  
Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam, Evan Brady, Ravi Padia, Huidong Shi1, 
Muthusamy Thangaraju, Puttur D. Prasad, Santhakumar Manicassamy, David H. Munn, 
Jeffrey R. Lee, Stefan Offermanns,  and V., & Ganapathy. (2014). Activation of the 
receptor (Gpr109a) for niacin and the commensal metabolite butyrate suppresses colonic 
inflammation and carcinogenesis, 72(2), 181–204. 
Nakajima, H., & Takatsu, K. (2007). Role of cytokines in allergic airway inflammation. 
International Archives of Allergy and Immunology, 142(4), 265–273.  
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., … Mckenzie, 
A. N. J. (2010). UKPMC Funders Group type-2 immunity. October, 464(7293), 1367–1370.  
Neish, A. S. (2009). Microbes in Gastrointestinal Health and Disease. Gastroenterology, 136(1), 
65–80.  
Netea, M. G., Quintin, J., & Van Der Meer, J. W. M. (2011). Trained immunity: A memory for 
innate host defense. Cell Host and Microbe, 9(5), 355–361.  
Niewiesk, S. (2014). Maternal antibodies: Clinical significance, mechanism of interference with 
immune responses, and possible vaccination strategies. Frontiers in Immunology, 5(SEP), 
1–15. 
Niladri Aichbhaumik, Edward M. Zoratti, Ronald Strickler, Ganesa Wegienka, Dennis R. 
Ownby, Suzanne Havstad,  and C. C., & Johnson. (2008). Prenatal exposure to household 
pets influences fetal IgE production, 72(2), 181–204.  
 
178 
 
Nistal, E., Caminero, A., Vivas, S., Ruiz de Morales, J. M., Sáenz de Miera, L. E., Rodríguez-
Aparicio, L. B., & Casqueiro, J. (2012). Differences in faecal bacteria populations and 
faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie, 94(8), 
1724–9.  
Nitta, T., Murata, S., Ueno, T., Tanaka, K., & Takahama, Y. (2008). Thymic microenvironments 
for T-cell repertoire formation. Advances in Immunology, 99, 59–94.  
Nobel, Y. R., Cox, L. M., Kirigin, F. F., Bokulich, N. a., Yamanishi, S., Teitler, I., … Blaser, M. 
J. (2015). Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. 
Nature Communications, 6(May), 7486.  
Nylund, L., Satokari, R., Nikkilä, J., Rajilić-Stojanović, M., Kalliomäki, M., Isolauri, E., … de 
Vos, W. M. (2013). Microarray analysis reveals marked intestinal microbiota aberrancy in 
infants having eczema compared to healthy children in at-risk for atopic disease. BMC 
Microbiology, 13(1), 12.  
Nylund, L., Satokari, R., Salminen, S., & de Vos, W. M. (2014). Intestinal microbiota during 
early life - impact on health and disease. The Proceedings of the Nutrition Society, 
(December 2013), 1–13.  
O’Hara, A. M., & Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Reports, 7(7), 
688–693. 
Odaka, Y., Nakano, M., Tanaka, T., Kaburagi, T., Yoshino, H., Sato-Mito, N., & Sato, K. 
(2010). The influence of a high-fat dietary environment in the fetal period on postnatal 
metabolic and immune function. Obesity (Silver Spring, Md.), 18(9), 1688–94.  
Oh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. a, Maddur, M. S., Bower, M., … Gewirtz, 
A. T. (2014). Article TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody 
Responses to Seasonal Influenza Vaccination. Immunity, 41(3), 478–492.  
Olszak, Torsten, Dingding An, Sebastian Zeissig, Miguel Pinilla Vera, Julia Richter, Andre 
Franke, J. N. G. et al. (2012). Microbial exposure during early life has persistent effects on 
natural killer T cell function. Science, 336(6080), 489–493. 
Openshaw, P. J. M. (1995). Immunity and Immunopathology to Respiratory Syncytial Virus. 
American Journal of Respiratory and Critical Care Medicine, 152(4_pt_2), S59–S62.  
Palm, N. W., Zoete, M. R. de, Cullen, T. W., Barry, N. A., Stefanowski, J., Liming Hao, P. H. 
D., … Richard A. Flavell. (2014). Immunoglobulin A coating identifies colitogenic bacteria 
in inflammatory bowel disease. PMC, 158(5), 1000–1010.  
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007). Development of 
the human infant intestinal microbiota. PLoS Biology, 5(7), 1556–1573.  
Parkin, J., & Cohen, B. (2001). An overview of the immune system. Lancet, 357(9270), 1777–
89.  
Penders, J., Thijs, C., Vink, C., Stelma, F. F., Snijders, B., Kummeling, I., … Stobberingh, E. E. 
(2006). Factors influencing the composition of the intestinal microbiota in early infancy. 
Pediatrics, 118(2), 511–21. 
179 
 
PETER J. DELVES, A. I. M. R. (2000). T HE I MMUNE S YSTEM. October, 37–50.  
Philbin, V. J., & Levy, O. (2009). Implications for Neonatal and Infant Vaccine Development. 
Pediatric Research, 65(2), 1–17.  
Piedimonte, G., & Perez, M. K. (2014). Respiratory Syncytial Virus Infection and Bronchiolitis. 
Pediatrics in Review, 35(12), 519–530.  
Power, S. E., O’Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014). Intestinal 
microbiota, diet and health. The British Journal of Nutrition, 111(3), 387–402.  
Presley, L. L., Wei, B., Braun, J., & Borneman, J. (2010). Bacteria associated with 
immunoregulatory cells in mice. Applied and Environmental Microbiology, 76(3), 936–941.  
Pribul, P. K., Harker, J., Wang, B., Wang, H., Tregoning, J. S., Schwarze, J., & Openshaw, P. J. 
M. (2008). Alveolar Macrophages Are a Major Determinant of Early Responses to Viral 
Lung Infection but Do Not Influence Subsequent Disease Development. Journal of 
Virology, 82(9), 4441–4448.  
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & 
Locksley, R. M. (2010). Systemically dispersed innate IL-13-expressing cells in type 2 
immunity. Proceedings of the National Academy of Sciences, 107(25), 11489–11494.  
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, S., Manichanh, C., … Yang, H. (2010). A 
human gut microbial gene catalog established by metagenomic sequencing. Nature, 
464(7285), 59–65. 
Quince, C., Lanzen, A., Davenport, R. J., & Turnbaugh, P. J. (2011). Removing Noise From 
Pyrosequenced Amplicons. BMC Bioinformatics, 12(1), 38. 
Ramanan, D., Bowcutt, R., Lee, S. C., Tang, M. S., Kurtz, Z. D., Ding, Y., … Lim, P. (2016). 
Helminth infection promotes colonization resistance via type 2 immunity, 3229(April), 1–9.  
Rausch, S., Held, J., Fischer, A., Heimesaat, M. M., Kühl, A. A., & Hartmann, S. (2013). Small 
Intestinal Nematode Infection of Mice Is Associated with Increased Enterobacterial Loads 
alongside the Intestinal Tract. PloS One, 8(9), 1–13.  
Reece, J. J., Siracusa, M. C., Southard, T. L., Brayton, C. F., Urban, J. F., & Scott, A. L. (2008). 
Hookworm-induced persistent changes to the immunological environment of the lung. 
Infection and Immunity, 76(8), 3511–3524.  
Reynolds, L. a, Smith, K. a, Filbey, K. J., Harcus, Y., Hewitson, J. P., Redpath, S. a, … Maizels, 
R. M. (2014). Commensal-pathogen interactions in the intestinal tract. Gut Microbes, 5(4), 
522–532. 
Roberfroid, M. (2007). Prebiotics : The Concept Revisited 1 , 2. The Journal of Nutrition, 
137(1), 830S–837S.  
Round, J. L., O’Connell, R. M., & Mazmanian, S. K. (2010). Coordination of tolerogenic 
immune responses by the commensal microbiota. J Autoimmun., 34(3), J220–J225.  
 
180 
 
Ruckwardt, T. J., Malloy, A. M. W., Morabito, K. M., & Graham, B. S. (2014). Quantitative and 
Qualitative Deficits in Neonatal Lung-Migratory Dendritic Cells Impact the Generation of 
the CD8+ T Cell Response. PLoS Pathogens, 10(2).  
Rutayisire, E., Huang, K., Liu, Y., & Tao, F. (2016). The mode of delivery affects the diversity 
and colonization pattern of the gut microbiota during the first year of infants’ life: a 
systematic review. BMC Gastroenterology, 16(1), 86.  
Salzman, N. H., Underwood, M. A., & Bevins, C. L. (2007). Paneth cells, defensins, and the 
commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. 
Seminars in Immunology, 19(2), 70–83.  
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, 
F., … Di Santo, J. P. (2008). Microbial Flora Drives Interleukin 22 Production in Intestinal 
NKp46+ Cells that Provide Innate Mucosal Immune Defense. Immunity, 29(6), 958–970.  
Schaub, B., Liu, J., Höppler, S., Schleich, I., Huehn, J., Olek, S., … von Mutius, E. (2009a). 
Maternal farm exposure modulates neonatal immune mechanisms through regulatory T 
cells. The Journal of Allergy and Clinical Immunology, 123(4), 774–82.e5.  
Schaub, B., Liu, J., Höppler, S., Schleich, I., Huehn, J., Olek, S., … von Mutius, E. (2009b). 
Maternal farm exposure modulates neonatal immune mechanisms through regulatory T 
cells. The Journal of Allergy and Clinical Immunology, 123(4), 774–82.e5.  
Schnupf, P., Gaboriau-Routhiau, V., Gros, M., Friedman, R., Moya-Nilges, M., Nigro, G., … 
Sansonetti, P. J. (2015). Growth and host interaction of mouse segmented filamentous 
bacteria in vitro. Nature, 520(7545), 99–103.  
Schuijs, M. J., Willart, M. A., Vergote, K., Gras, D., Deswarte, K., Ege, M. J., … Hammad, H. 
(2015). Farm dust and endotoxin protect against allergy through A20 induction in lung 
epithelial cells. Science, 349(6252). 
Schumacher, A., & Zenclussen, A. C. (2014). Regulatory T cells: Regulators of life. American 
Journal of Reproductive Immunology, 72(2), 158–170.  
Schwandner R, Dziarski R, Wesche H, Rothe M, K. C. (1999). Peptidoglycan-and lipoteichoic 
acid-induced cell activation is mediated by toll-like receptor 2. Journal of Biological …, 
274(25), 17406–17409.  
Scott, F. W. (1996). Food-induced type 1 diabetes in the BB rat. Diabetes/Metabolism Reviews, 
12(4), 341–359. http://doi.org/10.1002/(SICI)1099-0895(199612)12:4<341::AID-
DMR173>3.0.CO;2-O 
Shamri, R., Xenakis, J. J., & Spencer, L. A. (2011). Eosinophils in innate immunity: An evolving 
story. Cell and Tissue Research, 343(1), 57–83.  
Shapiro, H., Thaiss, C. a, Levy, M., & Elinav, E. (2014). The cross talk between microbiota and 
the immune system: metabolites take center stage. Current Opinion in Immunology, 30, 54–
62.  
 
181 
 
Shea-Donohue, T., Sullivan, C., Finkelman, F. D., Madden, K. B., Morris, S. C., Goldhill, J., … 
Urban, J. F. (2001). The role of IL-4 in Heligmosomoides polygyrus-induced alterations in 
murine intestinal epithelial cell function. Journal of Immunology (Baltimore, Md. : 1950), 
167(4), 2234–2239.  
Shi, C., Sahay, B., Russell, J. Q., Fortner, K. A., Hardin, N., Sellati, T. J., & Budd, R. C. (2011). 
Reduced immune response to Borrelia burgdorferi in the absence of ???? T cells. Infection 
and Immunity, 79(10), 3940–3946.  
Siegrist, C.-A. (2007). The challenges of vaccine responses in early life: selected examples. 
Journal of Comparative Pathology, 137 Suppl, S4-9.  
Siegrist, C. a. (2007). The Challenges of Vaccine Responses in Early Life: Selected Examples. 
Journal of Comparative Pathology, 137(SUPPL. 1), 4–9.  
Siegrist, C. A. (2001). Neonatal and early life vaccinology. Vaccine, 19(25–26), 3331–3346.  
Sjögren, Y. M., Tomicic, S., Lundberg, A., Böttcher, M. F., Björkstén, B., Sverremark-Ekström, 
E., & Jenmalm, M. C. (2009). Influence of early gut microbiota on the maturation of 
childhood mucosal and systemic immune responses: Gut microbiota and immune responses. 
Clinical and Experimental Allergy, 39(12), 1842–1851. 
Smith, N. L., Wissink, E., Wang, J., Pinello, J. F., Davenport, M. P., Grimson, A., & Rudd, B. D. 
(2014). Rapid proliferation and differentiation impairs the development of memory CD8+ T 
cells in early life. Journal of Immunology (Baltimore, Md. : 1950), 193(1), 177–84.  
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Ann, C., Bohlooly-y, M., … Garrett, W. 
S. (2013). The microbial metabolites, short chain fatty acids, regulate colonic Treg cell 
homeostasis, 341(6145). 
Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., & Artis, D. (2011). CD4+ 
lymphoid tissue inducer cells promote innate immunity in the gut. Immunity, 34(1), 122–
134.  
Stecher, B., Robbiani, R., Walker, A. W., Westendorf, A. M., Barthel, M., Kremer, M., … Hardt, 
W. D. (2007). Salmonella enterica serovar typhimurium exploits inflammation to compete 
with the intestinal microbiota. PLoS Biology, 5(10), 2177–2189.  
Stephania A Cormier1, You2, D., & Honnegowda1, S. (2010). The use of a neonatal mouse 
model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther, 8(12), 
1371–1380.  
Stern, A., Wold, A. E., & Östman, S. (2013). Neonatal Mucosal Immune Stimulation by 
Microbial Superantigen Improves the Tolerogenic Capacity of CD103+ Dendritic Cells. 
PLoS ONE, 8(9).  
Stevens, W. B. C., Netea, M. G., Kater, A. P., & van der Velden, W. J. F. M. (2016). ???Trained 
immunity???: Consequences for lymphoid malignancies. Haematologica, 101(12), 1460–
1468.  
 
182 
 
Suen, Y., Lee, S. M., Qian, J., Van De Ven, C., & Cairo, M. S. (1998). Dysregulation of 
lymphokine production in the neonate and its impact on neonatal cell mediated immunity. 
Vaccine, 16(14–15), 1369–1377.  
Surana, N. K., & Kasper, D. L. (2014). Deciphering the tÃate-Ã� -tÃate between the microbiota 
and the immune system. The Journal of Clinical Investigation, 124(10), 4197–4203.  
Tanaka, S., Kobayashi, T., Songjinda, P., Tateyama, A., Tsubouchi, M., Kiyohara, C., … 
Nakayama, J. (2009). Influence of antibiotic exposure in the early postnatal period on the 
development of intestinal microbiota. FEMS Immunology and Medical Microbiology, 56(1), 
80–87.  
Tannock, G. W., Lawley, B., Munro, K., Pathmanathan, S. G., Zhou, S. J., Makrides, M., … 
Hodgkinson, A. J. (2013). Comparison of the compositions of the stool microbiotas of 
infants fed goat milk formula, cow milk-based formula, or breast milk. Applied and 
Environmental Microbiology, 79(9), 3040–3048. 
Thompson, M. R., Kaminski, J. J., Kurt-Jones, E. A., & Fitzgerald, K. A. (2011). Pattern 
recognition receptors and the innate immune response to viral infection. Viruses, 3(6), 920–
940. 
Tian, C., Kron, G. K., Dischert, K. M., Higginbotham, J. N., & Crowe, J. E. (2006). Low 
expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 
receptor complex in human neonatal B cells. Immunology, 119(1), 54–62.  
Tomkovich, S., & Jobin, C. (2015). Microbiota and host immune responses: a love-hate 
relationship. Immunology, n/a-n/a. 
Tormo-Badia, N., Håkansson, Å., Vasudevan, K., Molin, G., Ahrné, S., & Cilio, C. M. (2014). 
Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and 
intestinal immunological changes in the offspring. Scandinavian Journal of Immunology, 
80(4), 250–60. 
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003). The IL-12 family of heterodimeric 
cytokines: New players in the regulation of T cell responses. Immunity, 19(5), 641–644.  
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., … 
Marsland, B. J. (2014). Gut microbiota metabolism of dietary fiber influences allergic 
airway disease and hematopoiesis. Nature Medicine, 20(2), 159–66.  
Troy, E. B., & Kasper, D. L. (2010). Beneficial effects of Bacteroides fragilis polysaccharides on 
the immune system. Frontiers in Bioscience (Landmark Edition), 15(8), 25–34.  
Tsuji, M., Suzuki, K., Kinoshita, K., & Fagarasan, S. (2008). Dynamic interactions between 
bacteria and immune cells leading to intestinal IgA synthesis. Seminars in Immunology, 
20(1), 59–66. 
Turroni, F., Peano, C., Pass, D. A., Foroni, E., Severgnini, M., Claesson, M. J., … Ventura, M. 
(2012). Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE, 7(5), 20–
24.  
 
183 
 
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., … Pamer, E. G. (2010). 
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by 
antibiotic treatment in mice and precedes bloodstream invasion in humans. Conflict, 
120(12).  
ULRICH H. VON ANDRIAN, A. C. R. M. . (2000). T-C ELL F UNCTION AND M 
IGRATION. New England Journal of Medicine. 
Upham, J. W., Lee, P. T., Holt, B. J., Heaton, T., Prescott, S. L., Sharp, M. J., … Holt, P. G. 
(2002). Development of interleukin-12-producing capacity throughout childhood. Infection 
and Immunity, 70(12), 6583–6588. 
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & 
Finkelman, F. D. (1998). IL-13, IL-4Rα, and Stat6 Are Required for the Expulsion of the 
Gastrointestinal Nematode Parasite Nippostrongylus brasiliensis. Immunity, 8(2), 255–264.  
VAN Panhuys, N., Camberis, M., Yamada, M., Tegoshi, T., Arizono, N., & LE Gros, G. (2013). 
Mucosal trapping and degradation of Nippostrongylus brasiliensis occurs in the absence of 
STAT6. Parasitology, (May), 1–11.  
Vantourout, P., & Hayday, A. (2013). Six-of-the-best: unique contributions of γδ T cells to 
immunology. Nature Reviews Immunology, 13(2), 88–100.  
Verhasselt, V., Milcent, V., Cazareth, J., Kanda, A., Fleury, S., Dombrowicz, D., … Julia, V. 
(2008). Breast milk-mediated transfer of an antigen induces tolerance and protection from 
allergic asthma. Nature Medicine, 14(2), 170–175.  
Virella, G., Silveira Nunes, M. A., & Tamagnini, G. (1972). Placental transfer of human IgG 
subclasses. Clinical and Experimental Immunology, 10(3), 475–8.  
Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., … Nieuwdorp, M. (2014). 
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. 
Journal of Hepatology, 60(4), 824–31. 
Wadhwa, P. D., Buss, C., Entringer, S., & James M. Swanson. (2009). Developmental Origins of 
Health and Disease: Brief History of the Approach and Current Focus on Epigenetic 
Mechanisms, 27(5), 358–368.  
Walker, J. C., Smolders, M. A. J. C., Gemen, E. F. A., Antonius, T. A. J., Leuvenink, J., & De 
Vries, E. (2011). Development of Lymphocyte Subpopulations in Preterm Infants. 
Scandinavian Journal of Immunology, 73(1), 53–58.  
Walther, D. J. (2003). Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform. 
Science, 299(5603), 76–76.  
Wegienka, G., Havstad, S., Zoratti, E. M., Kimberley, J., Bobbitt, K. R., Ownby, D. R., & Cole, 
C. (2009). Regulatory T Cells in Prenatal Blood Samples: Variability with Pet Exposure and 
Sensitization. Journal of Reproductive Immunology, 81(1), 74–81.  
 
 
184 
 
Welliver, R. C. (2003). Respiratory syncytial virus and other respiratory viruses. Pediatr Infect 
Dis J, 22(2 Suppl), S6-10–2.  
Welliver, T. P., Garofalo, R. P., Hosakote, Y., Hintz, K. H., Avendano, L., Sanchez, K., … 
Welliver, R. C. (2007). Severe human lower respiratory tract illness caused by respiratory 
syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic 
lymphocyte responses. The Journal of Infectious Diseases, 195(8), 1126–36.  
WHO. (2001). Health and Nutritional Properties of Probiotics in Food including Powder Milk 
with Live Lactic Acid Bacteria. Fao & Who, (October), 1–34.  
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. 
(2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood 
metabolites. Proceedings of the National Academy of Sciences of the United States of 
America, 106(10), 3698–703.  
Willems, F., Vollstedt, S., & Suter, M. (2009). Phenotype and function of neonatal DC. 
European Journal of Immunology, 39(1), 26–35. 
Woodburn, P. W., Muhangi, L., Hillier, S., Ndibazza, J., Namujju, P. B., Kizza, M., … Elliott, A. 
M. (2009). Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, 
Uganda. PLoS Neglected Tropical Diseases, 3(6), e473.  
Wynn, Ofer Levy., J. L. (2014). A Prime Time for Trained Immunity: Innate Immune Memory 
in Newborns & Infants. Neonatology, 72(2), 181–204.  
Yanofsky, C. (2004). The different roles of tryptophan transfer RNA in regulating trp operon 
expression in E. coli versus B. subtilis. Trends in Genetics, 20(8), 367–374.  
Yasmine Belkaid, S. N. (2013). Compartmentalized and systemic control of tissue immunity by 
commensals, 72(2), 181–204.  
Yatich, N. J., Yi, J., Agbenyega, T., Turpin, A., Rayner, J. C., Stiles, J. K., … Jolly, P. E. (2009). 
Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence 
and risk factors. The American Journal of Tropical Medicine and Hygiene, 80(6), 896–901.  
Yoshiyuki Goto, Casandra Panea, Gaku Nakato, Anna Cebula, Carolyn Lee, M., & Galan Diez, 
Terri M. Laufer, Leszek Ignatowicz,  and I. I. I. (2014). Segmented filamentous bacteria 
antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. 
Changes, 29(6), 997–1003.  
Young, S. (2013). Acute tryptophan depletion in humans: a review of theoretical, practical and 
ethical aspects. Journal of Psychiatry & Neuroscience, 38(5), 294–305.  
Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z., & Forney, L. J. (2012). Evaluation of methods for 
the extraction and purification of DNA from the human microbiome. PLoS ONE, 7(3).  
Zaiss, M. M., Rapin, A., Lebon, L., Junt, T., Marsland, B. J., & Harris Correspondence, N. L. 
(2015). The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate 
Allergic Inflammation. Immunity, 1–13.  
 
185 
 
Zakrzewski, M., Proietti, C., Ellis, J. J., Hasan, S., Brion, M.-J., Berger, B., & Krause, L. (2016). 
Calypso: a user-friendly web-server for mining and visualizing microbiome–environment 
interactions. Bioinformatics, 9(December 2016), 2261–2274.  
Zhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L., & Pickles, R. J. (2002). Respiratory 
Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized , Specific to 
Ciliated Cells , and without Obvious Cytopathology Respiratory Syncytial Virus Infection 
of Human Airway Epithelial Cells Is Polarized , Specific to Ciliated. Journal of Virology, 
76(11), 5654–5666.  
Zhao, A., Morimoto, M., Dawson, H., Elfrey, J. E., Kathleen, B., Gause, W. C., … Shea-
donohue, T. (2007). Immune Regulation of Protease-Activated Receptor-1 Expression in 
Murine Small Intestine during Nippostrongylus brasiliensis Infection, 175(4), 2563–2569. 
Zhao, D., Su, H., Cheng, J., Wang, X., Xie, M., Li, K., … Yang, H. (2015). Prenatal antibiotic 
use and risk of childhood wheeze/asthma: A meta-analysis. Pediatric Allergy and 
Immunology, 26(8), 756–764.  
Zheng, S. G. (2013). Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the 
mutually exclusive? American Journal of Clinical and Experimental Immunology, 2(1), 94–
106. 
Zhou, J., He, Z., Yang, Y., Deng, Y., Tringe, S. G., & Lisa Alvarez-Cohenc. (2015). High-
Throughput Metagenomic Technologies for Complex Microbial Community Analysis: 
Open and Closed Formats. CEUR Workshop Proceedings, 1542(1), 33–36.  
 
 
 
 
 
 
 
 
 
 
 
 
186 
